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Abstract 
The tetraazatriphenylene chromophore, dpqC, efficiently sensitises europium(III) and 
terbium(III) emission. It has been incorporated into a series of ligands, based on the 
cyclen macrocycle, which saturate the coordination sphere of the metal ion and lead to 
complexes that exhibit high luminescent quantum yields in aerated aqueous media of the 
order of 15 - 50 0/0, with long emission lifetimes of the order of milliseconds. Dynamic 
quenching of the lanthanide excited state occurs with electron-rich donors (e.g. urate, 
ascorbate and iodide). The high efficiency of S I to T I intersystem crossing and the low 
susceptibility of the aryl triplet excited state to quenching by molecular oxygen, allowed 
an assessment to be made of the deactivation of the lanthanide excited state through a 
charge-transfer mechanism. Comparison has been drawn between structurally related 
complexes of differing charge and lipophilicity. Terbium(III) complexes were shown to 
be more strongly quenched than their europium(III) analogues. The order of sensitivity 
to quenching generally followed the ease of oxidation of the quenching anion, but urate 
was anomalous. In each case, it was shown to quench by an order of magnitude more 
strongly than ascorbate, despite having a redox potential of 0.59 V, compared to 0.30 V 
for ascorbate. These differences have been exploited in the development of a ratiometric 
assay for the detennination of uric acid concentration in biological samples. 
The complexes have been shown to be taken up by a number of eukaryotic cell lines and 
are amenable to time resolved fluorescence microscopy. The cationic and lipophilic 
complexes give brighter images 'in cellula' than their neutral and anionic analogues. 
However, detennination of the intracellular lanthanide concentration has revealed that 
the complexes are taken up to a similar extent. By relating the structure of the complexes 
to their uptake and localisation profiles, it should be possible to design complexes for 
specific intracellular applications, for example, as probes or components in biological 
assays. 
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Introduction 
Chapter 1 - Introduction 
1 Introduction 
Luminescent lanthanide complexes demonstrate a huge potential to complement and 
extend the current range of tags and probes that are available for the analysis of 
living biological systems. Our understanding of their unique photophysical properties 
and how these can be exploited through careful ligand design allows for the targeted 
synthesis of complexes for specific applications. 
1.1 Luminescence Properties of the Lanthanides 
Lanthanide ions exhibit line-like absorption and emISSIOn spectra that are 
characteristic of their 4f electronic configurations; the 4f oritals are effectively 
shielded by filled 5p66s2 energy levels and 4f-4f transitions are forbidden by electric 
dipole selection rules leading to low molar absorbance coefficients « 3 M- 1 S-I), but 
long natural luminescence lifetimes. The contracted nature of these orbitals results in 
emission spectra that do not significantly broaden or shift in wavelength upon 
complexation: ligand field splittings are typically small, with values of the order of 
100 cm- I. The difference between the lowest lying excited state of the metal ion and 
the sub-levels of its ground state defines in which region of the spectrum the 
lanthanide will emit. (Figure 1.1) 
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Figure 1. 1 - Partial energy diagram for the lanthanide aqua ions. Red lines indicate the main emissive 
levels, blue lines the ground state. 
Europium(III), terbium(III), samarium(III) and dysprosium(III) complexes are all 
emissive in the visible region with energy gaps between the lowest emissive state and 
the ground-state manifold, Llli = 12 300 CDo ---+ 7F6), 14 800 CD4 ---+ 7Fo), 7 400 
(4GS12 ---+ 6F 1112) and 7 850 (4F9/2 ---+ 6F312) cm- l respectively.l In order for a compound 
to be useful in luminescence based applications, it is necessary to maximise the 
quantum yield of emission i.e. to minimise non-radiative deactivation pathways such 
as quenching through interaction with vibrational transitions of proximate molecular 
oscillators (e.g. O-H) and bound ligands? The larger the energy gap between the 
ground and emissive state of the lanthanide ion, the less efficient these processes will 
be. Hence, it is not surprising that the majority of examples of luminescent 
lanthanide probes in the literature focus on europium(III) and terbium(III). I Some 
interest has also been shown in samarium(III) and dysprosium(III) complexes in the 
development of dual luminescent time-resolved immunoassays.3 Apart from 
gadolinium(III), all of the remaining lanthanides have low emissive quantum yields 
in aqueous solution. Gd(III) emits in the UV, and is not useful as a luminescent probe 
for bioanalysis since the aromatic components of most biologically relevant 
molecule either absorb or emit in this region. Neodymium(III) holmium(III) 
erbium(IlI) and ytterbium(III) are interesting since they emit in the near-IR (NIR) 
3 
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spectral range: a range in which biological tissue is relatively transparent.4,5 They 
have also found applications in the construction of lasers and telecommunications 
devices.] 
1.1.1 Sensitised Emission 
4f -4f Transitions are Laporte (parity) and, in some cases also, spin forbidden. As a 
result they have very low molar absorption coefficients (£ < 1 M- I em-I) and are 
made only partially allowed through coupling with vibrational states, through J-
mixing and mixing with opposite parity wavefunctions. The extent of shielding of the 
4f orbital by the 6s and 5d orbitals and its contracted nature mean that the strength of 
these interactions is weak. 
Excitation through the use of a high intensity source such as a laser is possible, but is 
not practicable if these compounds are to reach widespread applications as probes or 
sensors for biological systems. An alternative solution, which allows the use of lower 
intensity light, is sensitised emission whereby the excited state is reached following 
energy transfer from the triplet level of a suitable chromophore. (Figure 1.2) 
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Figure 1. 2 - Jablonski diagram showing the indirect excitation of a lanthanide ion via an 
organic chromophore 
A photon is first absorbed by the sensitiser, raising it to a vibrationally excited level 
of the SI band. Relaxation may occur through either non-radiative vibrational 
relaxation to the lowest level of the S I band followed by sensitiser fluorescence or by 
intersystem crossing to the triplet, T I, band. From the T I state there are three 
competing processes: back intersystem crossing to the S I state; sensitiser 
phosphorescence; energy transfer to the lanthanide excited states. If the chromophore 
has a high molar absorption coefficient and the intersystem crossing and energy 
transfer processes are efficient, then the "'effective" molar absorption coefficient of 
the metal is greatly increased and intense emission can be observed following 
excitation with conventional light sources. 
For efficient sensitisation, the triplet energy of the chromophore should be slightly 
higher (> 1700 cm- I) than the lanthanide emissive state eDo Eu = 17 240 cln·', 5D4 
Tb = 20 400 cm· I). If the energy difference is too small i.e. less than 1500 cm· 1 then 
thermally activated back energy transfer can occur leading to both a reduction in the 
emission intensity and lifetime. For europium, a photoinduced electron transfer from 
the chromophore to the metal can occur owing to the ease of reduction of Eu(lII) to 
5 
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Eu(II). This process often deactivates the singlet excited state of the sensitiser in a 
non-radiative way, thus reducing its efficiency as a sensitiser. 
1.1.1.1 Mechanism of Energy Transfer6 
There are two main classes of electronic energy transfer mechanism, radiative and 
non-radiative. Both the radiative and non-radiative processes rely on overlap between 
the emission spectrum of the donor and the absorption spectrum of the acceptor. 
Radiative energy transfer involves the donor emitting light that is subsequently re-
absorbed by the acceptor. This mechanism is favoured where the overlap is good and 
the quantum yield of emission of the donor and the light absorbing properties of the 
acceptor are maximised. For sensitised lanthanide emission, whilst there is good 
overlap between the chromophore triplet energy and the metal luminescent level, the 
low Ln(III) molar absorption coefficient makes this process unlikely. 
A number of different mechanisms have been considered in an attempt to understand 
a non-radiative sensitiser-Ianthanide energy transfer process. In principle, energy 
transfer can occur either from the chromophore singlet or triplet excited states; in 
most cases only the latter case is significant,7 although some examples of direct 
energy transfer from the ligand first singlet excited state to the higher levels of 
europium(III) and terbium(III) ions have been reported in cases where the triplet 
state of the ligand lies below the emissive level of the metal. 8, 9 There are three 
mechanisms that are usually invoked for the energy transfer from the lowest band of 
the triplet manifold to the lanthanide(lIl) ion: i) the exchange (Dexter) mechanism; 
ii) a dipole-dipole (Forster) mechanism; iii) a dipole-multipole mechanism. 
The exchange mechanism (Figure 1.3) involves mutual electron exchange between 
the sensitiser and acceptor, with conservation of multiplicity of the system. For this 
to occur the dectronic orbitals of the donor and acceptor species must overlap. 
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The rate of energy transfer decreases exponentially with increasing separation 
between the donor and acceptor, RDA. 
Thc dipole-dipole and dipole-multipole mechanisms are through-space interactions 
between the electronic dipole moments of the sensitiser triplet state and the 
lanthanide 4f orbitals. The rate of energy transfer via the Forster mechanism exhibits 
a distance dependence of lIROA 6. 
1.1.1.2 Alternative Routes to Sensitised Emission 
Coordination of an orgamc chromophore with a suitable triplet energy to a 
lanthanide(lII) ion is by far the most studied and well understood technique for 
sensitising emission. However, several other techniques have been demonstrated; the 
first requires the presence of available charge transfer states and as such is only valid 
for lanthanides that are able to accept electrons. This is true for Sm(III), Eu(III) and 
Yb(llI) and involves transfer from a ligand-to-metal charge transfer (LMCT) state 
provided that it is of sufficient energy. Common examples involve the insertion of 
these compounds into inorganic matrices I; the second example relies on energy 
transfer from a transition metal. One example from Bunzli et al involves the use of 
Cr(lll) both to sensitise Nd and Yb and to extent the lifetime of their emission into 
the millisecond range. 10 There are a number of other examples where transition metal 
complexes have been used to sensitise NIR emissive lanthanides mostly involying 
energy transfer from metal-to-ligand charge transfer (MLCT) states (e.g. through 
coordination of the Nd(lll). Er(l II) or Yb(lI I) to complexes of Ru( II), Re(l L Os(l I) or 
7 
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Pt(II) 1 1-13; a final mechanism has been demonstrated by Faulkner et af where 
lanthanide complexes have been used to sensitise lanthanide emission, in this case Tb 
complexes being used to sensitise Yb emission. 14 
1.1.2 Minimising Competing De-activation Pathways 
ligand fluorescence 
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energy 
kern transfer 
hv klsc kET 
lanthanide 
luminescence 
sens-Ln 
kem 1 hv" 
sens-Ln • 1sens-Ln---. 3sens-Ln" .... sens-Ln* 
kBET .• / \~ 
kq,,[X7 k'ET' 
, ~ 
absorption / \ 
keT kq[Q] 
~ ~ , 
Figure 1. 4 - A diagram to show the competing deactivation pathways for sensitised lanthanide 
emission 
The efficiency of energy transfer or emissive processes is usually expressed in terms 
of their quantum yields. For the case of sensitised lanthanide emission, we define the 
luminescence quantum yield as the ratio of the number of photons emitted through 
lanthanide luminescence to the number absorbed by the sample. This value is the 
product of the quantum yields of each of the individual energy transfer steps 
involved in reaching the lanthanide emissive state. Figure 1.4 depicts possible 
deactivation pathways for a lanthanide ion sensitised by an organic chromophore. 
There are three excited states that may be perturbed: the chromophore singlet and 
triplet states, and the lanthanide emissive state. In order to maximise the quantum 
yield, it is necessary to have fast intersystem crossing between the chromophore 
singlet and triplet levels and a high rate of energy transfer from the chromophore to 
the lanthanide. More particularly, the rates should be high when compared to those 
for competitive deactivation, through either radiative processes such as chromophore 
fluorescence or phosphorescence, or radiationless decay via electron/energy transfer 
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or by interaction with molecular quenching speCIes. Examples of such processes 
include singlet state quenching by halide anions or by Eu(IlI) ions and triplet 
quenching by oxygen.32-34 In addition to a high quantum yield, it is also desirable that 
the sensitising moiety should possess a high molar absorption coefficient to 
maximise the light output per unit concentration of sample. 
1.1.2.1 Vibrational Quenching of Lanthanide Excited States 
Lanthanide emISSIve states are strongly susceptible to non-radiative deactivation 
through interaction with molecular vibrational modes. In general, quenching by 
bound and closely diffusing O-H oscillators (e.g. water molecules) is most efficient, 
but N-H, C-H and c=o stretching vibrations may also have a significant effect. 16 A 
particular harmonic of an X-D oscillator (X = 0, N, C) is at lower energy than its 
corresponding X-H equivalent; as a result the Franck-Condon overlap factor with the 
metal emissive state is less favourable. It was demonstrated some time ago that 
quenching of europium complexes observed in H20 is greatly reduced in D20. 16, 17 
Similarly, lanthanide ions with a comparatively larger energy gap between their 
ground and lowest energy excited states are less efficiently quenched; this accounts 
for the observation that terbium(lll) complexes typically have higher emissive 
quantum yields than europium(lII) complexes with the same ligand (Figure 1.5). 
9 
Chapter 1 - Introduction 
x 1000 cm~l x 1000 cm-1 
30 - Eu
3+ Tb3+ 
H2O D20 H2O 
- 30 
sIr, 5G6 
25- 5L6 5D3 
- 25 
v=5 v=7 v=5 5D 2 v=6 
20- - 5D4 5D v=4 v=4 20 -
.1 v=:=5 
-
5Do 
v=3 v=4 v=3 
15 -
- 15 
v=3 
v=2 v=2 
10- v=:2 
v=l v = 1 - 10 
v=l 
7P6 v=o v=o v=o 7F 5- 0 
- 5 
7F4 7F4 
0 7FO 7F6 0 
Figure 1. 5 - Energy level diagram showing correlation between the vibrational harmonic 
overtones of H20 and D20 relative to the emissive 5DO and 5D4 states of europium and terbium 
respectively 
Experimentally, the lower susceptibility of a complex to quenching in D20 compared 
to H20 is observed as an increase in lifetime and intensity of the metal-centred 
emission. The inverse of the emissive lifetime defines the rate constant for 
depopulation of the lanthanide excited state. Equations have been derived that allow 
the number of water molecules, q, directly coordinated to Nd(IlI), Sm(Ill), Eu(IlI), 
Tb(Ill) and Yb(Ill) lanthanide centres to be calculated; this is done through 
comparison between the rate constants for a given complex in H20 and D20.18-21 The 
basic assumptions of these relationships are that X-D oscillators do not contribute to 
de-activation and that all other competing pathways are the same in both D20 and 
water (however a number of correction factors are necessary). 
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The relationships have the general form: 
A 
B 
C 
The number of unbound water molecules 
The rate of deactivation of the lanthanide excited state in H20 
The rate of deactivation of the lanthanide excited state in 0 20 
A proportionality constant that scales the difference between the rate 
constants in 0 20 and H20 to account for the relative sensitivity of the 
particular lanthanide. 
A correction factor to account for quenching by bound and closely 
diffusing oscillators: most importantly O-H, but depending upon the 
lanthanide, the effect of N-H (amine and amide) and C-H oscillators 
should also be taken into account; in the latter two cases care must be 
taken to establish whether HID exchange has occurred. B has the 
same units as k 
A further experimentally determined correction term to account for 
other Ln-dependent factors. 
Quenching by O-H oscillators is predominant in aqueous media and the multipole-
multipole mechanism that is thought to operate has a distance dependence of r-6 
(where r is the distance between the energy donor and acceptor). Therefore, bound 
water molecules display the strongest effect. However, in order to obtain accurate q 
values, it is necessary to make corrections for contributions due to outer-sphere O-H 
quenching and deuterium exchangeable X-H oscillators, within the ligand structure. 
The effect of second- and outer-sphere water molecules has been determined through 
analysis of a series of well characterised cyclen complexes that have been shown by 
X-ray crystallographic data to have no bound water molecules within their 
coordination sphere. 19 By comparing the radiative rate constants of complexes with 
the same ligand but different lanthanide ions in both H20 and D~O, an estimate can 
be made of the relati\c contribution of unbound O-H oscillators. The use of a number 
I I 
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of ligands of varying lipophilicity has been used to support the validity of these 
correction factors. As would be predicted from the difference in energy gap between 
their emissive state and ground state manifold, it follows that the order of 
sensitivities is Yb > Eu > Tb (correction factors are - 0.20 f.lS·I, - 0.25 ms·1 and -
0.06 ms·1 respectively). I 8, 19 
The quenching effect of other X-H oscillators needs to be taken into account only if 
they readily undergo HID exchange. The use of amide based ligands is common with 
lanthanides: Eu(III) and Yb(III) centres are able to act as a charge sink, so that the N-
H bonds of coordinated amide groups are able to undergo rapid HID exchange 
(Figure 1.6). In contrast, for the other lanthanides where a 2+ oxidation state is of 
considerably higher energy, rates ofNHIND exchange may be much slower. 
l~ 
.. 
Figure 1. 6 - Base catalysed NH/ND exchange of coordinated amide NH bonds in Eu and Vb 
complexes, aided by the metal centre acting as a charge sink.19 
In practice, correction is usually only necessary for europium complexes, since for 
ytterbium the quenching effect of N-H oscillators is small compared to the effect of 
proximate O-H oscillators. Comparison of a large number of tetraamide europium 
complexes has allowed the definition of the average quenching effect of an 
individual bound amide oscillator to be assessed as 0.075 ms· l . 
An example of the application of the general expression is provided in Chapter 2. 
1.2 Ligand Design 
Thc europium(I II) and terbium(I II) complexes that are the subject of the current 
\\'ork are intended for ill cd/ll/o fluorescence based applications as probes or as 
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components of biological assays. A number of factors need to be taken into 
consideration in the design of appropriate ligands which are considered in detail. 
1.2.1 The Choice of Chromophore 
As discussed in Section 1.1.1, due to the low molar absorption coefficients of the 
lanthanides « I M-I em-I), it is essential that a suitable sensitiser should be inserted 
into the ligand structure. The most important requirement is that the chromophore 
should have a high molar absorption coefficient at an excitation wavelength suitable 
for the intended application; for single photon excitation of biological samples this 
should be in the range 337 - 420 nm. The lower limit is set by the poor transparency 
of biological tissue to ultraviolet radiation and the harmful effects it has on live cells 
in microscopy; excitation in this range also obviates the need for quartz optics. The 
upper limit is defined by the excited state energies of the lanthanides. The 5Do 
europium(lII) and 5D4 terbium(lII) excited states lie at 17200 and 20400 cm-I 
respectively; the triplet energy of the chromophore should be at least 1500 cm- I 
greater than the terbium 5D4 state so as to prevent thermally activated back energy 
transfer. Generally, a requirement for such large triplet energies is that the 
chromophore S I - T I energy gap should be as small as possible. Excitation 
wavelengths that are particularly interesting are those that correspond to readily 
available laser lines (337, 355 or 405 nm for Eu/Tb), or those that are close in energy 
to the growing range of powerful light emitting diodes (e.g. 365 or 390 nm).24 
In order to get efficient energy transfer to the lanathanide ion, the triplet state of the 
chromophore should be readily populated. This is achieved through having a fast rate 
of intersystem crossing compared to the rates of either radiative deactivation (i.e. 
fluorescence) or non-radiative decay processes. Furthermore, energy transfer is 
distance dependent and so the maximum quantum efficiency is achieved when the 
sensitiser-Ianthanide distance is minimised. This is achieved through the use of a 
chromophore that can coordinate directly to the metal centre. 
l3 
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In recent years work In the Parker lab has focused on the use of 
tetraazatriphenylenes,24-26 azaxanthones and azathiaxanthones24, 27-28 but there are a 
number of other suitable examples, in particular those based on bi- and tri-pyridyls 
and their N-oxides.29-31 
1.2.2 The Use of Macrocycles 
The interactions between lanthanide ions and their ligands are mostly electrostatic. If 
a complex is to be used in any biological medium then there are significant 
concentrations of potentially competitive ligating molecules to consider (e.g. 
proteins, phospho-anions). In order to prevent metal ion dissociation it is essential 
that the complex should display high kinetic and thermodynamic stability, over a 
wide range of pH. 
Lanthanide ions have high coordination numbers (8 or 9) and in aqueous solution are 
fully hydrated. Oxygen is a strong a-donor and water is a good ligand for the 
lanthanides, often the enthalpy of bond formation does not fully compensate for the 
enthalpy of dehydration. A favourable Gibbs free energy term is still possible if there 
is a sufficient entropy change; this can be achieved through the use of a polydentate 
and in particular a macrocyclic ligand. Further stability can be provided by the 
incorporation of groups that provide strong electrostatic bonds by charge 
compensation upon complexation and the formation of stable 5 or 6 membered 
chelate rings. 
1.2.3 Further considerations of Ligand Design 
Further to the basic requirements that the ligand should be macrocyclic and 
incorporate a suitable chromophore, the design can be extended to include additional 
functionality through which the complex can be linked to another chemical 
compound or biological moiety. For example, to some fonn of targeting vector to be 
used for in cellular studies through coordination to an antibody or other component 
l-f 
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in a fluorescence assay. [Much work has been carried out by Cisbio international in 
France towards the development of europium cryptates for use in heterogeneous time 
resolved fluorescence assays].30 
1.2.4 Tetraazatriphenylenes: Highly Efficient Sensitisers for 
Europium and Terbium Emission 
Figure 1. 7 Examples of tetraazatriphenylene chromophores dpq (left), dpqC (right) 
Dipyrido[3,2-f:2',3' -h ]quinoxaline (dpq) and 10,11,12, 13-tetrahydrodipyrido[3,2-
a:2',3'-c]phenazine (dpqC) (Figure 1.7) are excellent antenna chromophores.3Ia, 31b 
They absorb at 340 and 348 nm respectively; in both cases, their quantum yields of 
triplet formation are close to unity; They both have triplet state energies of about 
23500 em-I (dpq 23800, dpqC 23400) which is sufficiently high for energy transfer 
to the emissive states of Eu(lll) (17500 em-I) and Tb(lll) (20400 em-I); They are 
reasonably strong ligands towards both Eu(lll) and Tb(lll) ions and as a result, the 
distance between donor and acceptor is small and the rate of energy transfer is high. 
The dpqC chromophore was chosen for the current work since it has a longer 
wavelength first excited triplet state and has a significantly higher molar absorption 
coefficient in aqueous media (6440 M- I em-I for dpqC cf. 3800 M-I em-I for dpq). 
1.2.5 Cyclen Based Ligand Systems31C 
1,4,7, I 0-Tetraazacyclododecane (cyclen) based ligands are commonly used with the 
lanthanides since they afford well defined complexes with high thermodynamic and 
kinetic stability with respect to metal ion dissociation. Research in Durham has 
centred on this ligand system for a number of years and. as a result. its 
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functionalisation is well understood; this is usually done by coordinating pendent 
amide, carboxylic acid or phosphinate arms to the ring nitrogen atoms. Through the 
use of appropriate protecting strategies, the ring can be either mono, di, tri or tetra 
substituted; indeed attachment of up to four different arms is achievable. However, if 
conformational rigidity and a well defined structure are important, it is necessary that 
at least three of the four arms should be the same or very similar. 
To understand the descriptions of conformation used with cyc1en based ligands the 
commonly used example is 1,4,7,1 O-tetraazacyc1ododecane-N,N' ,N" ,N'" -tetraacetic 
acid (DOT A). There are two elements of chirality that need to be defined: the 
conformation of the macrocyc1ic ring (A or 8), associated with the N-C-C-N torsion 
angle (typically ± 60°) and the orientation of the acetate arms (A or ~) associated 
with the N-C-C-O torsion angle (usually ± 30°) . 
... 
n 
Cy-~ NI Ln I) ~-4 
V N 
... 
L\ 
Figure 1. 8 DOT A conformations 
As a result there are two possible macrocyclic ring conformations (Figure 1.8), 
AAAA and bbbb, and two conformations for the acetate arms, A or ~ giving rise to 
four stereoisomers that exist as two pairs of enantiomers. The stereo isomers adopt 
either a square antiprismatic geometry (SAP) with a twist angle of approximately 40° 
between the oxygen and nitrogen planes (A(bbbb) and ~(AAAA)) or a twisted square 
antiprismatic gcomctry with a t\\ist angle of approximately -30° (i\(AAAA) and 
16 
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~(8888)). In solution, the isomers can interconvert by either ring inversion (AAAA. to 
8888) or arm rotation (A to ~). Either process alone results in a change between the 
capped SAP and TSAP geometries whereas a combination of the two gives 
interconversion between the two enantiomers (Figure 1.9). 
Ring 
Inversion 
Arm 
Rotation 
Arm 
Rotation 
o 
Ring 
Inversion 
A(ill'J...) 
Square 
Antiprism 
Twisted 
Square 
Antiprism 
Figure 1. 9 Inversion between enantiomeric pairs through arm rotation and ring inversion 
The introduction of a chiral centre (i to the ring nitrogen in tetraamide Ln(III) 
complexes imparts conformational rigidity.3 ld Ann rotation is inhibited, and ring 
inversion remains relatively slow (50 S-I at 298 K); thus, one isomer may be 
preferred in solution. The configuration of the stereocentre determines the helicity of 
the complex, and the configuration of the macrocyclic ring, with the Rand S isomers 
producing the A(i(i(i(i) and ~(MM) configurations respectively, in a regular square 
antiprismatic geometry. 
17 
Chapter 1 - Introduction 
Figure 1. 10 
For the complexes shown above (Figure 1.10) the ligand is nonadentate and has been 
shown to have no directly coordinating water molecules that cause a reduction in 
both luminescent quantum yield and lifetime by quenching of the lanthanide 
emissive state. VT IH NMR spectra of ~- and A- complexes in D20 and CD30D 
showed that only one major isomer is present in solution and circularly polarised 
luminescence spectroscopy has been used to confirm the absolute configuration of 
the complex by comparison with related systems studied crystallographically. The 
(RRR)-ligand gives rise to a A complex, and for the (SSS) enantiomer a 
~ configurateion is found. The complexes have also been shown to have the same 
geometry as their parent tetraamide complexes and to adopt a preferred square 
antiprismatic structure.26, 31 e 
Lanthanide complexes incorporating phosphinate donors possess a stereogenic centre 
at P, leading to further series of enantiomeric pairs. A full discussion of the 
stereoisomerism of cyclen-based lanthanide complexes is provided in reference 31 c. 
1.3 Luminescence Microscopy 
Fluorescence microscopy is an important tool that is used for the analysis of living 
biological systems, in particular for the imaging of live cells and the molecular 
events that occur within them. In fact technology has now reached a level where 
through the usc of an appropriate tag it is possible to monitor single molecules in real 
I S 
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time.35 Essential to the use of luminescence mteroscopy IS the availability of 
fluorescent stains, tags or probes to label particular molecules or compartments 
inside a cell or quantitatively probe the presence of specific analytes. The following 
sections will outline key microscopy techniques and the range of luminescent 
compounds that are currently in use or are in development, focusing particularly on 
luminescent lanthanide complexes. 
1.3.1 Fluorescence Microscopy - The Basics 
o 
Broadband 
Light Source 
CCD Camera 
Emission Filter 
Excitation Filter 
Beamsplitter 
Sample 
Figure I. II - Schematic of a basic fluorescence microscope 
The figure above illustrates how a conventional fluorescence microscope operates. 
An external light source provides energy that is focussed through an objecti e onto 
the sample where it is absorbed by a luminescent molecule raising this molecule to 
an excited state. Usually, a broad band excitation source (such as a Xe lamp) i u ed 
1 
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and the excitation wavelength (or range of wavelengths) is chosen through the use of 
an appropriate filter. Emission from the molecule is observed as it relaxes back to its 
ground state; the light is focussed by the objective either to the eye or onto a CCD. 
Since the emitted light is of lower energy than that absorbed by the molecule, it 
allows discrimination between the excitation and the emission signal. Practically, this 
is done through the use of a dichroic mirror inclined at 45° to the direction of the 
excitation source. The mirror is chosen such that the excitation light is reflected, 
whilst the lower energy light emitted by the sample is allowed to pass through. 
However, often the absorption and emission spectra of fluorophores are broad and 
overlap, so that some reflected or scattered excitation light can pass through the 
mirror giving a lower than optimal signal/noise ratio and hence reduced sensitivity. A 
second filter is usually used that is appropriate for the emissive range of the 
chromophore; this allows more specific selection of the wavelengths of interest.35 
Modifications to this basic system allow the luminescent emission to be characterised 
not only by its intensity, but also by its lifetime, polarisation and wavelength. Thus, it 
is possible to carry out multidimensional analysis of a system to determine 
information about the position, concentration, environment or interaction of 
1 1 . h· h 36 37 rno ecu es WIt III t at system. . 
1.3.2 Confocal Microscopy 
A problem associated with traditional fluorescence microscopy is that the images are 
often degraded by the presence of light that is emitted or scattered by features that 
are out of the plane of focus. This problem can be overcome in a number of ways: 
through the use of image processing and deconvolution software,38 through the use of 
an apotome (a commercially available attachment for most fluorescent microscopes) 
or through confocal imaging.37 
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Figure I. 12 The confocal principle 
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In a confocal microscope, both the illumination and detection systems are focussed 
on the same focal point within the sample. Out of focus light from the areas above or 
below the focal plane are simply eliminated through the use of a pinhole. The 
diagram illustrates how behind the objective lens, all of the light rays come together 
at a crossover point. The crossover point for light from the out-of-focus plane is 
above or below that for light from the in-focus plane. The insertion of a pinhole at 
the correct height allows the in-focus light to pass, but blocks nearly all of the 
dispersed light from planes that are higher or lower. Scattered light can inevitably 
still pass through the pinhole and it is for this reason that the excitation light is also 
focussed onto the focal point. If the light reaching regions above and below the focal 
plane is weak, then the intensity of scattered light will also be low. In confocal 
microscopy, the field of view is restricted to the size of the de-magnified pinhole; 
therefore, the image must be built up by scanning over the sample until the area of 
interest has been covered. Because a useful image often consists of 105 to 106 pixels, 
the time taken to record each pixel must be kept short and hence an intense source is 
necessary; this usually means that a laser must be used.38 Whilst confocal 
microscopy gives the advantage of better resolution compared to traditional wide-
field microscopy this advantage must be evaluated against the increased cost of the 
instrument and the limitations associated with the availability of a laser of 
appropriate wa\clength for the tluorophore. In addition. the light intensity at the 
focal point is \l'rV high (1\1\\'/CIll 2) and can cause strong photobleaching and 
:2 I 
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degradation of the specimen under study (above and below the focal plane). As a 
result, the light intensity should be carefully controlled so that it is of sufficient 
intensity to produce a high signal to background intensity, but should not be too high 
as to degrade the fluorescent tag or sample. 
1.3.3 Multiphoton Excitation 
The use of multiphoton excitation causes less photobleaching and damage to the 
sample than with single photon methods, since excitation is through ultrashort laser 
pulses (l0- 14 s). Whilst the laser energy is high, the sample is only illuminated for a 
very short period of time; practically this means that a much smaller area of the 
fluorescent specimen is being stimulated and consequently photobleaching only 
occurs III the focal plane.37 However, it should also be noted that multi photon 
excitation requires considerably higher laser intensities than for single photon 
methods: three photon excitation requires 5 to 10 times more laser power than for 
two photon excitation in order to observe the same intensity emission from the 
sample (exact values depend on the absorption cross section of the dye ).46 
An additional advantage of multiphoton excitation is that it allows excitation using 
light in the near-IR region of the spectrum, whilst still observing visible emission: 
biological tissue is most effectively penetrated in the range 710 - 820 nm in the near-
I R region of the spectrum. This can increase the penetration depth of luminescence 
microscopies and may allow the method to be extended to in vivo applications. 
Whilst multiphoton excitation is becoming more accessible with the development of 
new and cheaper lasers capable of producing ultrafast pulses, it is not yet practicable 
to design probes for biological systems with the sole intention of using multi photon 
methods. However, many of the europium and terbium complexes reported in the 
literature to have potential as sensors to signal the presence of analytes in solution 
require excitation in the near-UV, the use of two photon excitation could facilitate 
their use in the analysis of biological samples. 
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1.3.4 Time-Gated Detection 
detection 
window 
Time 
phosphorescent 
decay 
Figure 1. 13 Schematic showing the principle of time gated detection 
4f-4f Transitions are Laporte forbidden. As a result, the lanthanides display long 
emissive lifetimes; for europium and terbium these values are of the order of 
milliseconds, much longer than the fluorescent background emission common to 
biological samples. The difference can be used to significantly enhance signal to 
noise and signal to background intensity ratios. Experimentally, this is done using a 
pulsed excitation source and an integrating camera. The excitation source is pulsed to 
excite the sample, a delay of the order of 10 - 100 ns is then introduced, over this 
time period the background emission intensity will decay to zero whilst the 
lanthanide intensity remains high. The camera then detects only emission from the 
lanthanide: scattered light does not reach the CCD, since the excitation is off whilst 
the signal is being acquired. The use of an integrating camera allows for the use of 
lower intensity excitation, since a number of pulses and detection cycles can be used. 
1.3.5 Time-Resolved Fluorescence Microscopy36, 39 
Fluorescence lifetime imaging (FLIM) and time-resolved fluorescence anisotropy 
imaging (TR-F AIM) are two techniques that take advantage of changes in the 
lifetime of emission to provide information about the environment of a fluorophore 
that would otherwise be difficult to obtain by fluorescence intensity imaging. FLIM 
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provides a map of lifetimes over a sample, whereas TR-FAIM tells us about the 
rotational mobility of a fluorophore. 
1.3.6 Fluorescence Resonance Energy Transfer (FRET) 
FRET is a technique that is used to monitor interactions between two or more 
molecules, often for the purpose of studying specific protein-protein interactions, 
lipids, enzymes, DNA or RNA. This is done through the use of two (or more) 
different chromophores with suitably matched energy levels, such that efficient 
energy transfer can occur between them. Energy transfer is through a dipole-dipole 
mechanism and its rate constant is dependent on the distance between the two 
chromophores, the extent of overlap between the emission spectum of the donor and 
the absorption spectrum of the acceptor, the quantum yield of the donor and the 
relative orientation of the donor and acceptor. Experimentally, what is nonnally 
quoted as the FRET efficiency can be defined as the ratio of the deactivation of the 
donor by energy transfer over all of the deactivation pathways. The acceptor does not 
need to be fluorescent, its deactivation can be either radiative or non-radiative (dark 
quenching). A limitation to the technique is the requirement for a short donor-
acceptor distance. In practice, this should be in the range 2 - 8 nm.39 In combination 
with microscopy it is possible to obtain both spatial infonnation about the specific 
binding interaction and its time-course.4o 
A detailed exatnple of the use of a lanthanide complex III a homogeneous time 
rcsolved fluorescence assay is provided in chapter 2. 
1.4 Luminescent Compounds for in cellulo Fluorescence 
Based Applications 
Over the years a number of different classes of compound have been used, or have 
been suggested to have potential application as probes for imaging and sensing both 
in \';\'(} and in c('lIuto. Much of the understanding relating to the composition of cells 
and the processes that occur within them has been gained through the usc of mutant 
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fonns of green fluorescent protein (from Aequorea victoria) and from the application 
of commercially available organic dyes. More recently, the application of metal 
complexes and quantum dots has also shown promise. 51 -n 
1.4.1 Fluorescent Proteins 
TyrOO " 7 
Figure 1. 14 Structure of GFP and its Fluorophore 
The above figure displays the structure of green fluorescent protein and its 
chromophore. It is obtained from the bioluminescent jellyfish Aequorea victoria the 
chromophore is contained within a barrel of ~-sheet protein and fonns spontaneously 
upon folding of the polypeptide chain.38 Its absorption and emission spectra are at 
uitably long wavelengths: excitation is at greater than 350 nm and the emi ion i in 
the visible region of the spectruln. A range of fluorescent proteins is now a ailable 
that pan the i ible pectrum : blue fluorescent protein (BFP), green fIuore c nt 
pr t in (GFP), ellow fluorescen t protein (YFP), cyan fluore cent protein ( FP) and 
red fluor , cnt prot in (RFP). Figure 1.15 gi e the emi ion profile for the range f 
Chapter 1 - Introduction 
proteins (full lines) a comparison of the fluorophore structures for GFP and RFP is 
. 44 45 gIven. ' 
500 600 
Wavelength (nm) 
700 
Figure 1. 15 - Emission spectra (solid lines) for a range of commercially available fluorescent 
proteins. Examples of chromophore structures are also provided 
Fluorescent protein-based tags can be designed to respond to a wide variety of 
biological events and signals, targeted to sub-cellular compartments, introduced into 
a range of tissues and intact organisms and they rarely display any phototoxicity.41 
They are usually characterised by their fluorescent intensity, although the emissive 
lifetime of GFP is sensitive to changes in the refractive index of its environment and 
hence can be used to probe such changes.36 The photophysical properties of 
Aequorea fluorescent proteins are complex, different mutant forms often have more 
than one emissive state with different fluorescent lifetimes.42 Whilst FLIM of GFP 
and related proteins (with an average emissive lifetime of the order of 2-3 ns) has 
proved useful in some applications,43 this complication can limit their application 
where multidimensional acquisition is desirable. In addition, their large steric bulk 
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(high MW) and slow rates of labelling mean that for many applications simple 
organic dyes have clear advantages. 
1.4.2 Organic Fluorescent Dyes 
A wide range of organic compounds is available for use as fluorescent probes or in 
labelling technologies; for many years they have constituted the main alternative to 
fluorescent proteins. They are highly emissive, they have large molar absorption 
coefficients, they are fast-responding and their structure and linking functionality can 
be easily modified in order to suite a particular application. However, despite the 
large number of compounds that are available, they all stem from only a few 
different classes of chromophore.24 This is, in part, due to the requirements for a 
compound that is to be used for the fluorescence imaging of biological samples i.e.: 
they should be visible (or near-IR emissive); they should be amenable to excitation at 
wavelengths> 350 nm; their Stokes' shift should be as large as possible; their 
quantum efficiencies should be high and, importantly, they should also be water 
soluble. The relationship between chemical structure and photophysical properties is 
not yet at such a level where compounds can be designed to meet a set of physical 
requirements predictably, hence at present the route to new fluorophores is mostly 
empirical.47A8 However, once a suitable chromophore has been found, the task of 
modulating its properties, for example, to blue shift or red shift the emission 
spectrum, is relatively facile. 
HO -0 
NCS 
o 
Figure l. t 6 Left: FITC "isomer I' Right: reactive rhodamine green dye 
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Derivatives of fluorescein and rhodamine perhaps constitute the most well known 
class of fluorescent dyes.47-49 They both have relatively high molar absorption 
coefficients, excellent fluorescent quantum yield and good water solubility. 
Fluorescein has an excitation maximum at 494 nm (close to the 488 nm argon laser 
line) and remains an important chromophore for confocal laser-scanning microscopy. 
Both can readily be used as labels by conjugating with their reactive ester or amine 
derivatives. Fluorescein dyes (and rhodamine to a lesser extent) have a number of 
limitations: a relatively high rate of photobleaching; pH sensitive fluorescence 
(fluorescein pKa ~ 6.4), absorption and emission bands that are broad (limiting their 
use in multicolour applications) and fluorescence that can be quenched upon 
coordination to biopolymers. These problems have been reduced to some extent by 
the introduction of Alexa Fluor® and BODIPYC8 fluorescent dyes that are less 
susceptible to photobleaching and whose emission spectra display virtually no pH 
dependence (pH 4 - 9). In addition, they have high molar absorption coefficients (up 
to 200 000 M- I em-I) and quantum yields that are often in excess of 0.7.49, 50 
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Figure 1. 17 Examples of two of the Alexa Fluor dyes, Left: Alexa Fluor 488 Right: Alexa Fluor 
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Figure 1. 18 Absorption and emission profiles for the range of Alexa Fluor dyes 
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Figure 1. 19 Examples of BODIPY dyes, Left: BODIPY Fluorophore Right: BODIPY FL, CASE 
Both Alexa Fluor® and BODIPY® dyes are available with a wide range of excitation 
and emission wavelengths and can span most of the visible spectrum (Figure 1.18). 
Alexa Fluor® dyes are similar in structure to fluorescein and rhodamine. BODIPY R 
dyes are based on 4,4-difluoro-4-bora-3a,4a-diaaza-5-indacene they are unusual in 
that they are relatively non-polar and the chromophore is charge neutral. It is 
interesting to note that their low molecular weight conjugates are also more 
permeable in live cells than those of charged fluorophores. They also possess 
multiphoton absorption cross sections.49 
However, all organic dyes have certain limitations, as a result of their short emissive 
lifetimes (of the order of nanoseconds) and small Stokes' shift. In fluorescence and 
confocal microscopy this can lead to noisy images due to light scattering. and also to 
interferencc from the natural fluorescence from certain biomolccules. ~ letal 
complexes and quantum dots ha\'c recein:,d increasing interest o\cr recent ycars for 
Chapter 1 - Introduction 
their potential to act in these roles for a number of reasons relating to their 
photophysical properties (which shall be discussed further in the following sections) 
but particularly because they display a long-lived emission that allows the possibility 
of time-resolved detection. 
1.4.3 Quantum Dots as Fluorescent Labels in the Analysis of 
Living Systems 
Quantum dots are fluorescent semiconducting nanocrystals; they are generally made 
from either group II and VI (e.g. CdSe and CdTe) or group III and V elements (e.g. 
InP and InAs). They have recently received interest for applications in in vivo (and in 
cellula) imaging and in diagnostics, due to their unique photophysical properties. In 
particular, they have attracted attention because of their very high molar absorption 
coefficients (0.5 - 5 x 106 M- I cm- I ) and emissive quantum yields (values up to 80 -
90 % have been reported), their broad absorption bands and narrow emission 
profiles, their relatively long emissive lifetimes (~ 20 - 50 ns) and their large Stokes' 
shift (up to 300 - 400 nm). In addition, the optical and electronic properties of the 
quantum dots can be modulated through varying the composition and size of the 
crystal. 51 In terms of imaging applications, this allows the emissive wavelength to be 
tuned continuously from 400 to 2000 nm. An interesting recent article by Alivisatos52 
explains in simple terms, how the changes in band structure upon moving from 
single molecule to bulk semiconductor materials lead to this sensitivity. 
Semiconducting nanocrystals are synthesised in high-boiling point, non-polar organic 
solvents such as tri-octylphosphine oxide (Tapa) and hexadecylamine. These 
coordinate to unsaturated metal atoms on the surface and prevent the formation of a 
bulk semiconductor. However, as a result the nanocrystals are coated with a 
monolayer of the organic solvent that renders them soluble only in other non-polar. 
hydrophobic solvents (e.g. chloroform). In order for them to be used in an aqueous 
biological medium some fonn of solubilisation strategy must be employed. An 
extensive list of these strategies has recently been compi led. 53 The general 
methodologies usual involve either I igand exchange: layering of appropriate 
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molecules onto the surface; or encapsulation, for example by an amphiphilic 
polymer. This final method is perhaps the most useful, since it allows easy 
functionalisation of the quantum dot. This allows the possibility of linking, so that it 
can be used as a tag or as a component in a biological assay, if it is attached to an 
appropriate recognition element (bioconjugation). 
Figure 1. 20 - The structure of a multifunctional quantum dot probe showing the capping ligand 
TOPO, an encapsulating copolymer layer, tumor targeting ligands (such as peptides, antibodies 
or small molecule inhibitors, and polyethylene glycol (PEG)51 
Quantum dots have dimensions in the range of 2 - 8 nm, of a similar order to that of 
the fluorescent proteins discussed above (4 - 6 nm). They also show resistance to 
photobleaching. Both of these properties mean that single quantum dots can be 
observed or tracked over long periods of time (minutes to hours) without significant 
degradation of the signal by microscopic techniques such as confocal microscopy 
total internal reflection microscopy or basic wide-field epifluorescence microscopy. 
Single molecule fluorescence microscopy is a powerful technique that is providing a 
significant contribution towards the understanding of processes that occur within 
organisms and living cells; the use of single molecule FRET can provide further 
information about interactions between individual pairs of molecules. 
31 
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A number of reviews have been published in the last two or three years detailing 
examples where quantum dots have been used for both in cellula and in vivo 
. . 51 52 Wh·l h h· 11 ImagIng. ' 1 st P otop YSlca y they have clear advantages over the organic 
dyes more commonly used for cellular imaging, they suffer from difficulties 
associated with their intracellular delivery. This is usually done either through 
microinjection or via an endocytosis pathway (although there are one or two reported 
examples where peptide coated nanoparticles have been able to enter cells). 54 Once 
inside the cell, however, targeting is relatively facile through linking to an 
appropriate vector. 
As has been previously mentioned,24 biological tissue is most transparent to visible 
and near-IR radiation. If luminescence-based techniques are to be used for imaging 
in vivo, then in order to achieve a sufficient penetration depth, it is necessary that 
they should both absorb and emit in this region. Quantum dots typically display a 
large Stokes' shift, and, whilst they may emit in the visible or near-IR, excitation 
wavelengths are often less favourable. A method to overcome this is through the use 
of multiphoton techniques; in fact quantum dots have been shown to have two 
photon absorption cross-sections that are up to 2 or 3 times higher than for common 
organic fluorophores. 
A further requirement of any compound that is to be used in vivo or in cellula is that 
it should have a high stability with respect to dissociation and that it should display 
low cytotoxicity. Encapsulated quantum dots are relatively stable with respect to 
dissociation, although this stability is due in large to the stability of the shell 
protecting the core. Both Weiss53 and Nie51 report that quantum dots do not appear to 
adversely affect cell viability in cellula. However, they conclude that there is a need 
to examine more thoroughly both their toxicity in cells and inside animals and to 
understand if there is a mechanism by which they can be excreted from the body. 
Quantum dots constitute an important new tool to complement the techniques 
currently avai lable, but they are limited by the fact that they can act only as 
fluorescent tags. they cannot act as responsive probes or provide information about 
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their local environment. This is perhaps one area where metal complexes could 
extend the range of analyses possible in live cells. 
1.4.4 Transition Metal Complexes 
Complexes of transition metal ions, and in particular those belonging to the platinum 
group (i.e. ruthenium, rhodium, palladium, osmium, iridium and platinum) have 
received much attention for applications relating to their use as luminescent sensors 
or probes. The majority are designed to provide quantitative information about the 
presence of certain analytes in solution either indirectly via the attachment of a 
pendant group, or by direct coordination to the meta1.55 The response is generally 
observed as a change in the emission profile of the complex, often as a result of a 
charge (MLCT/LMCT/ILCT) or energy transfer interaction (Forster). There are a 
number of examples of complexes that are designed for DNA intercalation (such as 
the well known ruthenium dppz complexes - Figure 1.21), 56-58 membrane binding 
and micelle encapsulation. 59 However, as yet there are very few examples where this 
has been extended to in cellula or in vivo use; fluorescence imaging of p02 in liver 
tissue has been reported using a ruthenium tris-1, 1 O-phenanthroline complex.6o The 
successful application of both ruthenium and rhenium in immunological assays has 
also been demonstrated.61 , 62 The emission lifetimes of these and similar transition 
metal complexes are of the order of microseconds, allowing the use of time-resolved 
techniques, similar to those already being commercially used in lanthanide based 
63 
assays. 
12+ 12+ 
N~ I~ 
N 
N~ I~ 
N 
2+ Z+ Figure 1. 21 - Structures of Ru(bpYhdppz and Ru(phenhdppz 
1.4.5 Luminescent Lanthanide Complexes 
.:n 
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Luminescent lanthanide complexes combine almost all of the beneficial properties 
that are associated with the fluorescent proteins and organic dyes that are 
commercially available for live-cell imaging, in addition to those of the rapidly 
developing quantum-dot luminescent tags. To reiterate, the span of emission 
wavelengths is broad, ranging from the near-IR for complexes of Yb(III), Er(lII) and 
Nd(III) to the visible for Eu(III), Tb(lll), Sm(III) and Dy(lII). They possess sharper 
line-like emission spectra than quantum dots. Their large Stokes' shifts, and long 
emissive lifetimes ranging from microseconds e.g. Yb(III), Er(lII), Nd(III) to 
milliseconds e.g. Eu(III), Tb(lll), allow the use of time-gated detection methods. 
Through the use of appropriate ligands, complexes are water soluble, have high 
quantum yields of emission and can incorporate a linking functionality, allowing the 
possibility of bioconjugation (perhaps to be used as a component in a FRET based 
assay) or attachment to a targeting vector. 
Despite these very favourable properties, there are relatively few examples in the 
literature where lanthanide complexes have been used for the imaging of live cells. 
However, recent work has shown that following the incubation of certain complexes 
in the presence of a range of eukaryotic cell lines, they are able to cross the cell 
membrane and localise within the cell. Microinjection and induced endocytosis can 
be used where compounds are non-cell permeable, as has been demonstrated in 
recent work using quantum dots (see lA.3). This is not desirable, if they are to 
achieve widespread application. 
A useful perspective on the engineering of emissive lanthanide complexes for 
molecular imaging and sensing was published earlier this year and provides a review 
of the status quo in using lanthanide complexes for in cellula imaging.24 The 
mechanisln by which the complexes are able to penetrate the plasma membrane is 
not well understood and a number of different compartmentalisation profiles has 
been observed. Given the small number of studies that have been undertaken, it is 
possible only to draw very tentative conclusions as to which structural features may 
be responsible for mediating the uptake, transport and localisation of the complexes. 
34 
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Representative examples are presented below (Figures l.22 - l.24); in each case, a 
series of images confirming the localisation of the complexes are provided. 
Me CO~t 
HN ~ ~ 
" 0 rr~\ N N Nr--/ 
. , ~ o.--C-- U-OH2 EtO~ )L)N ~N ~ }-N LJ ') 
~'e H ~ 
NH 
Et02C.,(Me 
a Eu Complex 
Lysottacker Green Merged Image 
Figure 1. 22 - Confocal microscopy images of europium complex 'a' co-localised with 
Lysotracker green in NIH 3T3 cells. Orange regions of the merged image correspond to areas 
where the complex and stain are coincident and indicate that localisation is concentrated in 
Iysosomes. 
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Eu Complex 
Bref eldin·A Merged Image 
Figure 1. 23 - Confocal microscopy images of europium complex 'b' co-localised with Brefeldin-
A in NIH 3T3 cells. Brefeldin-A is commonly used as a stain for the endoplasmic reticulum. The 
merged image indicates that specific localisation is observed in the ER, but a more diffuse 
background is also apparent, corresponding to distribution throughout the cytosol. 
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Ph 
Ph 
c Eu Complex 
Syto-RNASel eel Merged Image 
Figure 1. 24 - Confocal microscopy images of europium complex 'c' co-loaded with Syto-
RNASelect in NIH 3T3 cells, showing the cellular localisation and revealing the staining of the 
nucleolus inside the cell nucleus. 
Each of the complexes shown in Figures 1.22 - 1.24 share many common structural 
features. In each case they have a cationic charge, are relatively lipophilic, are based 
on the cyclen macrocycle, have amide-based pendent arms and incorporate a planar 
aromatic sensitising group. In particular, complexes a and b are constitutional 
isomers differing only in the position through which the chromophore has been 
linked to the cyclen ring. Each of the complexes is clearly taken up by the cell line 
(NIH 3T3), but display markedly different localisations. In co-locali ation tudie 
with Ly otracker-green, the 'N-linked' isomer a, shows good corre pondence with 
the organic dye that is known to localise in acidic lysosomal compartment. It ha 
7 
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been suggested that the complex is taken up by an endosomal pathway. The 'C-
linked' isomer, b, distributes quite well in the cytosol and shows a tendency to stain 
the endoplasmic reticulum (localisation strongly suggested in co-staining 
. . h . f B fi ld· A) 24 70 71 C . expenments WIt a conjugate 0 re e In- ." omplex C, III contrast, appears 
to be able to cross both the plasma and nuclear membranes and localises within the 
nucleolus.73 NIH 3T3 are a transformed cell line; similar localisation has been 
reported in primary human dermal fibroblast (HDF) and HeLa carcinoma cells. 
Given the otherwise identical structures of complexes a and b, and their similarity 
with C it appears that the nature and orientation of the chromophore are able to 
influence the uptake profile of the complex. This could be due to either the operation 
of different uptake mechanisms or redistribution of the complex once it has been 
taken up by the cell. This can only be confinned through the systematic variation and 
imaging of series of structurally related complexes. Incorporation of a suitable vector 
into the ligand structure that is already known to target specific locations could 
provide a useful alternative route. 
The majority of complexes that have so far been shown to be cell-permeable are 
relatively lipophilic and positively charged. However, single examples of neutral and 
anionic complexes related to complex a (again based on the cyclen macrocycle, 
bearing pendent amide arms and incorporating an acridone chromophore) have also 
been imaged in cellulo. The complexes are shown in Figure 1.25. 
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a d 
e 
Figure I. 25 - A series of europium complexes incorporating an acridone chromophore with 
positive, neutral and anionic charge respectively 
Figure 1. 26 - Fluorescence microscopy images of ' a ' (centre), ' d ' and 'e' (left), showing each 
complex inside NIH 3T3 cells 
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Preliminary screenIng of these three related complexes of cationic, neutral and 
negative charge (Figure 1.25) incubated with NIH-3T3 mouse fibroblasts (1 mM, 3 
h) revealed that they had low toxicity and that they were able to penetrate the cells. 
Each complex showed a similar punctuated localisation profile, centred around the 
periphery of the nucleus (Figure 1.26); staining appeared to be independent of the 
period of incubation. The localisation of d and e has not been confirmed through co-
localisation studies, but appears to be similar to that observed for complex a. 
This amphipathic and cationic group of complexes (Figure 1.27) provide the starting 
point for much of the work reported herein. The enantiopure A and L1 isomers were 
originally synthesised and examined in vitro for there ability to bind to helical B-
DNA stereoselectively.25, 72 
H H f 
Figure 1. 27 
Preliminary experiments were carried out which showed that f is taken up by NIH 
3T3 mouse fibroblast cells (1 mM loading concentration); 72 localisation has not been 
confirmed. Time course analysis indicated that uptake of the europium complex 
appears faster than for the terbium analogue and that migration occurred over a 
period of hours through the cytosol, across the nuclear membrane and into the 
nucleus (Figure 1.28); in the absence of a positive concentration of complex in the 
external medium the images show a transfer of luminescence from the nucleus back 
to the cytoplasm (Figure 1.29). 
..lO 
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1 hour 3 hours 6 hours 24 hours 48 hours 
Eu 
Tb 
Figure 1. 28 - Microscopy images for the internalisation of the (Ln.]] Eu and Tb probes at 
different times. (] mM loading concentration in DMEM supplemented with 50 mg mrl 
penecillin/streptomycin and] 0 % NCS) 
1 hOllr 3 hours 6 hours 24 hours 48 hours 
Eu 
Figure 1. 29 - Microscopy images for the transit of Eu probe after 3 hours incubation and 
washing of unbound complex. 
These images constituted some of the first examples where a lanthanide complex had 
been shown to be taken up by cells. Discussion and further analyses are presented in 
Chapter 4 of this thesis. 
The following section (1.4.5.1) provides examples of lanthanide-based sensors and 
probes; if the application of these or similar complexes could be extended to 
intracellular use, they could perhaps constitute a new class of responsive sensor or 
probe. Their spectral emission profile, lifetime or circular polarisation may vary as a 
function of the local concentration of a targeted analyte, and also could provide 
information about the binding environment of the complex.24 For example 
complexes a and b were developed to report on local concentrations of HC03- by 
monitoring changes in the ratio of two ( or more) europium emi ion band . 
Bicarbonate is an important intracellular species as it bind reversibly to the nzyme 
adenylcycla e, thereby regulating release of the key econdary me ng r clic-
AMP.24 If the anion could be bound with a high enough lecti ity in an intra ellul ar 
medium, it ould be u ed to pro ide infonnation n these proce in. i ie li\ c cc ll :. 
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The use of responsive complexes would also introduce the possibility of using 
multidimensional acquisition. For example, a labelled cell could be analysed in terms 
of the spatial localisation of the complex by intensity and at the same time, the 
change in concentration of a local analyte could be monitored by measuring the 
emission profile or lifetime at specific points within the image. 
1.4.5.1 Responsive Lanthanide-Based Sensors 
There are a number of examples of responsive lanthanide sensors that provide 
information about the presence of particular analytes in solution by modulations in 
their photophysical properties, usually through either a change in their emission 
intensity or in the form of their emission spectra. 
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Figure 1. 32 
Figure 1. 33 
Figure 1.34 
Selected examples include complexes that are sensitive to pH (Figure 1.30),64-66 can 
report on the concentration of singlet oxygen in solution (Figure 1.31 ),(1' can bind 
cations (Figure I.J~), (,S.69 can n?\Trsibly bind bicarbonate in intracellular media 
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(Figure 1.33);70,71 and can selectively bind citrate in a competitive medium (Figure 
1.34).27 
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2 Ligand and Complex Synthesis 
A series of europium(lII) and terbium(III) complexes has been synthesised that is 
based on the cyclen macrocycle and incorporates a common antenna group. The 
cyclen macocycle has four ring nitrogens that may readily be alkylated; through the 
use of an appropriate protecting strategy, up to four different pendent arms can be 
attached. These arms should bear a functional group in the correct position and with 
an orientation that allows them to coordinate to the metal centre in order to give a 
complex with high kinetic and thermodynamic stability with respect to metal ion 
dissociation. Common examples include: amides (in particular those obtained 
through the use of amino acids), carboxylic acids (DOT A and DTP A complexes of 
gadolinium are perhaps the most widely used lanthanide complexes - in common use 
as MRI contrast agents) and phosphinates. Through the presence of two or more 
arms of the same chirality, a degree of control is possible over the overall chirality of 
the complex. Where three or four of the arms have the same chirality, the chirality of 
the complex can be predicted with some certainty (see Chapter 1.2.5). In the present 
work, the pendent anns are varied in order to provide a series of complexes of 
varying overall charge and lipophilicity.l 
2. 1 Synthesis of a Series of Cyclen Based Complexes with a 
Tetraazatriphenylene Sensitising Moiety Incorporating 
Amide or Carboxylic Acid Pendent Arms 
Me,!Ph 
HN
yO (. r\, \ 
,....-N. "N-..., ,.1 ~Ln~N 
Ph ~\ ~N' \'~~ )- /"--/ L J N N _ \ 
Me H 
o NH 
H H 
Ph~ 
Me 
Figure 2. 1 - LnPh3dpq/dpqC (Ln = Eu(111). Tb(lll» 
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The favourable photophysical properties of the ~-SSS and A-RRR enantiomeric 
europium and terbium complexes depicted in Figure 2.1 have been previously 
reported.2,3 Complexes [Ln.1-4] constitute a series of structurally related compounds, 
each with an appended tetraazatriphenylene sensitising chromophore (Figure 2.2). 
Due to the contracted nature of lanthanide 4f orbitals and the mostly electrostatic 
nature of the metal-ligand interaction, the pendent arms can be varied without greatly 
affecting the photophysical properties of the complex.4 
[Ln.1]3+ [Ln.2] 
[Ln.3] [Ln.4]3-
Figure 2. 2 - A series of structurally related lantha~ide c?~~lexes (Ln = Eu(III), Tb(lll» of 
differing charge and hpophlhclty 
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2.1.1 10,11,12,13-Tetrahydrodipyrido-[3,2a:2' ,3' -c]-phenazine 
(dpqC) 
10,11,12,13-Tetrahydrodipyrido-[3,2a:2',3'-c]-phenazine (dpqC) has been shown to 
be an excellent antenna chromophore for both europium(III) and terbium(III). It has a 
reasonably high molar absorption coefficient (~ 6440 em-I); it possesses a high 
quantum yield of triplet formation (<1>r - 1) as a result of its fast rate of intersystem 
crossing. It displays virtually no fluorescence either as the free chromophore or when 
coordinated to a metal centre and has a suitably high triplet energy ( 23400 em-I) 
such that it can excite both europium(lII) and terbium(lII) and is sufficiently higher 
in energy such that it is not excited by thermally activated back energy transfer from 
the lanthanide. It can also coordinate through the two pyridyl nitrogens to the 
lanthanide, minimising the donor-acceptor distance for energy transfer and enabling 
the ligand to be nonadentate, thus excluding water or other possible ligands from the 
coordination sphere of the metal. 5,6 
Although the number of steps (Scheme 2.1) required to synthesise the chloro 
derivative of the tetraazatriphenylene chromophore is rather high, the synthesis may 
be accomplished in reasonable yield, utilises low cost starting materials and the 
product is stable to storage in air. It has been demonstrated that the synthesis is 
amenable to scale-up to a multigram scale. The procedure used follows a similar 
route to that previously used for the synthesis of the related tetraazatriphenylene 
chromophore • dpq' .7 
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0 
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65 % 
3 Se02 
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6 5 4 
Scheme 2. 1 - Reaction scheme for the synthesis of the chloromethyl derivative of the 
10,11 ,12,13-tetrahydrodipyrido-[3,2a:2',3' -c ]-phenazine (dpqC) chromophore 
1,10-Phenanthroline was first alkylated in order to provide a position that can be 
functionalised and from which the chromophore can be attached to 1,4,7,10-
tetraazacyc1ododecane. The methylation step involved a nucleophilic aromatic 
substitution reaction using MeLi at O°C in THF to form a Meisenheimer 
intermediate, which was subsequently re-aromatised by oxidation with manganese 
oxide. The established procedure7 used a small excess of MeLi leading to some 2,9-
dimethyl-I, 10-phenanthroline that persisted in small quantities after purification both 
by chromatography and recrystallisation. The problem was overcome by using the 
reagents in stoichiometric amounts. 2-Methyl-l, 1 O-phenanthroline, 1, was purified 
by recrystallisation from an ethyl acetate/hexane mixture. The relatively low yield 
was ascribed to an inefficient extraction of the anionic intermediate into diethyl ether 
from water. 
Oxidation of 2-methyl-l, 1 O-phenanthroline to the 5,6-quinone, 2, used molecular 
bromine (generated in situ from KBr and H2S04) and HN03, according to a literature 
procedure8. Care was taken in neutralising the strongly acidic mixture due to the base 
sensitivity of the quinone. Under basic conditions, decarboxylation can occur to give 
4,5-diazafluoren-9-one.9 
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Condensation of 2-methyl-I,IO-phenanthroline-5,6-quinone, 2, with 1 2-, 
diaminocyclohexane gave the corresponding Schiff base which, upon oxidation by 
oxygen from the air, yielded the IO,II,I2,I3-tetrahydrodipyrido-[3,2a:2',3'-c]-
phenazine chromophore with a methyl substituent at the 3-position, 3. Early attempts 
at the reaction were carried out using THF as a solvent under high dilution as 
previously carried out within the group. However this procedure led to low yields of 
about 40 0/0. The yield was greatly improved by changing the solvent to ethanol, in 
accordance with a synthesis for 3,6-dimethyl-I 0, 11,12, I3-tetrahydrodipyrido[3,2-
a:2',3' -c ]-phenazine lO. Purification was successfully achieved by recrystallisation 
from hot ethanol. 
The final stages in the synthesis are associated with generation of the benzylic 
chloride of dpqC, 6. It has been shown7 that direct halogenation with one equivalent 
of N-chlorosuccinimide is not successful and that the use of an excess leads to the 
trichloromethyl derivative. Therefore, a three step strategy was used involving mild 
oxidation with selenium(lV) oxide to yield the aldehyde, 4, which was subsequently 
reduced with sodium borohydride. The alcohol, 5, was then chlorinated with 
phosphorus trichloride. 
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2.1.2 Amide Based Ligands and Complexes 
R 
I HNtO ,:\)~ \ ~ 
O~.L\n~N ~N ~,,~ 
HN L J ') N 
\ ~ \ 
R 0 NH 
I 
R 
16 - 21 
7 
N 
CI 
o 
CI0,R 
N 
H 
10 R = ~Me 
\: Ph 
11 
12 R = 
9 
Scheme 2. 2 - Synthesis of the series of complexes bearing pendent amide arms 
A procedure analogous to that used previously within the group 7 was followed to 
obtain the desired a-methyl-benzyl, alanine and glutamic acid based amide ligands, 
13, I"', 15 respectively (Scheme 2.2). In order to monofunctionalise cyclen with the 
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dpqC chromophore, cyclen was first triprotected using 2.4 equivalents of (BochO. 
Alkylation with the chloromethyl derivative was followed by removal of the 
protecting groups with trifluoroacetic acid in dichloromethane. 
N-Chloroacetyl-L-glutamic acid diethyl ester, 10, N-chloroacetyl-L-alanine ethyl 
ester, 11, and (S)-N-chloroethanoyl-2-phenylethylamine, 12, were each synthesised 
by addition of chloroacetyl chloride to the appropriate chiral amino acid ethyl ester 
hydrochloride or amine, in the presence of triethylamine, in THF at low temperature. 
Compounds 10 - 12 were then added to the macrocycle by an alkylation reaction in 
acetonitrile, with a catalytic amount of potassium iodide added. Each of the ligands 
was purified by chromatography on alumina using a dichloromethane/methanol 
solvent system. 
The europIUm and terbium complexes of each of the ligands were prepared in 
anhydrous acetonitrile by reaction of the ligands with the appropriate 
trifluoromethanesulphonate salt. Initial purification involved repeated precipitation 
onto dry diethyl ethyl. The final stage in the synthesis of the LnAla3dpqC, [Ln.2] and 
LnGlu3dpqC3- [Ln.4] ligands was to hydrolyse the esters to the corresponding 
carboxylic acid using dilute potassium hydroxide. 
HPLC provides a useful tool for the analysis of lanthanide complexes, in particular in 
terms of monitoring the progress of the complexation reaction and confirming the 
presence or absence of uncomplexed ligand that may otherwise affect the validity of 
photophysical measurelnents made on the complex. Complexes [Ln.1-4] were each 
analysed using a Phenomenex C 18 column using water/acetonitrile gradient elution. 
The amide based complexes each required the presence of 0.1 % trifluoroacetic acid 
to prevent sticking to the column. In each case, a single major product was observed 
in > 90 % purity. Semi-preparative HPLC allowed further prurification of small 
quantities of the complexes where necessary for quantitative measurements and in 
particular for the quantum yield determinations. 
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2.1.3 Tris(Carboxymethyl) Ligands and Their Lanthanide 
Complexes 
CI 
.. 
27, 28 
H20 
pH 5.5 
26 
TFAI 
CH2CI2 
Scheme 2. 3 - Synthesis of the tris(carboxymethyl) ligands and their lanthanide complexes 
Tris( carboxymethyl) ligands constitute one of the simplest and most studied group of 
ligands used for lanthanide chelation; appropriate synthetic strategies are well 
established. Alkylation of the tert-butyl ester of D03A with the chloromethyl dpqC 
derivative, 6, afforded 26 in good yield. The ester was hydrolysed with 
trifluoroacetic acid and the product analysed by IH NMR to ensure complete removal 
of the tert-butyl groups. The crude ligand was immediately complexed with the 
appropriate lanthanide(lII) chloride in a synthetic procedure that involved the 
adjustment of pH both prior to reaction (to pH 5.5) and after 18 hours (to pH 10) to 
allow removal of free lanthanide as the hydroxide salt. 
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2.1.4 Characterisation of The Series of Amide and Carboxylic 
Acid Based Complexes 
2.1.4.1 Solution NMR studies 
The majority of lanthanide(III) ions are paramagnetic. As a result, the NMR 
resonances of atoms that are either directly coordinated, or are in close proximity to 
the metal exhibit both a broadening and a shift; the extent to which they are affected 
is dependent upon the lanthanide under study. These effects have been exploited in 
the development of shift reagents and MRI contrast agents. II ,12 Where the 
coordination environment around the metal ion is well defined, and in particular 
when the lanthanide is coordinatively saturated, solution NMR can provide structural 
information about the complex. Lanthanide induced shifts fall off rapidly as the 
distance of the nucleus under study from the metal increases. II For cyclen based 
complexes, the most shifted I H resonances are those of the macrocyclic ring protons. 
The spectrum of the europium(III) complex, [Ln.l]3+, in D20 closely resembled that 
of the previously synthesised ~- and A-EuPh3dpq and of the related triamide 
europium complexes7, 13, 14 The most paramagnetically shifted 'pseudo-axial' cyclen 
ring protons resonated as one set of four broadened singlets in the range 32-20 ppm. 
This is consistent with the presence of a major species, adopting a square 
antiprismatic geometry. An additional peak was evident in the region above 20 ppm 
and was assigned as the proton (X- to the nitrogen of the dpqC chromophore. The 
large chemical shift is accounted for since it falls within the McConnell cone and so 
experiences a large positive paramagnetic shift effect. Again, assignment was made 
through comparison with spectra that had previously been assigned for the EuPh3dpq 
complexes and confirmed by COSY I H NMR spectroscopy. The less rigid 
complexes [Ln.2 and 4] displayed broader spectra. Spectral resolution of each of the 
chiral complexes ilnproved in CD30D at low temperatures « 0 °C). Arm rotation is 
inhibited by the chiral groups introduced 8 to the ring nitrogen atoms, therefore the 
sharpening of signals is assigned to freezing out of cyclen ring 'wobble' or in\ersion, 
previously noted for a multitude of related complexes. I. 15 
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A number of different stereoisomers are possible for [Ln.3] and other D03A1DOT A 
based complexes as was explained in Chapter 1.1 It was therefore unsurprising that 
the spectra of europium and terbium [Ln.3] were broad and poorly resolved. 
However, the ytterbium complex [Yb.3] has also been synthesised and at room 
temperature displayed a single set of resonances corresponding to the 'pseudo-axial'-
ring protons confirming that a preferred geometry was adopted. Such behaviour can 
perhaps be accounted for by the smaller size of ytterbium compared to europium and 
terbium, enhancing steric interactions between the ligand arms. 
2.1.4.2 Absorption and Emission Spectra 
0.8 
0.7 
0.6 
Q) 0.5 () 
s:: 
ns 
.Q 0.4 ... 
0 
In 
.Q 0.3 <t: 
0.2 
0.1 
0 
200 220 240 260 280 300 320 340 360 
wavelength (nm) 
Figure 2. 3 - Absorption spectrum of lEu.]] recorded in H20 at 295 K 
The absorption spectra for each of the complexes [Ln.1-4] in H20 were identical, 
with major bands at 224 (£ = 23 100 M- I em-I), 267 (£ = 30 200 M- I em-I), 308 (£ = 
10 200 M-I em-I), 332 (£ = 7 700 M- I em-I) and 348 nm (£ = 6440 M- I em-I). The 
spectral form is silnilar to that observed for the free chromophore and is indicative of 
the smal1 electronic interaction between the tetraazatriphenylene antenna and the 
metal acceptor. 
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Figure 2. 4 - Emission spectrum of (Eu.]] recorded in H20 at 295 K 
4000000 
3500000 
3000000 
~ 2500000 
-» 
:: 2000000 
II) 
c 
-E 1500000 
1000000 
500000 
450 
~J = 6 ~J =5 
i 
~J = 4 
~J = 3 
500 550 600 650 
Wavelength (nm) 
Figure 2. 5 - Emission spectrum of (Tb.]] recorded in H20 at 295 K 
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700 
The emission spectra of the lanthanide(III) complexes were recorded at 295 K in 
H20. Spectra shown are for the europium(III) and terbium(III) [Ln. t ]3+ complexes 
but are analogous to those obtained for each of the other pairs of complexes [Ln.2-4]. 
This is as would be predicted from the well defined and common coordination 
geometry around the metal centre, comprising four tertiary amine donors, three 
amide C=O donors and two pyridyl nitrogen donors. No fluorescencc was observed 
from the tetraazatriphenylene chromophore, consistent \\"ith the cxpected high 
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efficiency of the intersystem crossing process, as has been reported previously in 
studies involving this chromophore.2, 3, 7 
The fine-splitting of the europIum ~J = 1 band can be interpreted to provide 
confirmation as to whether there are one, or multiple structural isomers that exist in 
solution. Three transitions would be expected for a complex lacking a C
n 
element of 
symmetry. A fourth transition is apparent for the series of complexes [Ln.1-4] 
suggesting the presence of a minor isomer. HPLC and 1 H NMR confirm that the 
complexes adopt one major conformation; however previous low temperature IH 
NMR of complex EuPh3dpq (Figure 2.1) in CD30D have revealed the presence of a 
second isomer.7 This is likely also to be the case for the closely related complexes 
[Ln.1-4]. 
2.1.4.3 Circularly Polarised Luminescence Studies (CPL) 
The complexes [Ln.1], [Ln.2] and [Ln.4] are chiral and as such are amenable to study 
by chiroptical spectroscopy i.e. to circular dichroism and circularly polarized 
luminescence. Circular dichroism measures the differential absorption of left and 
right circularly polarised light; 16, 17 in order to probe the ground state structure of the 
complex we must be able to observe the absorption spectrum of the lanthanide (not 
the chromophore). The forbidden nature of 4f-4f transitions, and hence their low 
molar absorption coefficients mean that high sample concentrations would be 
required; this limits the utility of circular dichroism studies to such lanthanide(III) 
complex. Circularly polarized luminescence, in contrast, probes the excited state 
structure of the complex and measures the differential emission of left and right 
circularly polarized light. 16 Since excitation is indirect, being via an antenna 
chromophore, it does not suffer from the same limitation. Thus, CPL can provide 
information about both the helicity about the metal centre and the structure of the 
complex, in addition to some information regarding the electronic and magnetic 
environment of the lanthanide(III) ion. 18 
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Figure 2. 6 - Structures of an enantiomeric pair of LnPh3dpq3+ complexes 
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Figure 2. 7 Mirror image CPL spectra for (SSS)-~ (green) and {RRR)-A (purple) europium and 
terbium complexes of the structure shown above. The blue trace represents the total emission 
spectrum (Aex = 340 nm, pH 7.4, 100mM HEPES, 10 mM NaCl) 
Mirror image CPL spectra (Figure 2.7) have previously been reported for the 
enantiomeric lanthanide(III) complexes of the dpq ligand (Figure 2.6).7 The sign and 
sequence of the transitions observed for these complexes is the same as for the parent 
C-4 symmetric tetra-amide Eu(III) and Tb(IlI) analogues (Figure 2.8), whose 
absolute configuration has been verified by X-ray crystallography.l9 Only one 
exception was noted for the europium complex where a reversal in the ign of one 
transition in the ~J = 2 manifold was observed. This was attributed to the high 
ensitivity of this electric-dipole-allowed transition to the nature and polari ability of 
4 
Chapter 2 - Ligand and Complex Synthesis 
the donor atom that occupies the axial position in the mono-capped square anti-
prismatic coordination environment. 18 
S-~ 
Figure 2. 8 - Structure of a tetraamide complex that is structurally similar to ILn.] J and the 
LnPh3dpq complexes (Figure 2.4) 
For each of the europium and terbium complexes [Ln.l]3+, [Ln.2] and [Ln.4], the 
sign and sequence of the peaks (Figures 2.9 and 2.10) was observed to be the same as 
for both the LnPh3dpq complexes (Figure 2.6) and the parent tetraamide complexes 
(Figure 2.8) and as such it can be concluded that the lanthanide ion is in the same 
coordination environment in each case and that the helicity of the ligand around the 
metal centre is the same.7, 18, 19 Each of the (SSS)- complexes can therefore be 
assigned a ~ helicity. 
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Figure 2. 9 - CPL spectra of rEuPh3dpqC]C13, IEu.11 (top); EuAla3dpqC, IEu.21 and 
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2.1.4.4 Emission Dissymmetry Factors For the Series of Lanthanide 
Complexes [Ln.l], [Ln.2] and [Ln.4] 
Emission dis-symmetry factors, gem, provide a measure of the 'degree of chirality' 
sensed by an electronic transition and are calculated through application of Equation 
(1) below. 18 
(1) 
IL(R) is the intensity of the left (right) circularly polarised component. 
g-Factors were determined for each of the chiral europium and terbium complexes 
[Ln.t], [Ln.2] and [Ln.4]. Comparison is drawn with the parent tetraamide 
complexes, LnPh4, (see Figure 2.8) and the triamide LnPh3dpq analogues (Figure 
2.6).7,19 
Complex gem (589 nm) gem (595 nm) gem (615 nm) gem (617 nm) 
EuPh3dpqC, [Eu.t] + 0.18 - 0.16 -0.10 + 0.08 
EuAla3dpqC, [Eu.2] + 0.25 - 0.13 - 0.08 + 0.06 
EuGlu3dpqC, [Eu.4] + 0.17 - 0.13 - 0.07 +0.04 
EuPh3dpq + 0.18 - 0.16 - 0.04 
EuPh4 +0.09 - 0.09 + 0.08 
Table 2. ) - Emission dissymmetry factors (± ]0 %) for (Eu.]], (Eu.2], (Eu.4] and the related 
triamide EuPh3dpq (Figure 2.6) and tetra-amide EuPh4 (Figure 2.8) complexes (H20, 295 K, Aex 
= 340 (dpq) /348 (dpqC». In each case, the complexes have S-A helicity. 
Complex gem (541 nm) gem (544 nm) gem (547 nm) 
TbPh3dpqC, [Tb.t] + 0.15 - 0.08 + 0.08 
TbGlu3dpqC, [Tb.4] + 0.15 - 0.06 + 0.07 
TbPh3dpq + 0.15 - 0.09 + 0.12 
TbPh4 + 0.14 - 0.10 + 0.17 
Table 2. 2 - Emission dissymmetry factors (± ]0 0/0) for (Tb.)], (Tb.4] and the related triamide 
TbPh3dpq (Figure 2.6) and tetra-amide TbPh4 (Figure 2.8) complexes (H20, 295 K, Aex = 340 
(dpq) / 348 (dpqC». In each case, the complexes possess S-A helicity. 
For the series of europium complexes, g factors found for the ~J = 1 band havc the 
same sign in each case, although the magnitude of the valucs for the triamidc dpq 
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and dpqC complexes are up to twice those for the tetraamide parent. This may reflect 
the more sterically constrained coordination environment and correspondingly 
reduced motional freedom. A change in sign is observed at 615 nm compared to the 
C4 symmetric tetraamide complex; this has previously been related to its high 
sensitivity to the polarisability of the axial donor. 7 
Transitions for the terbium complexes again have the same sign in each case and the 
magnitudes are similar for both [Ln.t] and [Ln.4]. At 547 nm, the g factors are> 30 
0/0 lower than for TbPh4, perhaps again reflecting the sensitivity of the transition to 
the nature, of the axial donor atom. 
2.1.4.5 Determination of Luminescent Quantum Yield and Lifetime 
of Emission 
Luminescent lifetimes and absolute quantum yields were recorded in H20 at ambient 
temperature. 
Complex Lifetime (ms) Luminescent Quantum Yield 
[Eu.1]3+ 1.04 (1.59 in 0 20) 16 % (20 % in 0 20) 
[Eu.2] 0.96 18 %) 
[Eu.3] 1.08 18 0/0 
[Eu.4f- 1.00 15 0/0 
[Tb.1]3+ 1.56 (1.72 in 0 20) 40 % (48 % in 0 20) 
[Tb.2] 1.49 36 0/0 
[Tb.3] 1.46 33 0/0 
[Tb.4]3- 1.59 34 0/0 
Table 2. 3 - Emissive lifetimes and luminescent quantum yields for the series of comples /Ln.l-
4) (Ln = Eu, Tb) 
These values are SOlne of the highest recorded in aqueous media (Table 2.3). The 
high values may be ascribed to: the high quantum yield of triplet fonnation of thc 
. h . h b ~e ot' directly coordinatcd watcr tctraazatnphenylene chromop ore, tea sene 
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molecules; the efficiency of energy transfer from the sensitizer to the lanthanide, in 
part accounted for by the bidentate nature of the chromophore and the 
correspondingly short donor acceptor distance; a suitably large energy gap between 
the lowest lying excited state of the lanthanide and the triplet level of the 
chromophore such that thermally activate back energy transfer is not feasible. 
Additionally, the luminescent properties of this series of complexes remain virtually 
unchanged following deoxygenation of the sample. 
2.1.4.6 Analysis of Complex Hydration State 
The excited states of europium and terbium are particularly sensitive to quenching by 
OH and NH vibrational oscillators. The extent to which they are quenched is 
different in H20 and 0 20, as has been previously explained (1.2.1.1). This difference 
has been used to derive expressions that allow determination of the number of water 
molecules that are directly coordinated to the lanthanide centre. Practically, this is 
achieved through a comparison of the rates of depopulation of the lanthanide excited 
state in both H20 and 0 20. Care must be taken to ensure that HID exchange is 
complete through repeated exchange cycles in D20. The appropriate expressions for 
europium and terbium are respectively:2o 
qEu = 1.2(kH2o - kD20 - 0.25 - 3(0.075)) (2) 
qTb = 5(kH20 - kD20 - 0.06) (3) 
where the 0.25 term (0.06 for Tb) refers to quenching by second sphere water 
molecules, and the 0.075 factor is ascribed to quenching by each NH amide 
oscillator. 
Example: Determination of the number of water molecules coordinated to the 
europium and terbium complexes [Ln.1]. 
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Complex 'tH20 kH20 (= 1I'tH20) 'tD20 kD20 (= 1/'tD20) 
EuPh3dpqC, [Eu.t] 1.04 0.96 l.59 0.63 
ThPh3dpqC, [Th.t] 1.56 0.64 l.72 0.58 
Table 2.4 
Therefore: 
. . . . . Emission hfetJm~s and rate constants for depopulatIOn of the lanthanide emissive 
states of europIUm and terbium complexes [Ln.t] in H20 and D20 
qEu = l.2(kH2o - kD20 - 0.25 - 3(0.075)) 
= 1.2(0.96 - 0.93 - 0.25 - 3(0.075)) 
=0 
qTb = 5(kH20 - kD20 - 0.06) 
= 5(0.64 - 0.58 - 0.06) 
=0 
In every other case, the lanthanide was shown to possess no directly bound water 
molecules. 
2.2 Development of a Complex Suitable for Protein 
Conjugation 
The excellent photophysical properties of the senes of complexes [Ln.1-4], in 
particular in terms of their high luminescent quantum yields, long emissive lifetimes 
and well defined coordination environment make them of potential interest for use in 
FRET based biological assays. The complex [Ln.lf+ was thought to be the most 
appropriate candidate to assess as it shows a relatively low susceptibility to 
quenching, in particular by uric acid (which quenches the neutral and anionic 
complexes much more strongly - Chapter 3) and has been shown to be readily taken 
up by cells, opening up the possibility of developing' in cellulo' FRET studies. 
In order for the complex to be of use, it is necessary to have some point of 
attachlnent through which the complex can be linked, for example, to an antibody or 
enzytne, or other component depending on the system under study. for this series of 
complexes there are two ways in \\"hich this can be readily achie\l~d: firstly through 
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functionalisation of the chromophore; or secondly by modifying one (or more) of the 
cyclen pendent arms to incorporate an additional functionality. Within the Parker 
group both approaches have been adopted (unpublished work 2005/6), although 
linking via the pendant arm(s) is perhaps synthetically less challenging and offers 
more scope for incorporating a range of linkers, without adversely affecting the 
photophysical properties of the complex. The method that was adopted was to 
exchange the amide arm trans to the chromophore (synthetically simpler than cis 
modification) to incorporate a hydrocarbon spacer and a free amine, whilst 
maintaining the same coordination environment for the metal, I.e. 3 amide C=Q 
donors. The structure of the target complex is shown below. 
N1J 
N 
[Ln.5]3+ 
Figure 2. 11 - Structure of LnPh2dpqC _NH2, ILn.5] 
2.2.1 Synthetic Route to [Ln.5] 
The major advantage to the use of cyclen as a core, around which macrocyclic 
ligands can be built-up, is the ease with which up to four different pendent anns can 
be attached. This allows simple modification of a parent complex, whose properties 
are well understood, in order to meet the needs of a specific application. The 
synthetic procedure that was adopted for the synthesis of [Ln.S] could be adapted to 
allow a range of different linking groups and functionalities to be used. 
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Scheme 2. 4 - Synthetic scheme leading to the synthesis of an amide-based lanthanide chelate 
for protein conjugation. 
In order to synthesise the di-functionalised cyclen species, 3 L it is possible to carry 
out a direct alkylation reaction with two equivalents of 2-chloro-N-[(S)-I-
phenylethylJethanamide. However, this usually leads to a mixture of mono. tri and 
tetra alkylated products. in addition to the required di-substituted compound. Column 
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chromatography of mixtures of cyclen complexes, in particular where the desired 
product has free amine NH groups, is commonly difficult and low yielding. An 
alternative approach, and the one that was adopted for this synthesis, was to use a 
protecting group strategy whereby cyclen is first di-protected as a trans-bis(benzyl 
carbamate). The reaction is carried out in phosphate buffer, with the pH adjusted to 
2.5. Under these conditions, in the presence of excess benzyl chloroformate, the 
major product of the reaction is the di-protected cyclen. Purification takes advantages 
of the differing solubilities of the 'over' and 'under-alkylated' compounds at high 
and low pH, allowing the desired product to be obtained in high yield by extraction 
into diethyl ether, without the need for column chromatography. The reaction can be 
carried out on a multi gram scale. Previous approaches involved the careful 
maintenance of pH during addition of benzyl chloroformate; the use of a buffer 
obviates the need to do this. 
Alkylation of I,7-bis(benzyloxycarbonyl)-I,4,7,IO-tetraazacyclododecane, 29, using 
a small excess of 2-chloro-N-[(S)- I -phenylethyl]ethanamide proceeded to give 
mostly the desired product, 30, which was readily purified by column 
chromatography on silica in reasonable yield. The protecting groups were removed 
by hydrogenation over a palladium hydroxide on carbon catalyst (Pearlman's 
catalyst) in ethanol. 
The two N-4 and N- I 0 substituted arms, i.e. the chloromethyl derivative of the 
chromophore and the linking group, could be added in different sequence. The 
difficulty associated with this first step is that monofuctionalisation is required. It 
was decided to functionalise firstly with the tetraazatriphenylene derivative, since it 
was thought in the case of over-alkylation, that there was likely to be a larger Rf 
difference between the two products, facilitating separation by column 
chromatography. 
Alkylation with the chloromethyl derivative of the tetraazatriphenylene 
chromophore, 6, was undertaken in acetonitrile, with one equivalent of base. The 
product 32 was obtained, with no sign of over-alkylation, perhaps due to its sterie 
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bulk making the cyc1en ring too crowded for a second functionalisation to occur 
rapidly under the reaction conditions. The final alkylation step required the use of 
CS2C03 as a base and a catalytic amount of KI before any reaction was observed, in-
line with the observation of low reactivity in the previous step. It should be noted 
that purification of both 32 and 35 required column chromatography on alumina as a 
result of the basic nature of the ligand; unfortunately this results in a 50 % loss of 
product per purification. By NMR analysis, the crude product was> 90 % pure; if the 
synthesis were to be scaled up it would be desirable to improve the purification 
procedures for these final two products. 
2.2.2 Characterisation 
2.2.2.1 HPLC Analysis 
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Figure 2. 12 - Comparative HPLC traces of LnPh2dpqC ligand (top), [Tb.51 and [Tb.ll 
(bottom) O .. abs = 348 nm), For gradient see general experimental Chapter 5. 
The above HPLC traces (Figure 2.12) were recorded for the Ph2dpqC _NH2 ligand, 
its complex [Ln.5] and for comparison, the parent complex [Ln.1]. The free ligand 
was shown to be one major species in solution; NMR and ESMS characterisation 
confirmed its assignment and purity. Upon complexation to give [Ln.5], a major 
species was observed, but also a number of new peaks that eluted over se eral 
minutes following the major peak and constitute a significant percentage of the total 
7 
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material. Complexation of the parent triamide-dpqC ligand to give [Ln.I] proceeds to 
give only one major product as can be seen from the lower of the three spectra 
presented above. 
The HPLC traces were all recorded using a diode array UV -Vis detector operating at 
348 nm (also measured at 280 nm). This corresponds to the longest wavelength 
absorption band of the tetraazatriphenylene chromophore and is to longer wavelength 
of any likely organic contaminants. Such behaviour indicated that each of the 
species that were eluted bear this chromophore. A fluorescence detector was also 
connected to the HPLC, monitoring eluent from the column at a wavelength 
corresponding to the lanthanide centred emission (546 nm for Tb, 616 nm for Eu); 
again emission was seen for each of these peaks, suggesting that, in addition, to each 
peak corresponding to a chromophore bound species, they also have a lanthanide ion 
coordinated in such a way that it can be efficiently sensitised. Based on these 
observations, it was tentatively suggested that they may be a result of different 
stereoisomers that are retained to different extents by the C 18 column. Separation of 
the major peak was possible by preparative HPLC, and the ESMS spectrum and 
luminescence spectral data (excitation/emission profiles) were in agreement with the 
proposed structure. 
The most notable difference between the complexes [Ln.5] and [Ln.1] is the number 
of chiral centres () to the cyclen ring nitrogen atoms. It is known that these impart 
rigidity on the complex and as a result restrict the number of isomers that the 
complex may adopt. 18 This effect decreases as the number of stereocentres is reduced 
and may, in part, account for the number of species observed by HPLC. 
2.2.2.2 Variable Temperature Solution IH NMR Analyses 
In D20, the room temperature I H NMR spectrum of [Ln.5]3+ is exchange broadened 
(200 - 500 MHz) and does not provide any definitive structural information about 
the complex. To overCOlne this problem, low temperature spectra were recorded in 
CD30D. Below 0 °C the same features can be discerned as for the parent compk:\ 
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[Ln.1] i.e. the observation of resonance ascribed to 'pseudo-axial' ring protons in the 
range 20-32 ppm in addition to a fifth peak corresponding to the chromophore proton 
taking up a position close to the principal axis of the complex. The peaks become 
increasingly sharp as the temperature decreases (reaching a limit as the viscosity of 
the solvent increases) and one major species was discernible. 
2.2.2.3 Absorption and Emission Spectral Properties of [Ln.S] (Ln = 
Tb, Eu) 
The absorption and emission spectra had the same fonn as for the parent amide 
complexes, consistent with their well defined coordination environments. The 
emission lifetimes for the europium(III) and terbium(III) complexes were measured 
to be 1.0 ms and 1.5 ms respectively. 
2.2.2.4 CPL Analysis 
7S 
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Figure 2. 13 - CPL spectra for SS-Ll [Ln.5] (top) and for comparison the parent triamjde 
species SSS-Ll [Ln. I] (bottom). The blue trace represents the total emission spectrum/50 (H20, 
298 K, A.ex = 348) nm, 
The CPL spectrum of [Th.S] was recorded in H20 at ambient temperature, 
comparison is drawn with [Th.l]. The form and sign of the spectra are similar in each 
case. The overall chirality of the complex can again be assigned as L1-SS. 
Complex gem (541 nm) gem (544 nm) gem (547 nm) 
TbPh3dpqC, [Th.l] + 0.15 - 0.06 + 0.07 
TbPh2dpqC _ NH2, [Tb.S] + 0.09 - 0.02 + 0.02 
Table 2.5 - Emission dissymmetry factors (± 10 0/0) for [Tb.11 and [Tb.5] (H20 , 295 K, A.e = 348 
(dpqC». In each case the complexes have all-S-~ helicity. 
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Emission dissymmetry factors were measured for [Tb.S] and were compared to those 
for the parent triamide complex [Th.t]. The sign of the factors follows the same 
order in both cases, confirming assignment of a ~-helicity. The lower magnitudes of 
the values are consistent with a lower overall 'degree of chirality': the helicity of the 
complex i.e. A or ~ is determined by the chirality of the pendent arms; as the number 
of chiral arms is decreased, so is their influence. A similar decrease in the 
magnitudes of emission dissymmetry factors has previously been reported for a 
series of tetra, tri and trans-di substituted chiral amide complexes. 18 
2.2.2.5 Homogeneous Time Resolved Fluorescence Assay (HTRF) 
A model HTRF assay was undertaken in order to assess the potential application of 
[Tb.S]3+ in a FRET experiment. The majority of commercially available HTRF 
assays use europium chelates21 (although examples of terbium complexes are 
available from Wallac/Perkin Elmer; their application has been demonstrated using 
rhodamine as an acceptor by Hemmila et al)22. The ligands used typically incorporate 
chromophores with a triplet energy that is too low to excite terbium. The use of both 
terbium and europium complexes in combination would allow for the possibility of 
undertaking multicolour/multicomponent assays. 
The assay was undertaken at Cisbio International in collaboration with Drs Herve 
Bazin and Nathalie Gregor. Comparison was made to a europium tris-bipyridine 
cryptate labelled in the same way, as will be described below for [Tb.5]3+. It is 
important to note that the experimental setup was optimized for a europium complex 
using nitrogen laser excitation at 337 nm. Emission filter sets were considered to be 
appropriate for both complexes. 
The assay involved monitoring the interaction between the antibody labeled chelate 
Anti-GST -[Tb.S]3+ (Tb-Ab) and a streptavidin-XL665 conjugate (SA-XL) as a 
function of added GST -biotin conjugate (GST -biot). (Figure 2.14) 
GST-biotin 
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Anti-GST= 
cryptate 
Figure 2. 14 - A diagram to illustrate the principle of the HTRF assay monitoring the 
interaction of Tb-Ab and SA-XL as a fuction of added SA-XL 
In the absence of GST -biot, emission is seen only from the terbium chelate. The XL 
fluorescent protein is not excited by the 337 nm laser line used as an excitation 
source. Upon addition of GST -biot, it can interact with its antibody, and biotin with 
streptavidin; this brings the terbium chelate into the proximity of the XL665 
fluorescent protein and energy transfer can then occur from the terbium donor to the 
XL665 acceptor; emission was observed at 665 nm, corresponding to the protein 
based emission. 
2.2.2.5.1 Chelate Activation 
It is necessary that the chelate should react cleanly and at temperatures of 37° C or 
lower with the free thiol groups on the antibody; in order to do this, it is activated as 
a maleimide. 
1 
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Scheme 2. 5 - Activation of the terbium chelate using a sulphonated maleimide bifunctional 
linker 
[Ln.5]3+ was reacted with an excess of the sulphonated maleimide bifunctional linker 
s.SMCC for 30 mins at room temperature. The linker s.SMCC is poorly soluble in 
water and the reagents and product are sensitive to hydrolysis, therefore the reaction 
was carried out in a mixture of DMF and phosphate buffer, maintained at pH 6 - 7. 
After this period the reaction mixture was quenched with water and purified using 
size exclusion chromatography. Unfortunately unreacted chelate could not be 
recovered cleanly from the column, requiring elution with a high-salt buffer (I M 
NaCL 10 % DMF. 10 mM Phosphate); under these conditions some coelution of 
'free maleimide' with the sulfo-NHS species resulted. 
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'Activation' was carried out on both a purified fraction of the complex 
(corresponding to the major peak in its HPLC spectrum) and on the complex prior to 
preparative HPLC. HPLC was also used to confirm that the activation had been 
successful. It is interesting to note that it appeared that each of the peaks that was 
evident in the HPLC trace of the unpurified complex also appeared to shift by the 
same amount corresponding to activation of the complex. This perhaps indicates that 
each of the species also contain the linking functionality and support the propostion 
that the peaks can be explained as stereoisomers, with differing A/8 configurations in 
the NCCN chelates. 
2.2.2.5.2 Antibody Activation and Labelling 
Anti-GST is activated by partial reduction of disulfide bridges usmg DTT 
(dithiothreitol - Cleland' s reagent) the reaction proceeds in 10 minutes at 20°C and 
the product is again readily purified using size exclusion chromatography with 
phosphate buffer as the eluent. 
The maleimide-activated chelate was added to the reduced Anti-GST in phosphate 
buffer (pH 7) to obtain an initial chelate to antibody ratio of 15: 1. The reaction 
mixture was either kept at 37°C for 2 hours (GSS II-chelate Tb (l)) or at 4 °C 
overnight (GSS II-chelate Tb (2)). It was found that, under both sets of conditions, 
conjugates were obtained that gave similar results in the FRET assay. The reaction 
mixture was purified using size exclusion chromatography. 
2.2.2.5.3 Determination of the Average Label/Antibody Ratio 
The number of exposed functions available for labelling on Anti-GST IS not 
accurately known for a given experiment; also, the maleimide function on the 
activated complex is slowly hydrolysed in buffer pH 7 (more slowly at pH 6 or 
below). The true number of chelates per antibody is therefore lower than the initial 
ratio and must be detenllined experimentally in order to make a useful comparison 
between procedures and different complexes. Within a population of labelled 
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antibodies there is a distribution of complexJantibody ratios: it has been proposed 
that a Poisson distribution is approximated;23 therefore, what is actually measured is 
the average number of complexes per antibody. 
Since the extinction coefficients are known for both the antibody and the complex, 
the ratio can be determined by absorbance based techniques. As an example, 
consider labelling with the terbium complex [Tb.5]3+: 
200000 ....... 
- /\ ~ E u 150000 
. / \ ~ :E - - GSS11 CD 100000 u ) - lbPh2dpqC-NH-MCC c 
C'CI 
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Figure 2. 15 - Absorbance spectra of the GSSl1 antibody and the terbium chelate [Tb.6] 
£348 (complex) = 6440 M-1 cm- I 
£280 (complex) = 14480 M-1 cm- I 
£280 (Antibody) = 202500 M-1 cm- I 
If we assume that the spectrum of the conjugate is a combination of the antibody and 
the complex, the average number of complexes per antibody can be calculated by 
measuring the absorbances at 280 and 348 nm and substituting their value into 
equations (4) - (6). From the plot, it is clear that the contribution of the antibody in 
the estimation of the complex concentration (at 348 nm) is negligible but the 
estimation of the antibody concentration must be corrected due to the ub tantial 
contribution of the complex absorption at 280 nm. 
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[Complex] = A348 / £348 (4) 
[Antibody] = A280 - (£280 (chelate) x [chelate]) / £280 (antibody) (5) 
Therefore, labelling ratio = [ chelate] / [ antibody] (6) 
A280(348) = the absorbance of a solution of the chelate labelled antibody in 
phosphate buffer (pH = 6.5) at 280 (348) nm 
the molar absorption coefficient of the Tb chelate (i.e. [Ln.6]) 
at 348 nm 
£280 (chelate) = the molar absorption coefficient of the Tb chelate (i.e. [Ln.6]) 
at 280 nm 
£280 (antibody) = the molar absorption coefficient of the GSS 11 antibody at 280 
nm 
Sample (see below for explanation Labelling Ratio 
of code - chapter 2.2.2.5.4) (Complexes per Antibody) 
GSS11-K Prod 3.9 
GSS11-K 7.0 
GSS 11-chelate Tb (1) 2.5 
GSS11-chelate Tb (2) 3.2 
Table 2.6 - Labelling ratios for the GSSII antibody. GSSII-K Prod = The commercial EuTBP-
antibody labelled conjugate as supplied by Cisbio; GSSII-K = A EuTBP-antibody conjugate 
synthesised at the same time and using the same procedure as described for the terbium chelate 
ILn.5]3+; GSSll-chelate Tb (I) = The (Tb.5]3+ Tb chelate labelled over 2h at 37°C with the 
antibody; GSSll-chelate Tb (2) = The ITb.5]3+ Tb chelate labelled overnight at 4°C with the 
antibody 
2.2.2.5.4 HTRF Assay - The Experiment 
EuTBP (europium tris-bipyridine cryptate) is a commercially available label used in 
IITRF assays (Cisbio) and was therefore used as a reference in order to make a 
comparative assessment of the potential of [Tb.sf+ in similar applications. 
R5 
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Figure 2. 16 - Tris-bipyridyl based europium cryptate (EuTBP) used as a reference compound 
Six different labelled antibodies were prepared to allow a full comparison between 
the two different labelling methods and the effect of adding potassium fluoride to the 
assays. The emissive properties of the europium cryptate complex are sensitive its 
local environment in solution and the presence of a large excess of fluoride (a very 
hard ligand) is necessary to overcome this. The preparations were as follows: 
I) The commercial EuTBP-antibody labelled conjugate as supplied by Cisbio with 
potassium fluoride (GSS II-K Prod + KF) 
2) A EuTBP-antibody conjugate synthesised at the same time and using the same 
procedure as described for the terbium chelate [Ln.5]3+ with KF (GSS II-K + KF) 
3) The [Tb.5]3+ Tb chelate labelled over 2 hours at 37°C with the antibody, without 
KF (GSSII-Tb (1) - KF) 
4) The [Tb.5]3+ Tb chelate labelled over 2 hours at 37°C with the antibody, with KF 
(GSSII-Tb (I) + KF) 
5) The [Tb.5f+ Tb chelate labelled overnight at 4°C with the antibody, without KF 
(GSSII-Tb (2) - KF) 
6) The [Tb.5]3+ Tb chelate labelled overnight at 4°C with the antibody, with KF 
(GSSII-Tb (2) + KF) 
The assay was carried out as follows: 
Where no potassimn fluoride was used, the complex label1ed antibodies prepared as 
above were diluted to 8 nM in phosphate buffer (0.1 M phosphate pH 7 containing 
0.1 0 0 BSA). Streptavidin-XL665 conjugate (SA-XL) \\as diluted to 20 nl\ 1 in 
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phosphate buffer. GST-biotin conjugate (GST-biot) serial dilutions (5nM , 2.5 nM , 
1.25 nM , 0.62 nM and 0.31 nM) were prepared in phosphate buffer. 
To the wells of a black microtiter plate (Costar 96 wells) were added 50 III each of 
the complex-antibody solution, GST-biotin dilution, SA-XL solution and 50 III of 
phosphate buffer. Negative wells were prepared by replacing GST -biotin dilution by 
phosphate buffer. 
Where potassium fluoride was used, the same protocol as described above was used 
(8 nM in phosphate buffer), but in this case 50 III each of the EuTBP-Ab solution, 
GST -biotin dilution, SA-XL solution and 50 III of 1.6 M potassium fluoride in 
phosphate buffer were added to the wells. 
The fluorescence was measured after incubation (overnight 20 DC) on a RubyStar two 
channel (665 nm and 620 nm filters) time-resolved fluorimeter (BMG 
Labtechnologies) and an Analyst spectrofluorometer (LJL BioSystems, 665 nm, 620 
nm and 546 nm filters) set in time-resolved mode (td = 50 lIs , tg = 400 lIS). 
The concentration for labelled antibody refers to the antibody concentration and not 
to the label concentration since the number of label/antibody can change from one 
conjugate to another. 
2.2.2.5.5 Results and Discussion of the Pilot HTRF Assay 
A summary of the results is presented in Table 2.7 below. Both instruments were 
used in time-resolved mode; the intensities reported are the total intensity recorded 
during a gate time of 400 Jls; a delay time of 50 Jls was introduced in order that 
background fluorescent levels would have decayed to zero and scattered light would 
not reach the detector. Each measurement was made in duplicate and the intensities 
recorded in the Table as Ruby 620, Ana 620 and Ana 546 are an average of the two 
measurements. 'Ruby 620' refers to a measurement made on the 'Rubystar' using a 
620 nm emission filter, 'Ana 620' and' Ana 546' refer to measurements made on the 
'8.7 
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'Analyst' uSIng 620 nm and 546 nm emission filters respectively. A comparison 
between the two machines is interesting since they use different excitation sources: 
the 'Rubystar' uses a nitrogen laser (337 nm) and the 'Analytic' a pulsed xenon lamp 
source. The 'Rubystar' has been developed by BMG Labtech in collaboration with 
Cisbio International for use specifically with their europium cryptate based HTRF 
technologies. The Analyst is comparable to the multiwell plate readers more 
commonly used in analytical laboratories and is more easily modified for 
applications using labels requiring different excitation wavelengths and emission 
filters. The 620 nm wavelength corresponds to the strongest Eu i1J = 2 emission band 
and also the Tb i1J = 3 band. The 546 nm band is the most intense terbium i1J = 5 
emissive manifold. Emission from the XL665 fluorescent protein is monitored at 665 
nm. 
Fluorescent intensity measurements can be used to monitor directly the particular 
interaction under study, in this case by monitoring the decrease in intensity of the 
donor and/or the appearance of fluorescence from the acceptor. However, this 
method suffers from problems associated with the 'inner-filter' effect and the 
variability of the optical properties of the media. To overcome this, a ratiometric 
approach can be used. When the acceptor signal at 665 nm is taken as a ratio 
compared to the donor signal (chelate or cryptate), the data obtained is then 
independent of the optical characteristics of the media at the excitation wavelength 
i.e. the emissive intensities of both the donor and acceptor are proportional to the 
optical properties of the medium, such as its transmission. 
Results are normall y reported in terms of their i1FO/o values defined as: 
MOjo = «Calibrator or Sample Ratio - Rationeg) / Rationeg) x 100 
(Rationeg = negative control) 
4 Ratio = (1665 nm / 1620 or 546 nm) X 10 
(7) 
(X) 
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Values of ~FO/o for a senes of complex labelled antibodies provide not only a 
comparison between FRET efficiencies, but also between the labelling and the 
immunoreactivity of the labelled antibody. For instance, for a given antibody, the 
~F% term increases with an increase in the number of complex/antibody, but may 
also decrease as a result of "over labelling" if the complex binds to functionality 
involved in the antibody-antigen recognition. 
XI.) 
Ruby 620 Ana 620 Ana 546 Ruby 665/620 Ana 665/620 Ana 665/546 
Average I/chelate Average Vchelate Average Vchelate DF% DF% DF% 
Blank Buffer - KF 455 227 417 
Blank Buffer + KF 301 196 394 
Sa-XL 5 nM - KF 378 200 411 
Sa-XL 5 nM + KF 300 175 363 
GSS11-K prod 30 2 nM - KF 202181 51841 53123 13621 421 108 
GSS11-K prod 30 2 nM + KF 42096 10794 18754 4809 393 101 
GSS11-K TBP 23 05 2005 2 nM - KF 285773 41000 65843 9447 428 61 
GSS11-K TBP 23 05 2005 2 nM + KF 76088 10916 31629 4538 386 55 
GSS11-Chelate Tb (1) 23 05 2005 2 nM - KF 41873 16550 7574 2993 37871 14969 
GSS11-Chelate Tb (1) 23 05 2005 2 nM + KF 33851 13380 6170 2439 37636 14876 
GSS11-Chelate Tb (2) 23 05 2005 2nM - KF 40830 12563 7434 2287 38029 11701 
GSS11-Chelate Tb (2) 23 05 2005 2nM + KF 31966 9836 6195 1906 37509 11541 
std 0 - 0 nM GST -Biot 42921 11005 19109 4900 401 103 
std 1 = 0.07 nM GST -Biot 43181 11072 18934 4855 393 101 97% 113% 116% 
std 2 = 0.15 nM GST-Biot 43185 11073 19225 4929 372 95 189% 225% 250% 
std 3 = 0.31 nM GST-Biot 42792 10972 18761 4811 350 90 360% 405% 466% 
std 4 = 0.61 nM GST -Biot 41585 10663 18282 4688 349 89 669% 734% 831% 
std 5 = 1.25 nM GST -Biot 40165 10299 17894 4588 361 92 1241% 1309% 1367% 
std 0 - 0 nM GST -Biot 76368 10957 31554 4527 397 57 
std 1 = 0.07 nM GST -Biot 76660 10998 30976 4444 379 54 74% 89% 100% 
std 2 = 0.15 nM GST-Biot 76641 10996 30837 4424 380 55 148% 170% 169% 
std 3 = 0.31 nM GST-Biot 75904 10890 30598 4390 345 49 307% 334% 384% 
std 4 = 0.61 nM GST -Biot 72913 10461 29782 4273 331 47 586% 604% 686% 
std 5 = 1.25 nM GST -Biot 70334 10091 29103 4175 375 54 1207% 1105% 1081% 
std 0 - 0 nM GST -Blot 41285 16318 7567 2991 37340 14759 
std 1 = 0.07 nM GST -Biot 41718 16489 7562 2989 37642 14878 27% 27% 30% 
std 2 = 0.15 nM GST-Biot 40485 16002 7383 2918 38167 15086 52% 53% 54% 
std 3 = 0.31 nM GST-Biot 39275 15524 7276 2876 37854 14962 108% 107% 107% 
std 4 = 0.61 nM GST -Biot 38199 15098 7035 2780 37326 14753 209% 222% 199% 
std 5 = 1.25 nM GST -Biot 35240 13929 6516 2575 35454 14013 432% 402% 398% 
-Biot 32950 13024 6093 2408 36143 14286 
std 1 = 0.07 nM GST -Biot 34369 13585 6141 2427 36935 14559 27% 33% 22% 
std 2 = 0.15 nM GST-Biot 34258 13541 6199 2450 37428 14794 54% 55% 53% 
std 3 = 0.31 nM GST -Biot 34160 13502 6218 2458 37153 14685 104% 
34338 13572 6224 2460 36879 14577 197% 
32049 12667 5918 2339 35035 13848 395% 
517 12467 7503 2308 37429 11517 
40999 12615 7231 2225 38449 11830 27% 42% 14"t. 
40772 12545 7345 2260 38478 11839 50% 73% 45% 
40300 12400 7206 2217 38417 11821 106% 136% 95% 
37927 11670 6812 2096 37775 11623 210% 256% 179% 
36572 11253 6700 2062 37373 11499 423% 483% 349% 
std 0 = 0 nM GST -Blot 34571 10637 6311 1942 37697 11599 
std 1 = 0.07 nM GST-Biot 32851 10108 6143 1890 36656 11279 28% 27% 27"t. 
std 2 = 0.15 nM GST-Biot 34591 10643 6239 1920 37937 11673 50% 53% 61% 
std 3 = 0.31 nM GST-Biot 34737 10688 6216 1912 37797 11630 100% 98% 105% 
sid 4 = 0.61 nM GST-Biol 33473 10299 6068 1867 36685 11288 193% 198% 212% 
sid 5 = 1 25 nM GST -Biot 32677 10054 5985 1841 35786 11011 ,,96"0 
Table 2. 7 - Summary of the results obtained from the pilot HTRF assay 
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A number of conclusions can be drawn from a companson of the .1F% values 
reported in Table 2.7. 
1) For each of the experimental setups (i.e. the instrument used, the excitation source 
and the use of different emission filters) a similar set of results was obtained' this , 
confirms the validity of the method. The ratiometric nature of the analysis eliminates 
many of the 'sample to sample' and 'instrument to instrument' effects that otherwise 
make comparisons difficult. The advantage of the use of a 546 nm instead of a 620 nm 
emission filter for terbium complexes is that it provides a larger signal to noise ratio. 
This permits the use of a lower concentration of label. 
2) Each of the complexes participates in FRET. The terbium complexes each give a 
similar series of .1FO/o values regardless of whether the antibodies were labelled 
overnight at 4 degrees or in 2 hours at 37 degrees, despite having different numbers of 
antibodies per chelate (3.2 versus 2.5). 
3) The presence or absence of fluoride ions has no effect on the .1FO/o values observed 
for the terbium complexes. In contrast the reference chelate has a very strong 
dependence on added fluoride NB. The emissive lifetimes of the terbium chelate in the 
presence of fluoride increased somewhat although the observed decay profile was 
biexponential and exact values were not estimated. 
4) The terbium labelled chelates have .1F% values that are approximately 25 % of 
those of the europium cryptate reference. Whilst, to a small extent this may be due to 
differences in the number of labels per antibody, it is most probably accounted for by 
a less favourable energy match between the donor and acceptor used in this 'proof of 
principle study' . 
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2.2.2.5.6 Summary and Conclusions 
The potential of terbium complex, [Ln.S], as a FRET donor has clearly been 
demonstrated. However, in order to be commercially useful, it is necessary that the 
complex should adopt only one constitutional isomer in solution, similarly to the 
parent triamide dpqC complexes, [Ln.1]. This perhaps may be achieved through the 
use of a chiral amide linker whose structure is more similar to that of the other 
pendent arms. In order to achieve a high FRET efficiency, donor and acceptor pairs 
should be chosen such that their energies are well matched i.e. there should be good 
overlap between the emission spectrum of the donor and the absorption spectrum of 
the acceptor; in the current example, the choice of acceptor has been optimised for 
europium cryptates. Given the range of fluorescent proteins and organic fluorophores 
that are available (Chapters 1.4.1 and 1.4.2); systematic screening should provide a 
suitably matched pair. Finally, if terbium complexes are to be used as components in 
HTRF assays, it is necessary to carry out an extensive study to determine possible 
interferences. The higher sensitivity of this series of terbium complexes to quenching 
by a charge transfer process, compared to their europium analogues is covered in 
some detail in Chapter 3. 
2.3 Longer Wavelength Excitation - Tetraazatriphenylene N-
Oxides 
The tetraazatriphenylene sensitising moiety dpqC has a longest wavelength excitation 
band centred at 348 nm. Biological tissue is poorly transparent to ultraviolet 
irradiation and, whilst 348 nm is on the borderline of what is acceptable, it is desirable 
to red shift the absorption spectrum of the chromophore such that light of longer 
wavelength could be used. However, a limiting value is defined by the energy of the 
lanthanide elnissive state. In order to efficiently sensitise terbium, the chromophore 
should have a triplet energy that is more than 1500 - 2000 cm- I above the terbium 504 
emissive state (20400 cm- I ). Inherently, the energy of the chromophore triplet state is 
lower than the lowest energy singlet excited state from which intersystem crossing 
occurs, and which corresponds to the longest wavelength 0-0 transition in the 
absorption spectrum. The N-oxide of dpqC was synthesised with the aim of shifting 
its 101l!.!,cst wavelcn!.!,th absorbance to lower energy. 
'- '-
<)1 
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Figure 2. 17 - Structure of the tetraazatriphenylene-N oxide based lanthanide complex, (Ln.7J 
2.3.1 N-Oxide of Chloromethyl-tetraazatriphenylene 
The electronic interaction between a sensitising chromophore and the lanthanide to 
which it is coordinated is typically small and its photophysical properties are not 
expected to vary greatly upon binding (perhaps with the exception of ligands that 
undergo a conformational change upon coordination). Photophysical measurements 
that are made on the unbound chromophore generally provide a good means to assess 
its utility as a sensitiser. 
2.3.1.1 Synthesis of the N-oxide 
CI CI 
H 202/Acetic Acid 
.. 
6 38 
Scheme 2. 6 - Synthesis of dpqC-N Oxide, 38 
The N-oxide of the chloromethyl derivative of dpqC, 6, was prepared following a 
literature preparation for the synthesis of 2,9-dimethyl-l, 1 O-phenanthroline-N-oxide. 24 
The reaction was carried out using hydrogen peroxide in acetic acid; peroxyacetic 
acid was generated in situ, which reacted with 6 to form the mono-N-oxide, 38. 
Phenanthroline-di-N-oxides do not form unless extremely forcing conditions are used. 
The product was purified by column chromatography on alumina using a 
dichloromethane/methanol solvent system. I H NMR characterisation demonstrated 
that oxidation occUlTed only on the least hindered nitrogen as sho\\'n (38). 
9J 
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2.3.1.2 Photophysical Properties of dpqC-N-oxide 
2.3.1.2.1 Determination of the Longest Wavelength Absorbance 
Figure 2.18 depicts the absorption spectra of the chloromethyl derivative of dpqC, 29, 
and its N-oxide, 30. The form of the spectrum is similar for both compounds, but each 
of the major peaks was shifted to lower energy for the N-oxide. The longest 
wavelength absorbance showed a red-shift of 27 nm from 348 nm to 375 nm. At 400 
nm the absorbance remained significant, at approximately 25 % of its intensity at 375 
nrn. 
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Figure 2. 18 - Absorption spectra for the chloromethyl derivative of dpqC, 29, and its N-Oxide, 
30, in H20 at 295 K 
2.3.1.2.2 Measurement of the Triplet Energy 
Methodology used to detennine whether a particular chromophore has a sufficiently 
high triplet energy to sensitise europium and terbium traditionally involve synthesis of 
a gadolinium analogue of the target complex: gadolinium cannot be sensitised since 
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its first excited state lies at 32 150 cm- I , well above the aryl triplet state of any useful 
chromophore.25 However, for the reasons mentioned above (2.3.l), determination of 
the triplet energy of the unbound chromophore generally allows a good assessment to 
be made as to whether sensitisation of europium and terbium is feasible for a 
particular sensitiser.26 
The phosphorescence spectrum of the chloromethyl dpqC-N-oxide, 30, was recorded 
in an EPA glass at 77 K, its triplet energy was determined from the shortest-
wavelength transition to be 23 200 cm- I , significantly above the Eu (17,200 cm- I ) and 
Tb (20,400 cm- I ) emissive states. Consequently, synthesis of the complexes was 
undertaken. 
2.3.2 N-Oxide Lanthanide Complexes 
Degradation of the N-oxide of the chloromethyl-dpqC chromophore occurs on 
storage, therefore it was decided to undertake oxidation at the final stage, prior to 
deprotection of the ligand, and complexation. 
2.3.2.1 Synthesis 
H20;!Acetic Acid ~ 
.. 
40.41 
Scheme 2. 7 - Synthesis of the N-oxide derivative of LnD03AdpqC, I Ln.31 
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The ligand I-dpqC-4,7, 1 O-tris(tert-butyloxycarbonylmethyl)-l ,4,7,10-
tetraazacyclododecane, 26, was reacted with hydrogen peroxide in acetic acid. Work-
up for the reaction involved neutralisation with aqueous Na2C03, and extraction into 
dichloromethane. Fonnation of the N-oxide was confirmed by electrospray mass 
spectrometry and I H NMR and given that only one product was observed using thin 
layer chromatography, 39, was used without further purification. Deprotection of 39 
was monitored by I H NMR and the ligand was used immediately for complexation 
with Eu(IlI) and Tb(Ill) salts. 
2.3.2.2 Characterisation 
Initial characterisation by electrospray mass spectrometry indicated that synthesis of 
the europium and terbium complexes, [Ln.7], had been successful; although peaks 
were also present with mlz values consistent with the corresponding complexes [Ln.3] 
i.e. LnD03AdpqC, lacking the N-oxide functionality. Both metals appeared to be 
sensitised and the absorption spectrum of both complexes had the same form as for 
compound 38, although the intensity of the 375 nm transition appeared to be weaker 
than for the free chloromethyl-dpqC-N-oxide. However, after several hours in 
solution, the absorption spectrum of the complex again resembled that of [Ln.3], i.e. 
the transition to longer wavelength was lost, indicating the degradation of the 
chromophore. Loss of the peak corresponding to europium and terbium [Ln.7] was 
also confirmed by mass spectrometry. 
Unfortunately whilst the photophysical properties of the chromophore are very 
promising, the poor stability of their complexes with respect to reduction in solution 
limits their utility. The mechanism by which decomposition occurs is not well 
understood. The observation that both the europium and terbium complexes degrade 
suggests that reduction is not mediated by electron transfer involving the metal centre. 
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2.4 Phosphinic Acid Complexes 
Through the coordination of three pendent phosphinic acid arms to cyclen, it is 
possible to synthesise a series of complexes of neutral charge. The overall 
lipophilicity of the complex can be modified through the use of different alkyl or 
aromatic phosphinate arms. Two ligands were synthesised bearing methyl 
phosphinate [Ln.8] and benzyl phosphinate [Ln.9] functionality; the reasons why 
these complexes were synthesised and details about their properties are explained 
further in Chapter 3. 
N~ 
\ ~ 
N 
N~ 
\ ~ 
N 
[Ln.8] [Ln .9] 
Figure 2. 19 - Structures of complexes LnPMe3dpqC, (Ln.8] and LnPBn3dpqC, /Ln.9) 
2.4.1 Synthesis and Characterisation 
There are two approaches that may be adopted for the synthesis of cyclen based 
complexes bearing three pendent phosphinic acid arms and a tetraazatriphenylene 
chromophore. The first involves tris-protection of cyclen, follow by alkylation with 
the chromophore, then deprotection of the remaining positions and functionalisation 
as the methyl or benzyl phosphinate. The second is the reverse of this process, 
whereby the pendent arms are attached first and the chromophore sUbsequently. This 
second method requires a more involved protection strategy, but less chromophore is 
used to achieve the same final yield, since its attachment is only at the final stages of 
the synthesis and, as a result, is not wasted in the intermediate purification steps. Both 
methods were adopted, the first in the preparation of [Ln.8] and the second for [Ln.9]. 
2.4.1.1 Methyl Phosphinic Acid Complexes 
98 
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PMe(OEth I THF 
(CH20)n, reflux, 16h 
ND 6M HCI \ h .4--________ _ 
LnCI3·6H20 
H20/MeOH 
pH = 5.5 
N 
(as a mixture of 
d iastereoisomers) 
Scheme 2. 8 - Synthesis of LnPMe3dpqC, (Ln.8] 
Synthesis of the tri-Boc species 8 was described earlier for the amide based series of 
complexes [Ln.1, 2 and 4]. Deprotection using TFA in dichloromethane proceeded 
cleanly to give the mono-alkylated cyclen species, 9. Condensation with anhydrous 
paraformaldahyde in dry THF yielded an intermediate hydroxymethyl species which 
following dehydration was trapped with methyl diethoxyphosphine to give the 
corresponding methylphosphinate ester 42. Methyl diethoxyphosphine IS 
commercially available. Exclusion of moisture from the mixture was essential to 
prevent fonnation of hydroxymethylphosphinate esters; the reaction \Vas carried out 
using a Soxhlet apparatus containing 4 A molecular sieves to scavcnge any water. The 
yield from the reaction was difficult to gauge due to the inefficiency of thc 
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purification step. Thin layer chromatography revealed the product 42 to streak 
considerably on silica. Alumina appeared more promising using a mixture of 
methanol and dichloromethane to elute the product, but the recovered yield was less 
than 10 0/0. The following deprotection step progressed smoothly and the terbium(III) 
complex was synthesised without further purification. Characterisation of the free 
phosphinic acid ligand proved very difficult due to its low solubility in all but strong 
acid. Some success was met by carrying out the hydrolysis step in an NMR tube in 
order to monitor the characteristic change in the 31 P spectrum upon going from a 
phosphinate ester (8p 53.2 ppm) to a phosphinic acid (8p 37.7 ppm, pH 5). 
2.4.1.1.1 Absorption and Emission Spectra 
The absorption and emission spectra of the terbium complex are again consistent with 
those reported for the parent triamide and D03A based complexes. 
2.4.1.1.2 Quantum Yield and Lifetime 
TbPMe3dpqC displays an exceptionally long emissive lifetime in water of 2.9 ms and 
has a luminescent quantum yield of 49 0/0. This is one of the highest values yet 
reported for a lanthanide chelate. 
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2.4.1.2 Benzyl Phosphinic Acid Complexes 
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53.54 
The methodology used for the synthesis of the tribenzyl phosphinic acid complexcs, 
53 and 54, wcrc similar to that used for their methyl analogues, H()\\'cYcr. in this case 
the first steps \vere targeted towards phosphinate functionalisatioIl, Alkylation \\'ith 
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the chromophore was performed just prior to hydrolysis of the phosphinate ester and 
complexation. 
Previous attempts within the group to directly synthesise the tris-phosphinate complex 
50 using stoichiometric quantities of reagents have been met with only limited 
success; this is due to the formation of a distribution of mono, di, tri and the tetra 
substituted product. These could not be successfully separated by chromatography to 
give a good recovered yield. An alternative approach is to use a multi-step protecting 
strategy: the final aim is to obtain a mono-protected cyclen species in order that an 
excess of phosphine starting material can be used to 'drive' the reaction to 
completion; it should also allow easier chromatographic separation of the mixture. 
The basis of the protection strategy was to functionalise cyclen with two different 
protecting groups, one of which is base labile and the other acid labile. Whilst a few 
methodologies are available to monofunctionalise cyclen in one reaction (such as 
through its prior coordination to a molybdenum tricarbonyl complex) it was thought 
that this multistep approach would be both higher yielding and more amenable to 
scale-up. 
Synthesis of the tris-trifluoromethyl amide protected cyclen species was accomplished 
on a 109 scale by dropwise addition of ethyl trifluoroacetate onto a mixture of cyclen 
and triethylamine in ethanol at 0 °C over 30 minutes. After being allowed to warm to 
room temperature with stirring overnight, the volatiles were removed in vacuo and the 
crude product purified through a plug of silica using 100 % ethyl acetate as the eluent. 
The pure product was obtained in 85 % yield. There was no evidence for over-
alkylation leading to the tetra species. 
Surprisingly, further alkylation of 45 did not proceed easily and required very long 
reaction times and the periodic addition of a large excess of (Boc )20 . It is worth 
noting that (Boc )20 can also slowly react with methanol under the reaction conditions 
used. However the reaction did not proceed at all using the non-polar solvent 
dichloromethane. Following purification of 46 by column chromatography, the 
tritluoroacetamide protecting groups wcre removcd cleanly with base to gi\l~ ,,(7. 
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The benzyl phosphinate anns were introduced using the same procedure as described 
leading to the methyl phosphinic acid based complex 35 by condensation of the 
secondary cyclen amine groups with parafonnaldehyde in the presence of benzyl 
diethoxyphosphine (synthesized by reaction of dimethoxychlorophosphite with a 
benzyl magnesium Grignard and purified by distillation). Following an Arbuzov 
rearrangement the ester 51 was obtained. Functionalisation with the 
tetraazatriphenylene chromophore following deprotection of 51 with TF AlCH2Ch 
was straightforward and followed the same procedure as has previously been 
described. Purification was achieved by column chromatography on alumina using 
dichloromethane and methanol as eluents. Unfortunately, once again recovery from 
the column was low. Hydrolysis of the phosphinate esters proceeded in 6 M 
hydrochloric acid and complexation was carried out in a mixture of methanol and 
water at pH 5.5. The complex precipitated out of solution upon formation. 
2.4.1.2.1 Solubility 
The high lipophilicity of the peripheral benzyl phosphinic acid arms unfortunately led 
to very poor solubility of the europium and terbium complexes [Ln.9]. The only 
solvent system that could be found in which the complexes had a reasonable solubility 
limit was a 1: 1 mixture of methanol and dichloromethane leading to some problems 
associated with their characterization. 
2.4.1.2.2 Emissive Lifetimes and Determination of the Number of Bound 
Water Molecules, q 
Whilst the solubility limit of the complexes in water is very low, it was possible to 
obtain emissive lifetimes and from these, q-values could be determined. Due to the 
relatively poor signal to noise ratio it is estimated that the values are only accurate to 
within 20 0/0. The quoted lifetimes represent an average value obtained following three 
repeat measurelnents. 
10) 
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Complex 'tH20 'tD20 q 
[Eu.9] 1.14 1.69 0.05 
[Tb.9] 1.13 1.80 1.3 
. . Table 2. 8 - DetermmatlOn of the number of water molecules, q, coordinated to the lanthanide 
centre 
The europium complex was found to have no bound water molecules and to have a 
relatively long lifetime, as predicted from an analysis of the parent benzylphosphinic 
acid species. The terbium complex in contrast had a non-zero q value and a lifetime in 
water that is considerably lower than would be predicted (the lifetime of the methyl 
phosphinic acid analogue is 2.9 ms). It is suggested that the steric bulk of the ligand 
leads to 'overcrowding' around the metal centre and whilst complete coordination is 
possible for the slightly larger europium centre, for terbium it is not. The two 
complexes were synthesized at the same time, under identical conditions using the 
same batch of ligand. The synthesis was also repeated to confirm the result. 
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3 Quenching Studies 
The susceptibility of a series of europium and terbium complexes to quenching of the 
lanthanide excited state via a charge-transfer interaction by common electron-rich 
donors is assessed herein. The aim of the analysis is to gain both an appreciation of 
the mechanism that is in operation and to allow the future synthesis of complexes 
that show a reduced sensitivity. Finally, differences between europium and terbium 
complexes of a common ligand to quenching by urate and ascorbate are exploited in 
the development of a ratiometric method for the determination of uric acid 
concentration in biological fluids. 
3.1 Dynamic Quenching of the lanthanide excited state1 
For the case of sensitised emission by an organic chromophore, there are three 
excited states that may be perturbed: the singlet and triplet excited states of the 
chromophore and the lanthanide emissive state. Two key features that make the 
ligand dpqC particularly interesting are the facility of S\ to T\ intersystem crossing 
(and hence also its lack of fluorescence) and the negligible sensitivity of the triplet 
state to quenching by mechanisms other than energy transfer to the lanthanide 
excited state. \ In the absence of competitive chromophore localised deactivation 
processes, it is possible to probe the susceptibility of the lanthanide to dynamic 
quenching by a charge transfer mechanism. In addition, the nonadentate nature of the 
ligands used in the present investigation excludes water from their coordination 
sphere and hence quenching by vibrational energy transfer to OH oscillators is 
minimised.2,3 
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HNt _0 r\\ 
,N. ,.N-, \ ,1 
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NH 
Ph~ 
Me 
Figure 3. 1 LnPh3dpq3+ 
It has been reported in preliminary work,4 that upon addition of iodide or Fe(CN)64-
to the parent dpq triamide complex EuPh3dpq3+ (Figure 3.1), a decrease in both the 
intensity and lifetime of the metal centred emission is observed. A change in lifetime 
leads implicitly to the conclusion that the lanthanide excited state is directly involved 
in the quenching process. 
It is proposed that the free energy of the excited lanthanide ions (Tb and Eu excited 
states lie at 2.52 and 2.13 eV respectively) can be used to 'drive' the charge transfer 
process in quenching by electron rich species. The feasibility of this process can be 
assessed using the Weller equation (Equation 1 ):5 
Ln* 2/] 1-1 ~GET = nF[(Eox - Ered) - E - e £r J mo (1) 
Eox is the oxidation potential (versus NHE) of the electron donor (quencher, Q), 
Ered is the reduction potential of the acceptor (ligand or metal based) in the complex, 
ELn* is the energy of the lanthanide excited state, 
e2/£r is a Coulombic attraction correction term associated with the formation of a 
transient ion pair (or radical/ion) and is typically small « 0.2 eV). 
As an example of this approach, consider the quenching of EuPh3dpq3+ by iodide in 
the first instance and, secondly, the plausibility of quenching with chloride. 
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Example J: Given that the iodide oxidation potential is +0.54 V and that both the 
reduction of related cationic Eu(llI) complexes6-9 (metal-centred at -1.1 V) and of 
related [Ru(bpYhdpqC]2+ complexes (ligand-centred at -1.07 V)IO occur at a similar 
potential, then Equation 2 applies, giving a favourable free energy change of -65 kJ 
1-1 mo . 
~GET = 96.5[(0.54 + 1.07) - 2.13 - 0.15] = -65 kJ morl (2) 
Example 2: The oxidation potential of a chloride ion is +1.36 V. All other values 
remain constant and application of the Weller equation leads to Equation 3 and gives 
an unfavourable free energy of + 14 kJ mOrl. 
~GET = 96.5[(1.36 + 1.07) - 2.13 - 0.15] = +14 kJ mor l (3) 
This analysis is in line with the insensitivity of the europIUm emISSIon 
intensity/lifetime (± 10 %) to added chloride ions (up to 100 mM). The magnitude of 
the second-order rate constant that defines the iodide quenching process is of the 
order of 105 M- I S-I. This is a rather low value compared to the values of> 109 M- I S-I 
that characterise dynamic quenching of aryl triplet states by O2. This probably 
reflects the inhibition to collisional encounter on diffusion (i.e. the longer range 
nature of the process), associated with the relative inaccessibility of the encapsulated 
lanthanide to the quenching species. 
3.1.1 Susceptibility of a series of Cationic, Neutral and Anionic 
Complexes to Quenching by Electron Rich Species 
The photophysical properties of lanthanide complexes in solution (i.e. their molar 
absorption coefficients, quantum yields and emissive lifetimes) can be optimised 
through the careful choice of a sensitising chromophore and its incorporation into a 
suitable macrocyclic ligand framework. Usually, it is these factors that are used to 
out1ine the potential of the complexes for fluorescence based applications. However, 
if the complex is to be used in biological media. it is important to han? an 
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understanding of how other chemical species will affect these properties. Complexes 
such as LnPh3dpq (Figure 3.1) are highly emissive and, as has been previously 
described, are insensitive to the usual quenching mechanisms that would otherwise 
limit their utility, in particular in aerated aqueous media. This insensitivity is evident 
from their very high quantum yields that are observed under these conditions. 
However, electron-rich species that have an oxidation potential lower than that of 
iodide (e.g. ascorbate, urate, and polyhydroxyaromatics) are common in biological 
media and, as such, have the potential to quench the metal excited state similarly 
through a charge transfer mechanism. 
Me
yPh 
HNr-O \ r\, \ r N. ,N---, N ~ ~Ln--J 
Ph ~\ ~N' \'~') )-  LJ N N _ \ 
Me H o NH 
Ph.-Z. 
Me 
[Ln.1]3+ [Ln.2] 
[Ln.3] [Ln.4]~ = 
Figure 3.2 [Ln. 1]3+ = LnPh3dpqC, [Ln.2] = LnAla3dpqC, [Ln.3] = LnD03AdpqC, [Ln.4] 
LnGlu3dpqC 
In order to understand better and minilnise this quenching process, an analysis was 
. f 1 s [Ln 1-4] with cationic, 
undertaken of the structurally related senes 0 comp exe . 
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neutral and anionic charge. Inherent in a charge-transfer mechanism is the need to 
form an encounter-complex between the electron donor and acceptor; it was thought 
that by varying the overall charge on the complex and in particular by increasing the 
electrostatic repulsion around the periphery that these factors may disfavour 
encounter-complex formation and, as a result, reduce the efficiency of the quenching 
process. 
3.1.1.1 Stern-Volmer Quenching Constants 
The differing sensitivities of complexes to collisional quenching can be described 
using the Stem-Volmer equation: 
loll = 1 + kq'to[Q] = 1 + Ksy[Q] (4) 
where 10 and I are the luminescent intensities in the absence and presence of 
quencher, kq is the rate constant for a bimolecular quenching process, 'to is the 
emissive lifetime of the complex in the absence of quencher and [Q] is the 
concentration of the quenching species. The term Ksy is the Stem-Volmer quenching 
constant and has units of M- 1• For convenience we usually quote KSy-1 and use units 
of mM. The term KSy-1 defines the concentration of quencher needed to reduce the 
luminescent intensity to 50 % of its initial value. 
For a dynamic quenching process, equation (5) applies revealing the concomitant 
emission lifetime variation. 
'to/'t = loll = kq'to[Q] = 1 + Ksy[Q] (5) 
Stem-Volmer plots were obtained for each of the europium and terbium complexes 
[Ln.2-5] in pH buffered solution (HEPES, 100 mM, pH 7.4), in the presence of 
sodium chloride (1 OmM). The range of quenching species included, in addition to 
selected halide ions: urate (urine concentrations are usually 1 -- 4 mM, serum 
concentration are typically 10 times lower). ascorbate (typically 0.2 mM) and 
I 12 
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glutathione (well-established low molecular-weight anti-oxidants). 1 1- 13 
Representative plots are shown in Figures 3.3 and 3.4. The concentration of 
glutathione in serum or selected cells is typically much lower than that of ascorbate 
and averages 60 JlM in human serum. 14 Ascorbate is found at much higher 
concentrations (0.8 to 2 mM typically) in oxygen-sensitive tissues such as the eyes, 
adrenal glands and in the heart, liver and brain. 15 
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x TbGlu3dpqC 
- Linear (TbPh3dpqCCI3) 
- Linear (TbD03AdpqC) 
- Linear (TbGlu3dpqC) 
- Linear (EuPh3dpqCCI3) 
Figure 3. 3 - Stern-Volmer plots for the quenching.of ~u and TbPh3dpqC, fLn.l1, 
TbD03AdpqC, [Ln.21 and TbGlu3dpqC, [Ln.5] by IOdide, over the range 0 - 5 mM. 
Experimental conditions: Complex (10 ~), HEPES (100 mM, pH 7.4), NaCI (10 mM), 298 K. 
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Figure 3.4 - Stern-Volmer plots for the quenching of Eu and TbPh3dpqC, [Ln.ll , 
TbD03AdpqC, [Ln.2] and TbGlu3dpqC, [Ln.51 by ascorbate, over the range 0.1 - 0.5 mM. 
Experimental conditions: Complex (10 ~M), HEPES (100 mM, pH 7.4), NaCI (10 mM), 298 K. 
3.1.1.2 Results and General Trends Derived From Stern-Volmer 
Quenching Constants 
Stem-Volmer constants, KSy- 1 (mM) for quenching with urate, iodide and ascorbate 
are presented in Table 3.1 for the series of complexes [Ln.2-5]. 
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Complex Urate Iodide Ascorbate 
EuPh3dpqC3+ 
[Eu.1] 0.067 27.0 0.39 
TbPh3dpqC3+ 
[Tb.1] 0.020 0.90 0.18 
EuD03AdpqC 
[Eu.3] 0.040 >1000
a 4.31 
TbD03AdpqC 
[Tb.3] 0.006 2.10 0.30 
EuAla3dpqC 
0.048 >1000a 1.13c [Eu.2] 
TbAlaMe3dpqC 
0.008 4.97 0.42 [Tb.2a] 
EuGlu3dpqC3-
0.084 >1000a 2.55c 
[Eu.4] 
TbGlu3dpqC3-
0.012 2.50 0.38c 
[Tb.4] 
Table 3. 1 - Ksv-1 (mM) values for the complexes (Ln.1-4] (lOliM complex, 100 mM HEPES pH 
7.4, 10mM NaCI). N.B. (Tb.2] was re-esterified to give the tris-methoxy ester, (Tb.2a), in order 
to provide a further example of a cationic complex. Ksv·t values for glutathione were (Eu.I), 24 
mM, (Tb.I), 20 mM. Quenching by bromide/chloride was only observed at very high 
concentrations (> 1 M).3 No significant quenching was observed at iodide concentrations up to 
t M. C Curvature was observed in the Stern-Volmer plots of these complexes above - 0.5 mM. 
From an analysis of the Ksv-I values presented in Table 3.1, a number of trends are 
evident: 
• In each case, the terbium complexes are quenched considerably more strongly 
than their europimll analogues; this is consistent with the proposed 
mechanism that it is the excited state energy of the lanthanide that is dri\'ing 
the quenching process (i. e. due to the higher energy of the terbium 504 state). 
1 \ ~ 
• 
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The sequence of sensitivity to quenching generally follows the ease of 
oxidation of the quenching anion, i.e. ascorbate» r »> Br-;Cr. Glutathione 
does not readily fall into this sequence but is only partially ionised under the 
pH conditions used (thiol pKa is 8.66). Given its one electron oxidation 
potential compared to ascorbate, urate is surprising in that for each of the 
complexes studied it quenches more strongly (Chapter 3.1.1.3). 
• The anionic and neutral complexes are the least quenched by ascorbate and 
iodide as would be predicted using simple Coulombic considerations. 
Quenching by urate is again anomalous: the most sterically crowded 
complexes in this case are the least quenched; the neutral and least sterically 
shielded D03A complexes are the most quenched. 
• For the range of terbium complexes, the difference in sensitivity to quenching 
between ascorbate and iodide remains approximately constant with a relative 
factor of 5 to 10. (For europium it is not so clear since quenching by iodide is 
inefficient due to the lower excited state energy of the metal ion. At the high 
concentrations needed to observe a change in lifetime, static quenching 
becomes significant). With urate, there is considerably more variation from 
complex to complex. For example, complex TbPh3dpqC is approximately 10 
times more quenched by urate than ascorbate, whereas for TbD03AdpqC, the 
difference is of the order of 50 times. 
• The Stem-Volmer plots have constant gradient (Figures 3.3 and 3.4), but the 
range of quencher concentrations had to be carefully chosen; above a certain 
value the rate of change of 'tolr versus concentration of quencher decreases 
and curvature is apparent in the Stem-Volmer plot. i.e. a limiting value is 
reached. (Chapter 3.l.l.5). 
3.1.1.3 Accounting for the Enhanced Susceptibilities to Quenching 
by Urate compared to Ascorbate 
The ability of a cOlnpound to donate an electron is usually affected by its protonation 
. I 16.17 d b I state; the pKa values for ascorbate and urate are 4.2 and 5.4 respectIve y an ot 1 
exist as the mono-anion in neutral aqueous solution. Under these conditions. their 
I 16 
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one-electron redox potentials (vs NHE, 298 K) are 0.30 V and 0.59 V for ascorbate 
and urate respectively.17 The simple argument that holds true for the halides and 
ascorbate that show enhanced quenching ability with decreasing oxidation potential 
would predict that ascorbate should quench more strongly than urate. However, this 
trend is reversed and indeed, the Stem-Volmer quenching constants that define the 
deactivation of the lanthanide excited state by urate are, in some cases, more than an 
order of magnitude lower than for quenching with ascorbate. 
H02~Oyo 
HO )=\_ 
-0 OH 
Urate Ascorbate 
Figure 3.5 
Consideration of the structures of ascorbate and urate (Figure 3) and how they might 
interact with each of the complexes can perhaps help to provide some insight into the 
quenching mechanism. Urate has a 2-dimensional structure with an electron-rich 1t-
system in which charge is delocalised. 17.1 Ascorbate, in contrast, has a less 
conjugated 1t-system and is significantly more hydrophilic. 
Scheme 3.1 is a representation of the classic kinetic scheme proposed by Rehm and 
. d I t fi 18. 19 Weller for excIte state e ectron rans er. 
A* + 0 (A* D) A·- + 0·+ 
11't o 
A+O 
Scheme J. 1 - Rehm and Weller kinetic scheme for quenching via excited state electron transfer 
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Integral to electron transfer, is the formation of an encounter complex between the 
excited acceptor and the donor. 
It is tentatively suggested that quenching could be further enhanced by the presence 
of a weak, but favourable binding interaction, such as 1t-stacking involving the 
electron poor dpqC moiety. The neutral complexes LnD03AdpqC, [Ln.3], have the 
least steric crowding and, as such, have the most accessible chromophore; they 
would therefore be expected to be the most strongly quenched where such 
interactions are possible. The cationic complexes LnPh3dpqC, [Ln.2], in contrast, 
have the most aromatic character and are sterically crowded; any 1t-stacking 
interaction with the chromophore would likely be inhibited or at least greatly 
reduced. 
A 1t-type binding interaction may also introduce an additional quenching mechanism. 
It has been reported by several authors that for planar aromatic donor-acceptor pairs, 
quenching may be due to an exciplex quenching mechanism rather than through the 
c: . f d· I· . (S h 3 2) 19a,l9b lormatIon 0 ra lca -Ion paIrs c erne . . 
A* + D (A* D) 
1/'(0 1/'(0 
A+D A+D 
Scheme 3. 2 - Suggested kinetic scheme for quenching of pairs of planar aromatic compounds 
through an exciplex mechanism 
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3.1.1.4 Susceptibility to Quenching by Hydroxyaromatics 
0-
Vanillin 
Figure 3.6 - Structure of Vanillin, pKa = 7.4 
If the higher susceptibility to quenching of the complexes by urate when compared to 
ascorbate is due to the presence of a 1t-type binding interaction, then it would be 
predicted that other planar aromatic anions, with a suitable redox potential should 
show similar behaviour. A systematic analysis of a series of such compounds (for 
example Vanillin, pKa = 7.4, Eox ~ 0.5 V Figure 3.6) is currently underway at 
Durham. Preliminary results appear to be consistent with the proposed hypothesis. 
3.1.1.5 Incomplete Quenching of the Lanthanide Emissive State 
With each quenching species, it was noted that an upper limit may be reached, for a 
given complex, where the rate of change of 'tOiL with increasing quencher 
concentration tends to zero; such behaviour leads to curvature in the Stem-Volmer 
plot. As a result, the range of concentrations of a given quencher had to be carefully 
chosen, in order for classic Stem-Volmer behaviour to be observed. The ranges used 
were: for iodide 1 - 5 mM, for ascorbate 0.1 - 0.5 mM and for urate 10- 50 J..lM (the 
complex was used at a concentration of ~ 10 J..lM). However, the point at which this 
limit was reached with a given quenching species appears to be dependent upon the 
complex under study. For example, for quenching of the LnPh3dpqC complexes, 
[Ln. I ], with urate, it was apparent that a limiting lifetime is reached at low urate 
concentration and, in fact, some curvature was apparent in their Stem-Volmer plots 
in the range 100 - 200 J..lM. For the neutral and anionic complexes [Ln.2-"'J 
concentrations 5-10 tilnes as high were required before their Sten1-Volmer plots 
became non-linear. In contrast, the observed beha\iour is reversed for quenching 
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with ascorbate; limiting values were only observed with the hydrophilic neutral and 
anionic complexes [Ln.2,4]. 
These observations appear to suggest that limits are reached at lower added quencher 
concentrations, where there is the possibility of some favourable association between 
the complex and the quenching species (not involving the chromophore). This could 
be, for example, through a hydrogen-bonding interaction with ascorbate, or for urate, 
by some hydrophobic attraction. Incomplete quenching of the lanthanide excited 
state is indicative of the inefficiency of the quenching mechanism. It is suggested 
that the point at which the Stern-Volmer plots become non-linear defines the point at 
which kq[ q] = kern, i.e where the combined rate constant for deactivation of the 
lanthanide excited state is equal to the emissive lifetime of the complex. At very high 
quencher concentrations the emissive intensity decreases further, suggesting that 
static quenching or quenching of the chromophore excited states becomes significant. 
The quenching behaviour of the complexes studied here is clearly complex and care 
should be taken in assessing complexes for a particular application based only on a 
comparison of their Stern-Volmer quenching constants. 
3.1.2 Behaviour of Neutral Phosphinate Complexes Assessing the 
Importance of Lipophilicity 
From the analysis of complexes [Ln.2-5], a number of features have been identified 
that appear to affect the susceptibility of the complexes to quenching by electron rich 
donors. In order to minimise quenching by urate, it should possess one or more of the 
following attributes: high lipophilicity, a positive charge, aromatic pendant arms on 
the cyclen ring or steric bulk. Quenching by simple anions and ascorbate is less 
efficient where the complex is either neutral or negatively charged, incorporates 
hydrophilic pendent arms or where the lanthanide ion is sterically shielded. It is only 
through the synthesis of further groups of complexes that the relative importance of 
each of these features can be more fully understood. 
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Complexes [Ln.8,9] were synthesised in an attempt to discern the I t' . 
re a Ive Importance 
of charge and lipophilicity/hydrophobicity. 
[Ln.8] [Ln.9] 
Figure 3. 7 - Structures of LnPMe3dpqC, [Ln.8] and Ln,PBn3dpqC, [Ln.9] 
The parent mono-anionic tetraphosphinate complexes 8, 9 have been synthesised 
previously in Durham. 
Me, F? ° Bn ,0, 
, ° p- p-( r\, /- ,~e ( r\, /- ,,_Bn 
,-N N-, f\-o ,-N. "N-, f\-o ~'Ln"-r0 I L -0 
° L-.. ' \' .-J O~ \n:- .J 0' N N 0' N N Me~P-'/ L J ) Bn~P-,/ L J ) 
O-~ O-p, 1/ M II 
° e ° Bn 
Figure 3. 8 - Structures of Tetra-phosphinate complexes LnPMe4 (left) and LnPBn4 (right) 
LnPMe4 LnPBn4 
log P -4.75 -0.66 
Tb<j> 
em 0.01 0.44 
EU<j> 
em 0.6 X 10-3 0.9 X 10-3 
Tb / LH20 ms 2.96 4.13 
Eu / LH20 ms 1.25 1.59 
Table 3. 2 - Partition coefficients, quantum yield and lifetime values for the complexes LnPMe4 
and LnPBn4' Log P values were measured for the lS3Gd complexes in octanol/water.3 
A partition coefficient (Log P) of -0.66 demonstrates the high lipophilicity of the 
tetrakis(benzylphosphinate) complexes. 3 It was therefore thought that the related 
complexes [Ln.9] with a dpqC sensitising moiety would pro\ide examples of highly 
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lipophilic complexes, but which are charge neutral, for comparison with complexes 
[Ln.I-4]. The methyl analogue, [Tb.8] was also prepared as a control. 
3.1.2.1 Stern-Volmer Quenching Constants and Discussion 
A number of problems were unfortunately encountered in synthesising the benzyl 
phosphinate complexes, [Ln.9]. The ligand is sterically very demanding and through 
determination of the number of bound water molecules, it was found for the terbium 
complex that one of the metal coordination sites is occupied by a water molecule. 
The complex of the slightly larger europium ion, in contrast appeared to possess no 
bound water molecules. In addition, due to the high lipophilicity of the complexes, 
they showed very poor solubility in all but a 1: 1 mixture of dichloromethane and 
methanol. (Sections 2.4.1.2.1 and 2.4.1.2.2). Solubility in water was sufficient to 
observe fluorescence, but the concentration of the complex could not be accurately 
determined. As a result, Stem-Volmer quenching constants are reported only for the 
europium complex, [Eu.9] and, for comparison, [Tb.8]. 
Complex Urate Iodide Ascorbate 
TbPMe3dpqC, [Tb.8] 0.017 5.82 1.48 
EuPBn3dpqC, [Eu.9] Insensitive >1000 11.5 
Table 3. 3 - Stern-Volmer quenching constants for the complexes ITb.8] and IEu.9]. For IEu.9], 
the change in lifetime upon addition of urate was too small for a quenching constant to be 
accurately determined 
Quenching constants, KSy- l , for complex [Tb.8] with each of urate, iodide and 
ascorbate are consistent with a reduced susceptibility to quenching relative to the 
neutral and anionic complexes [Ln.2-4] by a factor of 2-3. Complex [Eu.9] showed a 
marked improvement over all of the previously synthesised complexes and in fact 
showed virtually no susceptibility to quenching with urate. 
Comparison between the phosphinate complexes [Ln.8] and [Ln.9], and the series of 
amide and carboxylate complexes [Ln.1-4] appears to demonstrate that the 
lipophilicity of the c01nplexes has a significant influence on the susceptibility to 
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quenching by urate. The smaller improvements with respect to quenching by iodide 
and ascorbate are likely to be due to the increased steric bulk of the phosphinate 
arms, providing further shielding of the lanthanide and chromophore. Whilst these 
results indicate that the phosphinate complexes warrant further study, the air and 
moisture sensitivity of the phosphorus starting materials, difficulties associated with 
purification of the final macrocyclic ligands, and the poor solubility of the more 
lipophilic complexes will limit their utility. 
3.1.3 Further Approaches Currently Underway in Durham in Order 
to Better Understand and Minimise Quenching of the 
Lanthanide Excited State by Electron-Rich Donors 
Two further approaches have been adopted in Durham in an attempt to understand 
and minimise quenching by electron-rich donors. Firstly, since the mechanism is 
thought to involve electron transfer to the chromophore, complexes have been 
synthesised with chromophores that have more negative reduction potentials than 
dpqC (example 1). Secondly, the structure of dpqC has been modified to incorporate 
carboxylate functionality, in place of the terminal cyclohexyl group, in an attempt to 
increase electrostatic repulsion between the electron donor and acceptor and disrupt 
the formation of a n-type encounter complex (example 2). Examples are shown in 
Figure 3.9. 
N~CO£ 
\ -:}-CO-
N 2 
Figure 3.9 - Structures of LnPh3AzaH (Synthesised in Durham by. S Richa~dson)~ ~ left 
(I'.xample J) and LnD03Adpq_diC02- (Synthesised in Durham by F Kielar) - right (Example 2) 
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Stem-Volmer quenching constants are provided for each of th I . . e comp exes III FIgure 
3.9 in the presence of urate, iodide and ascorbate Compan'son I'S d . h 
. fawn III eac case 
with the relevant structurally similar dpqC complex i.e. [Ln.t] and [Ln.3] 
respective I y. 
Example 1 - Comparative KSV- l values for LnPh3AzaH and [Ln.t] 
Me,! Ph 
HNr-
z.l, \ 
rN.\/N"--J // o~Ln J N 
Ph ~N'\'~ }-N Lj-j N 
Me H o-===Z \ 
NH 
Ph--\ 
Me 
[Ln.1 ] 
N~ 
\ )-J 
N 
Figure 3. to - Structures of LnPh3dpqC, [Ln.t] (left) and LnPh3AzaH (right) 
Complex Urate Iodide Ascorbate 
EuPh3dpqC, [Eu.1] 0.067 27 0.39 
----_. 
EuPh3AzaH 0.60 278 1.5 
TbPh3dpqC, [Tb.1] 0.02 0.9 0.18 
----
TbPh3AzaH 0.04 9.2 0.37 
Table 3.4 - Comparative Ksv-J values (mM) for LnPh3AzaH and (Ln.2] 
The reduction potentials (298 K, NHE) for the tetraazatriphenylene (dpqC) and 
azaxanthone (AzaH) moieties are - 1.1 V and - 1.6 V respectively in CH3CN. For 
quenching with each of iodide, ascorbate and urate, the europium and terbium 
LnPh3AzaH complexes are quenched less than their tetraazatriphenylene sensitised 
analogues (by a factor of approximately 10 with iodide and 3-4 with ascorbate). 
I:~'(ample 2 - Comparative KSy-1 values for LnD03AdpqC _ diC02- and [Ln.3] 
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[Ln.3] 
Figure 3. 11 - Structures of LnD03AdpqC, [Ln.3] (right) and LnD03Adp<LdiCOz-
Complex Urate Iodide Ascorbate 
EuD03AdpqC, [Eu.3] 0.048 >1000 4.31 
EuD03Adpq_diCO£ 0.16 1670 4.13 
TbD03AdpqC, [Tb.3] 0.006 2.1 0.3 
TbD03Adpq diCO£ 0.010 6.9 0.75 
. 
-I -Table 3.5 - ComparatIve Ksv values (mM) for LnD03Adp<LCOz and ILn.3) 
The presence of peripheral carboxylate function on the chromophore appears to have 
a small, but favourable effect on the susceptibilities of the complexes to quenching 
by urate, iodide and ascorbate. In each case, the Ksv-1 values for the 
LnD03AdpCL CO2- complexes are slightly larger than for the analogous 
LnD03AdpqC complex, [Ln.3]. 
A number of tentative conclusions can be drawn from the preliminary results 
exemplified by examples 1 and 2. The reduced susceptibility of complexes 
LnPh3AzaH to quenching by urate, ascorbate and iodide, when compared to the 
parent complexes [Ln.l], supports a mechanism that involves reduction of the 
chromophore (dpqC or AzaH). Finally, the slightly higher Ksv- 1 values reported in 
example 2 for the complex incorporating peripheral carboxylate groups indicates that 
the incorporation of such functionality onto new chromophores may have some 
affect in reducing the susceptibility of their complexes to quenching via a chargc-
transfer tnechanism with electron-rich donors. 
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3.2 Ratiometric Luminescence Assay 
Several of the complexes that have been described herein show a considerably higher 
sensitivity to quenching with urate than with ascorbate or other common electron-
rich quenching species (in particular complexes [Ln.3,4]). In addition, differential 
susceptibility is observed in each case between the europium and terbium complexes 
of a common ligand. This combination of features allows the possibility of 
undertaking ratiometric analysis for the determination of uric acid concentration in 
biological fluids. A major advantage to the use of ratiometric methods is that it 
allows non-specific effects that may affect the observed emission intensity or lifetime 
of a given sample to be overcome. Examples of such effects include sample to 
sample variation of protein, light scattering due to particulates and surface adhesion. 
In addition, any static quenching component, operating via deactivation of the 
chromophore singlet excited state is very likely to occur to the same extent for each 
of the Tb and Eu complexes. Examples of halides deactivating chromophore singlet 
excited states are well known and have been studied as simple halide sensors in 
lanthanide complexes.2o 
3.2.1 Background 
In humans, uric acid (pKa 5.7, MW 168) is the final breakdown product of purine 
(e.g. adenine, guanine) metabolism. Purines from nucleic acid breakdown are 
converted to uric acid in the liver. The uric acid is transported to the kidney where it 
is filtered by the glomerulus; 980/0 is reabsorbed by the proximal tubules and secreted 
by the distal tubules, ultimately appearing in the urine. The body uric acid level is 
determined by the balance between synthesis and unnary elimination. 
Hyperuricaemia is divided into primary and secondary forms, involving either over-
production or reduced elimination. Primary hyperuricaemia is usually due to 
reduced tubular secretion of urate and in 1 % of these patients this condition is linked 
to an enzymatic defect in purine metabolism. These patients lack phosphoribosyl 
transferase, leading to Lesch-Nyhan syndrome, a sex-linked genetic disorder. 
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Elevated levels of uric acid (hyperuricaemia) are most commonly associated with 
gout, increased breakdown of cell nuclei and renal disease. Patients on 
chemotherapy for proliferative diseases such as lymphoma, leukaemia or myeloma 
often exhibit hyperuricaemia and levels must be monitored to avoid kidney damage. 
Treatment involves administration of allopurinol, an inhibitor of uric acid 
synthesis.2oa In gout patients, precipitation of uric acid in the joints leads to pain and 
inflammation and in many examples, this is directly linked to over-production of uric 
acid. Plasma uric acid levels in such patients are usually high (above 60mg per litre 
[0.36 mM] cf 1.5 to 4.5 mM in urine). Patients with gout are also susceptible to the 
fonnation of kidney stones (renal calculi). 
Secondary hyperuricaemia may be caused by increased ingestion of foods rich in 
purines (shellfish/liver/kidney), leading to increased uric acid excretion. Secondary 
hyperuricaemia is linked to many conditions including excess alcohol consumption, 
haemolytic diseases, renal insufficiency, starvation/fasting, myeloproliferative 
diseases and lead intoxication. Hypouricaemia is much less common but may occur 
from under-production of uric acid, as in hereditary xanthinuria, toxemia in 
pregnancy, hereditary purine nucleoside phosphorylase deficiency and allopurinol 
therapy. Hypouricaemia (as measured in a urine analysis) may also result from a 
reduction in uric acid excretion, as may occur in AIDS, diabetes mellitus and various 
malignant diseases. 
Measurement of unc acid excretion may assist III the treatment regIme for 
hyperuricaemia, involving either use of uricosuric drugs, to enhance renal excretion 
I . . h· 20b or al opunnol to suppress punne synt eSIS. 
3.2.2 Current Commercially Available Uric Acid/Urate Assays 
Current in vitro clinical assays used to measure uric acid in urine and serum are 
predominantly based on the use of the uricase enzyme, which catalyses the 
hydrolysis of uric acid leading to fonnation of the more \vater-soluble compound, 
allantoin, and hydrogen peroxide?I-~4 The hydrogen peroxide is detected either 
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directly via oxidation of a phenolic dye to produce a strongly coloured compound, or 
indirectly by the action of a peroxidase enzyme, leading to fonnation of an intensely 
coloured chromogen or a strongly emissive fluorophore. These enzymatic methods 
are typically subject to interference from ascorbate (requiring co-administration of 
ascorbate oxidase) and bilirubin. Typically, clinical kits give a linear response for 
the range 0.09 to 1.8 mM for serum and plasma, and 0.12 to 6 mM for urine. 
Detection limits fall in the 5 J.1M range for serum analysis and 40 J.1M for urine. The 
analysis requires incubation for at least 30 minutes, careful control of the pH of the 
analyses, the enzymes must be stored carefully to avoid protein denaturation, and the 
organic dyes used are often light and temperature sensitive, requiring storage in the 
dark at low temperatures. 
3.2.3 The Principle of the Ratiometric Analysis for the 
Determination of Urate Concentration in Biological 
Fluids25,26 
The tetraazatriphenylene cyclen based complexes synthesised here are highly 
emissive with lifetimes in aqueous solution of the order of 1 ms. The chromophore 
has a reasonable molar absorption coefficient (6440 em-I M- 1); its triplet excited state 
is readily populated and is of suitable energy to efficiently sensitise both europium 
and terbium; it can also bind in a bidentate manner to the lanthanide, resulting in a 
short donor-acceptor distance and hence facilitates efficient energy transefer. The 
nonadentate coordination of the cyclen-based macrocyclic ligand provides a 
saturated and well-defined coordination sphere in addition to giving high kinetic and 
thennodynamic stability with respect to metal ion dissociation. These basic physical 
properties in combination with their high sensitivity to quenching by urate compared 
to other common biological oxidants (in particular ascorbate), and the differential 
sensitivities of the Eu and Tb complexes of a common ligand suggest an application 
for the direct analysis of urate concentration in aqueous samples. 
Using a mixture of Eu and Tb complexes with a common ligand, measurement of the 
ratio of intensities of a Tb emission band (e.g. at 546 nm) versus a dominant Eu 
emission band (e.g. at 700 nm or 616 nm) is a direct function of the amount of urate 
12~ 
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present in solution, providing that interfering species contribute little to the overall 
quenching effect. The only other requirement is that there should be no change in the 
form of the spectrum. Europium emission bands are sensitive to their coordination 
environment, in particular the strongest transition centred at 616 nm is sensitive to 
the polarisability of the donor in the axial position that can cause a change in ratio 
between the ~J= 1 and ~J=2 bands by up to an order of magnitude. However, the 
class of cyclen based ligand that has been used here saturates the coordination sphere 
of the lanthanide and thus its coordination environment does not vary with different 
solvent or with different potential ligands in the solution under analysis. 
3.2.4 Proof of Concept 
In order to establish the concept, an analysis was undertaken to detennine the 
concentration of uric acid in urine samples taken from healthy volunteers; 
determinations were made in duplicate, firstly using the commercially available 
Amplex Red uric acid/uricase kit and secondly using the ratiometric method defined 
here. 
3.2.4.1 AmpJex Red Uric Acid/Uricase Kit 
The Amplex Red uric acid/uricase kit is an enzymatic kit, similar to that used 
routinely for the analysis of urine or serum in most hospitals. The basis of the 
method is the oxidation of uric acid to the more water soluble allantoin. The method 
can suffer from interference from the presence of ascorbic acid; this problem is often 
overcome through the application of a third enzyme - ascorbate oxidase. 
3.2.4.2 A Ratiometric Determination of Urate in Urine Samples 
A stock solution containing a 1: 1 mixture of Eu and TbGlu3dpqC [LnA] was 
prepared in 100 InM HEPES (pH 7.4) to give a final absorbance of 0.1 at both 313 
and 348 nm (equates to approximately 5 ~M concentrations of each complex). This 
stock solution was used in each of the assays (it is important to note that the actual 
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concentration used is 50 % lower). The LnGlu3dpqC complexes were chosen since 
they show very little surface activity; even the most surface active complexes could 
be used if the stock solutions were modified to contain 10 - 20 % DMSO or DMF 
(this has been shown to give quantitative dilutions by monitoring absorbance 
changes). 
A calibration must be carried out using a standard urate solution at a ran oe of 
b 
dilutions. A 1 mM solution was prepared, again in 100 mM HEPES (pH 7.4); the 
concentration was verified by measuring the absorbance at 292 nm (£ = 1.22 x 104 
M-
I 
em-I). Dilutions were made in the range 0 - 100 JlM. Again it should be noted 
that the solutions are diluted by 50 % in the assay to give a working range of 0 - 50 
/lM. The calibration was performed by dispensing 100 JlL of each of the complex 
stock solution and the appropriately diluted urate solution into the wells of a 96-well 
plate; each urate concentration was repeated in triplicate. In parallel, samples from 
healthy volunteers were diluted 10, 100 and 500-fold and again wells prepared in 
triplicate containing the complex solution. 
For each well, 10 separate spectra were recorded over the range 450 - 720 nm 
(Analytik Flash Scan, Aex 313 nm) and averaged, and the ratio of the 546/616 and 
546/700 nm bands was determined. For the range of calibration solutions, a plot was 
made of emission intensity ratio versus urate concentration; the curve was fitted 
iteratively to a bi-exponential model (Figure 3.12); less than 1 % variance was found 
in the measured intensity ratio for a given urate concentration. Such precision is an 
inherent feature of a ratiometric assay. Both of the complexes share a common 
ligand, therefore, non-specific effects that affect both of the complexes to the same 
extent will cancel each other out. This is particularly useful when using a multiwell 
plate reader since absolute fluorescent intensities are dependent on factors such as 
the presence of particulates in the sample, light scattering, surface effects, variations 
in the smnple volume and the calibration of the plate reader. In addition, effects due 
to the presence of other components in the solution that may lead to variation in 
fluorescent intensities or lifetimes of emission, such as protein, will not reduce the 
accuracy of the method. Thus, the ratiometric method obviates any sample to sample 
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variation that compromises a method based on modulat' fl " . IOn 0 spectra emISSIOn usmg 
only one complex. 
o 
~ 
3.5 
3.0 
& 2.5 
~ 
~ 
CIJ 
c 2.0 
Q) 
~ 
c 
co ~ 1.5 
co 
-co 
..q 
L() 1.0 
0.5 
o 
5000 
4000 
.~ 3000 
c: 
] 2000 
z:. 
·iii 
1000 
a 
1000 
~ 500 
.5 
a 
Reference 
500 600 700 
Wavelength Inm 
10 ~M Urate 
500 600 700 
Wavelength Inm 
2000 
z:. 
~ 1000 
" £ 
z:. 
·iii 
a 
400 
~ 200 
£ 
a 
5 ~M Urate 
500 600 700 
Wavelength Inm 
50 ~M Urate 
500 600 700 
Wavelength Inm 
10 20 30 40 50 
Urate Concentration (!J.M) 
Figure 3. 12 - Variation of the Tb (546 nm) to Eu (616 nm) emission intensity ratio (pH 7.4, 0.1 
M HE PES, 298 K) as a function of sodium urate concentration. The curve depicts the iterative 
fit to a double exponential decay and the inset shows selected spectra recorded (Analytik 
Flashscan 530F multiwell plate reader) 
For the unknown samples, the urate concentration was readily computed, from the 
calibration curve or by applying the mathematical model. With the same samples the 
commercial uric aid kit was employed; agreement between the two methods wa 
within 10 0/0, but it should be noted that the enzymatic assay gave values that were 
estimated to have a precision of no better than 10 % for the three replicate 
examined. 
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3.2.5 Other Potential Applications 
The same methodology should also be applicable to diluted serum samples 
(preliminary results using reconstituted human serum appear encouraging) and to 
other common bio-fluids. The ratiometric luminescence method may be generically 
applicable to the determination of certain electron rich compounds in appropriately 
selected analytes, e.g. bioactive phenols, catechols and catecholamines and their 
conjugate bases, possessing a one-electron oxidation potential of less than 0.75 V. 
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4 Luminescent Europium and Terbium Complexes 
for in cellula Applications 
Luminescent lanthanide complexes have been developed that are able to serve as 
'tags' in bioconjugates for use in 'FRET' or tracking assays, or as responsive probes: 
information about their local coordination environment or the concentration of a 
specific analyte in solution can be gained through monitoring changes in their 
spectral emission profile, lifetime or circular polarisation. I Recently, lanthanide 
complexes have been reported that are taken up by live cells and can be observed by 
fluorescence based microscopy techniques. I-8 Of significant interest would be the 
possibility of using lanthanide complexes as in cellula probes. Their unique 
photophysical properties and the ease with which their structures can be modified to 
suit a particular application would both complement and extend the 'tool kit' 
currently available for the analysis of living cells and certain processes that occur 
within them. 
The mechanism by which these complexes are able to cross the cell membrane and 
the factors that govern their localisation/compartmentalisation are not well 
understood. The structures below provide a cross-section of cyclen-based complexes 
that have been shown to be taken up by cells. 
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(a) 
(c) 
Figure 4. I - Representative structures of a series of complexes (a), (b) LnAlaOEt3NAcr, (c) 
LnAlaOEt3CAcr and (d) LnPheOEt2ThiaH, that have been reported to be cell permeable 
Each of the complexes (a) to (d) shown in Figure 4.1 is based on the cyclen 
macrocycle, has one or more planar aromatic heterocycles (usually the sensitising 
moiety), is relatively lipophilic and has an overall positive charge (l + for (a) 3+ for 
(b )-( d). These features appear to be common to almost all of the examples reported 
in the literature thus far that exhibit cellular uptake (with the exception of the neutral 
and anionic acridone complexes discussed in 1.4.5). 
Whilst each of these examples is cell permeable, each displays a different 
localisation within the cell, as has been discussed in Chapter 1 (1.4.5): complex (a) 
has been suggested to localise in the outer mitochondrial membrane, \\'here the target 
receptors are expressed; (b) has been shown to localise in lysosomal compartments 
by co-localisation studies with Lysotracker green: complex (b), the isomer of (a), 
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distributes quite well in the cytosol and stains the endoplasmic reticulum, again 
confinned by localisation studies (using Brefeldin A); complex (d) is able to cross 
the nuclear membrane and stains the nucleoli of cells. Complexes (a) and (b) are 
thought to enter the cell via an endocytotic pathway. Molecules that enter cells via 
endocytosis are believed to be initially trapped in endocytotic vesicles and are 
subsequently transferred into endosomes. Endosomes age to become lysosomal 
compartments isolated from the rest of the cell. If complexes taken up by this 
mechanism are to localise in other regions or compartments inside of the cell then it 
is essential that they can escape from the endocytotic pathway. 
4.1 Uptake of a Series of Complexes of Differing Charge and 
Lipophilicity 
Me
yPh 
HN"J-O \. r\\ \ r N. ,N~ N ~ O.-:---Ln~ 
Ph \\ ~N' \'~') )- /--/ LJ N N __ \ 
Me H o NH 
Ph~ 
Me 
[Ln.1] 
N~ 
'\ J--/ 
N 
Figure 4. 2 - Structure of lanthanide complexes LnPh3dpqC, I Ln.t ] 
Preliminary experiments have previously been carried out which showed that [Ln.t] 
is taken up by NIH 3T3 mouse fibroblast cells (1 mM loading concentration). Time 
I . . d' t d that uptake of the europium complex appeared to be faster course ana YSIS In lca e 
than for the terbium analogue and that migration occured over a period of hours 
through the cytosol, across the nuclear membrane and into the nucleus. In the 
absence of a positive concentration of complex in the external medium. the images 
2 . 
showed a transfer of luminescence from the nucleus back to the cytoplasm. It IS 
difficult to explain why the europium and terbium complexes should exhibit different 
. h h . t and confonl1ations arc ,oirtually identical. It has 
uptake tImes: bot t elr struc ures 
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been suggested that it could be due to the higher susceptibility of the terbium excited 
state to quenching by electron rich donors (urate5, ascorbate and GC base pairs in 
DNA8.1) hence leading to a lower emissive intensity, perhaps with a higher 
concentration of complex being required before a signal can be observed. 
1.39 
1 hour 3 hours 6 hours 24 hours 48 hours 
Eu 
Tb 
Figure 4. 3 - M icroscopy images for the internalisation of the [Ln.t1 Eu and Tb probes at different times. (t mM loading concentration in DMEM supplemented 
with 50 mg mr! penecillin/streptomycin and 10 % NCS) 
1 hour 3 hours 6 hours 24 hours 48 hours 
Eu 
Figure 4. 4 - Microscopy images for the transit of Eu probe after 3 hours incubation and washing of unbound complex 
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Figure 4.5 - Structures of complexes, LnAla3dpqC, (Ln.2], LnD03AdpqC, (Ln.3] and 
LnGlu3dpqC, (Ln.4] 
A senes of comparative analyses was undertaken using the neutral and amomc 
complexes [Ln.2-4] to assess the relative importances of charge/lipophilicity on the 
uptake of the complexes. The cells were cultured in DMEM (Dulbecco's Modified 
Eagle Medium) supplemented with 10 % new-born calf serum, 50 Ilg mrl penicillin 
and streptomycin, and non-essential amino acids, on 10 mm cover slips. When the 
confluence on the cover slip reached approximately 70 %, the cells were loaded with 
an aqueous complex solution to give a final concentration in the growth medium of I 
mM. Following incubation for 24 hrs, the cover glass to which the cells were 
attached was washed repeatedly with PBS (phosphate buffered saline) and placed 
onto a microscope slide (under these conditions [Ln.l] is known to localise \\ithin 
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the cell nucleus). Each of the slides was imaged using a fluorescence microscope. 
Narrow excitation and emission filters were chosen (Excitation - 345 nm low pass or 
Zeiss G365; Emission - Eu 620 ± 25 nm or 575 - 625 nm band pass, Tb 546 ± 25 nm 
band pass) such that the chromophore was irradiated at wavelengths corresponding 
only to its longest wavelength absorbance (i.e. centred at 348 nm) and that the 
amount of scattered light reaching the CCD was minimised, to improve the signal to 
noise ratio. 
In capturing the images, it was apparent that considerably longer exposure times (by 
a factor of 3-4) were required to image luminescence from cells containing any of 
complexes [Ln.2-4] when compared to cells loaded with [Ln.1] under identical 
conditions. Even under these conditions, the signal to noise ratio was low and was 
only slightly above the level of background and scattered fluorescence; specific 
localisation was difficult to discern and there did not appear to be any nuclear 
localisation. 
In order to provide a further example of a cationic complex against which complexes 
[Ln.2-4] could be compared, [Tb.2] was re-esterified in dry (acidic) methanol to give 
the tri-positive methyl ester complex, [Tb.2a] as its chloride salt (Figure 4.6). In 
contrast to its neutral carboxylate analogue, it appeared to be taken up to a similar 
extent as [Ln.1] giving images that were considerably brighter than the unstained 
control sample. 
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Figure 4.6 - Structure of complex TbAlaMe3dpqC, [Tb.2aJ (upper); Fluorescence microscope 
image (0.5 mM complex concentration, 4 hours post-incubation) (lower) 
These results imply that either cellular uptake of the lipophilic and cationic complex 
[Ln.l] is favoured compared to that of the related neutral and anionic complexes 
[Ln.2-4], or that the complexes may be taken up to a similar extent but emission from 
complexes [Ln.2-4] is more strongly quenched 'in cellulo' than for complex [Ln.l]. 
(Chapter 3 provides a full description of the differing sensitivities of the series of 
complexes to quenching by electron-rich donors). The coordination environment of 
the complex inside the cell is also not known, but if for example the complexes were 
bound to protein this too would affect their susceptibilities to quenching. In order to 
confirm to what extent the complexes were taken up by the cells, an experiment was 
undertaken to determine the intracellular lanthanide concentration. 
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4.2 Combined Flow-Cytometry and ICP-MS Methodology for 
the Determination of the Intracellular Europium 
Concentration 
The images obtained by fluorescence microscopy allow a comparison to be made 
between complexes in terms of their localisation or compartmentalisation profile 
within a cell. However, this does not provide quantitative information about how 
effectively the complexes are taken up. In order to achieve this, the concentration of 
complex per cell was determined through a combination of flow-cytometry to 
determine the number of cells in a population, and ICP-MS (inductively coupled 
plasma - mass spectrometry) to determine the total lanthanide (europium) 
concentration. From knowledge of the number of cells, the total number of moles of 
europium in the sample and an approximate volume for a cell, the concentration per 
cell can be determined, also allowing a comparison to be drawn with the loading 
concentration. Alternatively, the number of moles of complex per cell can be quoted, 
eliminating the need to estimate the cell volume and allowing a comparison to be 
made between different cell lines. 
4.2.1 Flow Cytometry 
4.2.1.1 Instrumental Details: Background 
Flow cytometry is a fluorescence based technique that allows the counting and 
sorting of a population of cells. The sample is introduced into the flow chamber and 
is hydrodynamically focused in a sheath of PBS. Hydrodynamic focusing allows the 
diameter of the flow to be narrowed to such an extent that single cells are forced 
down the centre of the stream. The cells are interrogated by a laser appropriate for 
the lumophore under study. Light that is emitted is directed to a series of detectors, 
usually focussed onto a photomultiplier tube, PMT. The range of wavelengths that 
are permitted to reach each of the detectors is controlled through the use of band-pass 
filters, allowing tTIulti-colour analysis to be undertaken using two or more different 
luminescent stains. 
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4.2.1.2 Detection of Long-Lived Lanthanide Emission: Experimental 
Constraints 
The speed of a cell as it passes through the flow chamber is of the order of 1 - 25 ms-
I (depending upon the operating pressure and nozzle diameter); the emissive lifetimes 
of the series of europium and terbium complexes are of the order of 1 - 2 ms. In 
conventional instruments, the laser intersection point is imaged to a pinhole located 
in front of the PMT; similarly to confocal microscopy, this is done to eliminate out of 
focus light and scattered laser light from reaching the detector. However, due to the 
long emissive lifetimes of the lanthanide ions, only a small fraction of the total 
emission reaches the detector. Unless very high complex concentrations are used, 
this unfortunately renders them impractical as lumophores for cell sorting and 
counting. Time-resolved flow cytometers have been developed earlier for the 
measurement of lanthanide chelate fluorescence.9 Emission is collected from the cell 
as it covers a distance of several millimetres passing through the flow chamber, 
corresponding to a time of the same order as the emissive lifetime of the complexes. 
A pinhole arrangement is not needed to prevent scattered light from reaching the 
detector since the laser is effectively' off' during the acquisition period. 
4.2.1.3 Overcoming or Circumventing These Constraints 
The combined flow-cytometry and ICP-MS method has previously been used to 
determine the intracellular europium concentration of complex EuPheOEt2 ThiaH 
(Figure 4.7). 
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Figure 4. 7 - Structure of EuPheOEt2 ThiaH 
The emission spectrum of complex EuPheOEt2 ThiaH consists of two components, 
short lived fluorescence from the sensitising chromophore and longer lived europium 
centred emission (Figure 4.8). 
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Figure 4. 8 - Absorption (dashed line) and total emission spectra of EuPheOEt2 ThiaH (5 JlM) in 
water (dotted line) and in the presence of L-Asn (solid line, pH 7.3,300 JlM). 
The dual emISSIon indicates that the rate constants for deactivation of the singlet 
excited state by fluorescence and energy transfer to the triplet excited state are of a 
similar order. To obtain as high an emissive quantum yield as possible it is desirable 
to have a quantmn yield of triplet fonnation that is close to unity, however in this 
case a degree of fluorescence provides a useful handle that allows cells that are 
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stained with the complex to be sorted by detection at wavelengths appropriate for the 
chromophore fluorescent emission.9 
The series of complexes that are the subject of the current work all incorporate a 
tetraazatriphenylene sensitising moiety. Virtually no fluorescence is observed from 
this chromophore either as a free species, or when it is coordinated to a lanthanide 
centre. Consequentially, it was necessary to find an alternative means through which 
the sample of cells could be labelled. This was achieved by dual labelling with the 
complex of interest and the acetylmethoxy ester of calcein AM. 
Calcein AM is a dye that is often used to assess cell viability in eukaryotic cells; in 
live cells, the non-fluorescent calcein AM is converted to green fluorescent calcein, 
following ester hydrolysis catalysed by intracellular esterases. It was therefore 
decided to co-localise CHO cells with both the lanthanide complex and calcein AM, 
allowing live cells containing the lanthanide complex to be selectively sorted and 
unviable cells discarded. 
As a control experiment, it was necessary to confirm that for a population of cells co-
loaded with both calcein AM and complex, in every case where green calcein 
emission could be observed, so too could lanthanide centred emission. CHO Cells 
loaded with either europium complex EuPheOEt2ThiaH, or [Eu.t] (50 JiM, 3 hours 
incubation - both previously shown to be taken up by cells and to be observable by 
fluorescence microscopy) and Calcein AM (2 JiM, 30 min incubation) were analysed 
by fluorescence microscopy using appropriate excitation and emission filters so that 
the red europium and green calcein emission could be examined separately. An 
additional advantage to the experiment was that it allowed an assessment of the 
viability of the cells to be made: only live cells contain the active esterase enzymes 
necessary to catalyse hydrolysis of the acetylmethoxy ester. Using both complexes it 
was found that in >97 % of the cells examined, green and red emission could be 
observed, thus both validating the flow cytometry method and providing evidence of 
the viability of the populations of cells. 
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4.2.1.4 Experiment to Sort and Collect a Known Number of Cells 
Co-Labelled with Europium Complex and Calcein AM 
Populations of CHO cells were cultured to approximately 70 % confluence in 75 cm3 
culture flasks in F-12 (Ham) growth medium supplemented with 10 % FBS (foetal 
bovine serum) and 50 J.lg mrl penicillin and streptomycin. Additions of one or both 
of the europium complex and calcein AM were made as described below: 
1) CHO cells only - a reference sample used to set up the flow cytometer; 
2) CHO cells + Calcein AM (2 J.lM, 30 mins incubation) - a reference sample 
used to set up detection parameters; 
3) CHO cells + complex (one of[Eu.I, 3 or 4]) (~50 J.lM, 3 hours incubation) + 
Calcein AM (2 J.lM, 30 mins incubation). 
Each of the cultures was washed 5 times with PBS to ensure that excess complex had 
been removed and was harvested using trypsin. The cells were collected by 
centrifugation and resuspended in buffer; again the process was repeated 3 times. 
Each of the populations was finally suspended in 1 ml of phosphate buffer for 
injection into the flow cytometer. 
Following successful sorting and collection, populations of cells co-loaded with both 
calcein and complex [Eu.I, 3 or 4] were recovered, containing a known number of 
cells. Typically, 10 000 - 100 000 cells were sorted and counted in this operation. 
4.2.2 ICP-MS Analyses 
In inductively coupled plasma mass spectrometry, ICP-MS, the accurate 
determination of the concentration of an element in a sample may be determined; 
detection limits are of the order of ppt - ppb. In the ICP-MS method, the sample is 
injected into an argon plasma, where the elements in the sample are atomised and 
ionised; these ions are then passed through a series of cones to a quadrupole mass 
spectrometer. Through calibration with elemental standards, accurate concentrations 
can be calculated since the observed ion signal is proportional to the concentration. 
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Prior to injection of the sample into the ICP-mass spectrometer, it was necessary to 
dilute quantitatively the samples using 3 % nitric acid solution. It has previously 
been noted within the group, that the ICP-MS or OES determination of gadolinium 
concentration in cyclen based MRI contrast agents did not always give accurate 
results following quantitative dilution in water. It is thought that this is due to 
adherence of the complex to the sample vial. Addition of nitric acid overcomes this 
problem. 
4.2.3 Results and Discussion 
Complex Medium Concentration Intracellular Concentration 
EuPh3dpqC, [Eu.1] 49 11M 26 JlM 
EuD03AdpqC, [Eu.3] 31 11M 12 11M 
EuGlu3dpqC, [Eu .4] 33 J.lM 40 11M 
Table 4. I - Eu concentrations determined by ICP-MS for CHO cells incubated in the presence 
of (Eu.I], (Eu.3] and (Eu.4] (3 h). In each case values reported represent the concentration of 
complex present in the external growth medium and the concentration per cell (a mean cell 
volume of 4000 Jlm3 was assumed) 
Values reported in Table 4.1 show that each of the complexes is taken up to a similar 
extent by the cells; intracellular and extracellular concentrations also appear to be of 
the same magnitude. These results indicate that it is the extent to which the 
complexes are quenched' in cellula' that limits their utility as fluorescent probes, and 
not uptake preference. The intracellular concentration is an average across the whole 
cell and therefore it is suggested that the complex must be actively concentrated in 
certain compartments in accordance with the punctuate nature of localisation. 
4.3 Concentration and Time Dependent Localisation of 
Complex [Ln. 1] 
The uptake of terbium complex [Tb.l] by mouse skin fibroblasts (NIH 3T3) was 
investigated further as a function of both loading concentration and incubation time. 
Cultured cells were exposed to DMEM growth medium (supplemented with 10 0'0 
NCS and 50 Jlg mr) penicillin and streptomycin) containing between 50 11M and 1 
111M solution of the terbium complex. The living cells were imaged by fluorescence 
I-f9 
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microscopy at time intervals in the range of 30 minutes to 48 hours. In order to assess 
the effect on the localised complex of removing the external concentration gradient, a 
further analysis was undertaken by incubating the cells for up to 24 hours then 
replacing the complex containing medium with fresh medium (after washing the cells 
several time with PBS). Representative images are shown in Figures 4.9 - 4.11. 
Figure 4. 9 - Fluroescence microscope image showing a live NIHl3T3 cell stained with [Tb.ll 
(0.3 mM in growth medium), 4 h post-incubation 
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Figure 4. 10 - Fluorescence microscope image revealing the localisation of [Tb.l] (1 mM in 
medium, 24 h post-incubation) in the cell nucleus and defining the nuclear membrane 
Figure 4. 11 - Fluorescence microscope image highlighting the egress of the [Tb.ll complex out 
of the cell nucleus and back into the extra-nuclear compartments, 24 h after removal of the 
external concentration gradient. 
Figure 4.9, is taken of a cell that has been incubated in growth medium containing 
0.3 mM terbium complex for a period of 4 h. The complex is distributed thr ughout 
the cytoplasm and shows a punctuate localisation that is more inten e around the cell 
nucleus (although this remains dark) . At higher concentration and with Inger 
1 1 
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incubation periods, the complex is able to migrate across the nuclear membrane. In 
Figure 4.10 (l mM, 24 h incubation) the luminescence highlights the nucleus and 
appears to be concentrated in certain compartments; the nuclear membrane is clearly 
delineated; diffuse localisation persists in the cytoplasm, but again appears to be 
concentrated around the nucleus. Following removal of the external concentration 
gradient, the complex migrates out of the nucleus. Figure 4.11 was captured 24 h 
after the complex had been removed from the external medium. Distribution is again 
in the cytosol; areas of the image also have a spotty appearance, suggesting 
localisation in a particular cell organelle. However, this localisation is different to 
that observed using a low external concentration of complex with short incubation 
times (el Figure 4.3). 
These experiments provide confirmation that the complex is taken up by the cell and 
is able to cross the nuclear membrane in the presence of a sufficient external 
concentration gradient; the process reverses upon removal of the complex from the 
growth medium. At lower concentrations i.e. < 0.5 mM localisation is found only 
outside of the cell nucleus; the complex is taken up rapidly by the cell (15 - 30 
mins). These conditions are the most relevant for practical applications i.e. low 
external concentration and short incubation times; Figures 4.12 - 4.13 show a field of 
view for cells labelled with [Tb.1] (l00 IlM loading concentration, 3 h incubation) 
and demonstrates the consistency of labelling across the sample. 
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Figure 4. 12 - Transmitted microscope image of CHO cells loaded with [Tb.l] (100J.lM, 3 h post-
incubation) 
Figure 4. 13 - Fluorescence microscope image of the same population of CHO cell 
Figure 4.12 loaded with [Ln.IJ (100 )JM, 3 h post-incubation). 
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4.4 Comparative Uptake of [Ln. 1] Across a Series of 
Adherent Cell Lines 
Uptake of complex [Tb.1] by a range of primary (HDF), transformed (NIH 3T3 
CHO, COS, HEK) and carcinoma (HeLa) cell lines has been examined. Images that 
were taken using a time resolved fluorescence microscope were carried out in 
collaboration with M. Laget, Cisbio, France, using 337 nm excitation, corresponding 
to a nitrogen laser line). In each case, under the same loading conditions, a similar 
uptake and localisation profile was observed. Representative images are shown in 
Figures 4.14 - 4.19; common features are a spotty compartmentalisation centred 
around the nucleus and a diffuse brightness in the cytosol extending to the periphery 
of the cell. 
4.4.1 HEK (Human Embryonic Kidney Cells) 
4.4.1.1 [Eu.1] 
Figure 4. 14 _ Transmission (left) and fluorescence microscope images (ri~ht) of HEK cells 
localised with EuPh3dpqC, [Eu.l1 (50 iJ.M, 24 h post-incubatIOn) 
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4.4.1.2 [Tb.l] 
Figure 4. 15 - Transmission (left) and fluorescence microscope images (right) of HEK cells 
localised with TbPh3dpqC, [Tb.l] (50 ~, 24 h post-incubation) 
4.4.2 COS (Transformed African Green Monkey Kidney Fibroblast 
Cells) 
4.4.2.1 [Eu.l] 
Figure 4. 16 _ Transmission (left) and fluorescence microscope images (right) of CO cell 
localised with EuPh3dpqC, [Eu.l] (50 ~, 24 h post-incubation) 
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4.4.2.2 [Tb.l] 
Figure 4. 17 - Transmission (left) and fluorescence microscope images (right) of COS cells 
localised with TbPh3dpqC, [Tb.l] (50 JlM, 24 h post-incubation) 
4.4.3 CHO (Chinese Hamster Ovary Cells) 
4.4.3.1 [Eu.l] 
Figure 4. 18 - Transmission (left) and fluorescence microscope images (right) of HO cell 
localised with EuPh3dpqC, [Eu.l] (50 JlM, 24 h post-incubation) 
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4.4.3.2 [Tb.1] 
Figure 4. 19 - Transmission (left) and fluorescence microscope images (right) of CHO cells 
localised with TbPh3dpqC, [Tb.]] (50 J.lM, 24 h post-incubation) 
4.5 Assessing the Protein Binding Affinity of [Gd.1] 
4.5.1 Change in the Form of the NMRD Profile of [Gd.1] in the 
Presence of Protein 
A series of lanthanide complexes of a common ligand would be expected to adopt 
similar structures. However, different lanthanide ions are amenable to specific 
analytical techniques. For example, europium is a useful fluorescence based probe 
since its fine structure is sensitive to the coordination environment of the ion" in 
contrast, gadolinium complexes can be probed using magnetic resonance techniques 
in particular in terms of their affect on the relaxation times of bound or cIo ely 
diffusing water molecules. The gadolinium complex [Ln.1] was synthesi ed in order 
to assess its affinity for protein binding. It was thought that uptake of the c mpl x 
could be protein mediated; in addition, where complexes are protein bound, they may 
be expected to display a different sensitivity to a collisional quenching pr ce " 
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NMRD (Nuclear Magnetic Resonance Dispersion) spectroscopy monitors the change 
in relaxivity per unit concentration of a sample relative to bulk water as a function of 
the magnetic field. A comprehensive explanation of relaxation theory and the factors 
that govern the form of an NMRD profile have been provided in reviews by 
Laufferl7 and Caravan 18 It is sufficient to say in the current context, that protein 
binding would be predicted to give both an increase in relaxivity at all field strengths, 
and a change in the form of the spectrum at high field (where the rotational 
correlation term, 'tr associated with the reorientation of the metal ion-solvent nucleus 
vector, becomes dominant). 
Figures 4.20 - 4.21 are NMRD profiles that were recorded for complex [Gd.l]. 
Figure 4.20 was measured for the sample in water at 25°C, upon addition of a small 
excess of HSA (human serum albumin). The relaxivity increased by a factor of more 
than two in the range 0.01 - 10 MHz and exhibited a change in form and a much 
larger increase to higher field (Figure 4.21). In order to gain a more complete picture 
of the behaviour at high field, measurements were made (Ivrea, Italy) on a second 
instrument over the range 0.01 - 70 MHz. The profile (Figure 4.22) shows a narrow 
peak centred at ca. 30 MHz, indicating that a few second sphere water molecules are 
tightly bound to the complex. The form of the NMRD profile is typical of a complex 
that exhibits both a long 'tr and a relatively long water exchange lifetime, Lm, for the 
second-sphere waters. In each case, this behaviour is indicative of a protein bound 
complex. It should be noted that the relaxivities are relatively high in the presence of 
protein, for a q = 0 system. 19 
15~ 
lIilapter'l- - Luminescent europium and Terbium Complexes for in cellulo Applications 
7.0 ~ ~ ~ 
• • 
... 6.5 , 
U) 
... 
!:is 6.0 E 
I 
~ 
'S; 5.5 
';( 
ca 
-& 5.0 
4.5 
4.0 
0.01 
• 
• 
• 
0.10 
I 
! 
~ ~ 
• 
1.00 
BRLX (MHz) 
I 
I 
I 
J I 
• 
4 
• 
I 
i 
! 
i 
I : I : I I 
i 
, 
i I i 'i 
I I ! ! ' I l I 
iii I ! i I i i i i 
I I i: 
I I i· 
: ! 
I 
I 
i 
I 
: ! I 
i 
' I 
I ' , 
i 
I 
I I 
! ! I 
i I 
! 
! 
It 
• 
10.00 100.00 
Figure 4.20 - NMRD profile of [GdPh3dpqC]CI3, [Gd.l] (298 K, concentration = 0.2 mM, water 
Tl correction = 0.38 s) 
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Figure 4. 22 NMRD profile of (Gd.l], The vertical axis is expressed as a relaxation rate rather 
than a relaxivity. The form of the spectrum is identical in each case. (298 K, complex 
concentration = 0.4 mM, 'corrected' refers to data, for which the protein contribution to 
relaxivity has been subtracted) 
4.5.2 Assessment of the Binding Affinity of [Gd.1] to HSA 
The relaxivity of [Gd.l] was measured as a function of added HSA at 37°C using a 
Bruker Minispec at 60 MHz (Figure 4.23). The concentration of the complex was 
determined to be 1.69 mM for these analyses. 
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Figure 4. 23 - A plot of relaxivity versus concentration of human serum albumin in order to 
provide a measure of the binding affinity 
The binding constant for coordination of the complex to HSA could not be 
determined since the data does not follow a simple exponential fit. However, the 
large increase in relaxivity of approximately 10 S-I mM-1 confirms that the affinity 
towards binding is high. An upper limit is reached at a ratio of approximately 8 - 10 
complex molecules per protein, precluding a binding mechanism involving 
incorporation of the complex into a specific HSA binding pocket that has been 
observed for a range of lipophilic anionic Gd complexes.2o, 21 
4.6 Towards an Understanding of How the Complexes are 
Able to Penetrate the Plasma Membrane 
The mechanism by which complexes such as those described here are able to cross 
the plasma melnbrane is not well understood. The observation that uptake of [Ln.1] 
is fast and appears to be both concentration dependent and reversible can perhaps 
allow some tentative speculation. 
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The complexes are relatively large (MW ~ 1000) and although the uptake and 
localisation appears to be sensitive to the external concentration, they are unlikely to 
be able to cross the plasma membrane by either passive diffusion or through a 
transport protein. Each transport protein is considered to be specific for the narrow 
range of substance it translocates. However, recent work has demonstrated that the 
copper transporter CTR 1 can also mediate the uptake of the anticancer drug Cisplatin 
[cis-diamminedichloroplatinum(II)] despite them being structurally unrelated, and 
hence, the mechanism by which the two substrates are transported is likely to be 
different. 15, 16 
Endocytosis is a process by which eukaryotic cells are able to internalise both small 
and large molecules through their incorporation into membrane vesicles at the 
plasma membrane. 1O It is generally classified as either phagocytosis (cell eating) or 
pinocytosis (cell drinking). The former refers to the internalisation of large particles 
(> 0.5 !lm diameter) that must bind to specific plasma membrane receptors capable 
of triggering their own uptake. The latter refers to the formation of smaller « 0.2 !lm 
diameter) vesicles carrying extracellular fluid and macromolecules specifically or 
non-specifically bound to the plasma membrane; receptor mediated endocytosis can 
be included in this category.11,12 The rate of these processes and the amount of 
membrane and extracellular fluid that can be internalised are such that it is estimated 
for cells such as macrophages and fibroblasts, that more than 200 % of their entire 
cell surface is turned over every hour. Pinocytosis can be divided into two further 
sub-categories: clathrin dependent endocytosis, and clathrin independent 
endocytosis. 
161 
Chapter 4 - Luminescent Europium and Terbium Com pie f . 
xes or m cellulo Applications 
o 
o 0 ...... ~-----
1'31>4 
cabS 
ro...~ f'lfCaptCl'$ 
~ .. mp-r.egalhf'(1 
Figure 4. 24 - Representation of the endocytotic pathway for eukaryotic cells·· 
Clathrin is a large protein (180 kDa) and assists in the formation of coated pits on the 
inner surface of the plasma membrane. Within the pit are certain proteins and 
receptors (some of the best known are the LDL receptor which removes LDL 
cholesterol froln the blood and the transferrin receptor). The pits invaginate (or form 
inward) and pinch off to form clathrin-coated vesicles; the lifetime of the pit i of the 
order of about a minute. Once inside the cell, the clathrin coat is quickly 10 t and the 
vesicle combines with an early endosome. The endosomes act as sorting tation: 
membrane and receptor molecules are returned to the cell surface by exocyto i r 
alternatively transferred to lysosomes to be degraded. Remaining material 
transferred from early endosomes on microtubules to the p rinuclear cyt pia m (i . 
around the cel1 nucleus) where they fuse with late ndo om . LL te nd . m 
accumulate and concentrate intemali d content after their pa age thr ugh e rl 
I ( 
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endosomes. They have lysosome type characteristics and act to degrade their 
contents. 
Clathrin-independent endocytosis pathways include macropinocytosis, caveolae and 
other poorly understood constitutive processes of plasma membrane intemalisation. J3 
The investigation of these mechanisms has recently become possible only with the 
development of negative mutant proteins that suppress clathrin-mediated endocytosis 
and with studies using fluorescent tagged proteins and lipids to visualise the 
movement of molecules through-non-clathrin pathways. As a result, relatively little 
is known about the mechanisms that underlie these uptake pathways or where they 
lead inside the cell. I3 
Macropinocytosis exploits lateral heterogeneity in the plasma membrane and occurs 
when the rims of membrane folds fuse back forming a vesicle, taking extracellular 
fluid and macromolecules (non-specifically) inside the cel1." These structures are 
dynamic, frequently moving inwards towards the centre of the cell; their lifetime is 
of the order of 5-20 minutes. I3 Caveolar uptake is quite different and relies on the 
presents of flask-shaped invaginations in the cell membrane called Caveolae that are 
coated by a class of proteins called Caveolins. Their 'pinching-off into caveolin 
coated vesicles and uptake into the cell is ligand-triggered and allows routing of 
ligands to areas of the cell that are not easily accessible by other endocytotic 
mechanisms such as the endoplasmic reticulum (ER). This pathway also bypasses 
low pH and digestive compartments. I4 
Exocytosis is essentially the reverse of endocytosis: the cell excretes macromolecules 
by the fusion of vesicles with the plasma membrane. In order to account for the 
observed dependence on localisation inside the cell as a function of the external 
concentration it is essential that transport of the complex between the inside and , 
outside is dynamic and operates reversibly. 
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Figure 4. 25 
It has been reported that complexes shown in Figure 4.25 are taken up by an 
endosomal pathway since the efficiency of their uptake is considerably reduced at 4 
degrees (below this temperature endocytosis is generally considered to be 'switched 
off). Incubation of NIH 3T3 cells in the presence of [Ln.1] at 4 °C did not 
significantly reduce uptake of the complex. However, it is suggested that due to the 
lipophilic nature of the complex and its high (but unspecific) affinity for protein, it 
could remain associated with the cell surface even after several washings with cold 
PBS. Since the cells are imaged live, as the slide returns to room temperature, 
endocytosis would again be 'switched on' and the associated complex could be taken 
inside the cell. 
4.7 Which Structural Features Govern the Localisation of the 
Complex Within the Cell? 
Whilst the mechanism that allows these complexes to cross the cell membrane and 
localise into specific compartments requires further investigation, a comparison 
between structurally similar complexes that show different compartmentalisation can 
help us to design new complexes to target (or prevent) uptake by a particular 
organelle. It is immediately apparent from the few examples of cell-permeable 
lanthanide complexes that have been published in the literature to date, that 
structurally fairly similar complexes can exhibit uptake to a different compartment. 
The isomeric cOlnplexes LnAlaOEt3NAcL (b) and LnAlaOEt3C ACL (c). (Chapter -+. 
Figure -+.1) perhaps provide the best exatnple; an obvious conclusion in this case is 
Chapter 4 - Luminescent Europium and Terbium Complexes for in cellulo Applications 
that it is the structure and degree of confonnational freedom of the planar aromatic 
chromophore that may be most important for controlling localisation. 
The complex shown in Figure 4.26 has been synthesised during 2006 in the Parker 
lab and is similar in structure to complex [Ln.l], except it incorporates an 
. hI· 22 azaxanthone chromophore in place of the tetraazatnp eny ene mOIety. 
166 
vnap1er 4 - Lumlnescem europium and Terbium Complexes for in cellulo Applications 
Figure 4. 27 - Transmitted microscope image of CHO cells loaded with [Tb.ll (1 OO~, 3 h post-
incubation) 
Figure 4.28 _ Fluorescence microscope image of the same population of CHO cell a hown in 
Figure 4.12 loaded with [Ln.I] (100 ~,3 h post-incubation). 
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Figure 4.29 - Transmitted microscope image of CRO cells loaded with TbPh3AzaH (lOOJlM 3 
h post-incubation) 
Figure 4.30 _ Fluorescence microscope image of the same population of CHO cells a 
Figure 4.12 loaded with [Ln.l1 (100 JlM, 3 h post-incubation). 
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Figures 4.27 - 4.30 show CHO cells that have been cultured in F12 (Ham) medium 
supplemented with 50 J.lg mr! penicillin/streptomycin and 10 % foetal calf serum in 
the presence of either [Tb.l] or TbPh3AzaH (100 J.lM) for 3 hours. Despite their 
similar structures, they exhibit quite different localisation: [Ln. I ] shows a spotty 
localisation centred around the nucleus as has previously been discussed: 
TbPh3AzaH appears to show plate-like structures in the cytosol. Compartments are 
also illuminated within the nucleus, which perhaps correspond to the nucleolus. The 
plate-like structures are also visible in transmission (Figure 4.24) and appear to be 
peculiar to cells loaded with this complex. 
4.8 Preliminary Analysis of Intracellular Complex Emissive 
Lifetimes to Probe the Coordination Environment and 
Assess the Extent to Which Emission is Quenched within 
a Specific Compartment 
Through the use of a time resolved microscope, it is possible to detennine the 
lifetime at any point within an image; with appropriate treatment a lifetime 'density' 
map can be built Up.23 Quenching of the lanthanide excited state is characterised by a 
decrease in the metal centred emission lifetime (in addition to a decrease in the 
emissive intensity). This could prove a useful technique for probing the local 
environment of the complex. Figures 4.31 - 4.33 demonstrate the principle. CHO 
cells were incubated in the presence of a 1 mM solution containing EuPh3dpqC, 
[Eu.t] for 4 hours (Figure 4.31). 
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Figure 4. 31 - CHO cells labelled with EuPh3dpqC (1 mM, 4 hrs post-incubation). Two regions 
of interest are defined: ROIl and ROI2 
Images were then captured using gate times of between 0 and 2500 /..ls in 125 /..ls 
steps following excitation using a nitrogen laser at 337 nm. By plotting the change in 
emission intensity for individual pixels, or over a region of interest as a function of 
gate time, it is possible to estimate the lifetime of the complex over that area. This 
principle is depicted in Figures 4.32 and 4.33 for the regions of interest defined as 
ROIl (centred on the punctate localisation around the periphery of the nucleus) and 
ROI2 (centred inside the nucleus). 
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Figure 4. 32 - Decrease in emission intensity with increasing gate time for ROil (Lifetime = 714 
± 50 JlS) 
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Figure 4. 33 - Decrease in emission intensity with increasing gate time for ROl2 (Lifetime = 769 
± 50 Jls) 
Lifetimes were found to be 716 ~s and 769 ~s over regions of interst ROIl and ROI2 
respectively. Whilst these are preliminary results, it is interesting to note that the 
lifetimes are relatively long (cf 1 ms for the complex in water), indicating that the 
complex is not strongly quenched within the cell. Following repetition of the results 
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and optimisation of the method, it would be interesting to now compare these results 
to those for the complexes that appear to give only very weak emission in cellulo (for 
example [Eu.2,4] in order to support the results reported in sections 4.1 and 4.2. I.e. 
that each of the complexes EuPh3dpqC, [Eu.t], EuD03AdpqC, [Eu.2] and EuGlu-
3dpqC, [Eu.4] are taken up to a similar extent, but that [Eu.I] appears considerably 
more emissive and is assumed to be quenched to a lesser extent. 
In Figure 4.31, the nucleus appears dark and localisation is apparent only around the 
periphery. However, pixel intensities are significant in the nucleus as is evident from 
the lifetime measurement, and are 2 - 3 times brighter than background 
luminescence. Using conventional fluorescence microscopy, where there are 
particularly bright regions in the image, other localisation can be difficult to discern, 
since the image is captured using exposure times such that no part of the image is 
over-exposed. Producing a false-colour lifetime map, may help provide a clearer 
comparison between complexes, in particular, where distribution is more diffuse. 
I "7 ., 
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Conclusions and Future Work 
Structurally related complexes of europium(III) and terbium(III) have been 
synthesised, whose overall charge and lipophilicity have been modified through 
varying the pendent arms on cyclen; carboxylate, amide and phosphinate based 
systems have been investigated. The tetraazatriphenylene chromophore, dpqC, is 
common to each of the complexes and is an excellent sensitiser for both 
lanthanide(III) ions. It has a fast rate of S I to T I intersystem crossing, and a triplet 
state that is insensitive to quenching by molecular oxygen. These features, in 
combination with the well defined coordination environment of the lanthanide 
provided by the nonadentate ligand, lead to high luminescent quantum yields in 
aerated aqueous media of the order of 15 - 50 % and long luminescent lifetimes of 
the order of milliseconds. The metal-centred excited state has been shown to be 
susceptible to quenching by electron-rich donors, for example, urate, ascorbate and 
iodide. The favourable photophysical properties of the series of complexes reported 
herein has allowed an assessment to be made of deactivation though a dynamic 
charge-transfer mechanism, driven by the excited state energy of the lanthanide ion. 
It has been shown that the terbium(III) complexes are quenched more than their 
europium(III) analogues, and that the order of sensitivity to quenching generally 
follows the ease of oxidation of the quenching anion. However, urate quenches by an 
order of magnitude more than ascorbate, despite having a redox potential of 0.59 V, 
compared to 0.30 V for ascorbate. These differences have been exploited in the 
development of a ratiometric assay for the determination of uric acid concentration in 
biological samples. A number of mechanisms have been tentatively proposed to 
account for the quenching behaviour of these complexes in the presence of electron-
rich donors and supporting evidence has been provided through comparison with 
examples of related complexes also synthesised in Durham. 
The use of fast, time-resolved spectroscopies is essential if the mechanism is to be 
fully elucidated. It has been proposed that charge transfer occurs from the donor to 
the sensitising ChrOlTIOphore; this would be expected to manifest itself as a change in 
the excited state UV -Vis absorption spectrum of the complex. The work reported in 
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this thesis is aimed towards the design of lanthanide complexes for use 'in cellula'. 
In order to attain maximum efficiency using luminescence based detection 
techniques it is necessary that the susceptibility to quenching is reduced as much as 
is possible. Further systematic modification of complex structure, and careful 
determination of quenching behaviour currently provides the most effective method 
for achieving this. 
The complexes have been shown to be taken up by a number of eukaryotic cell lines 
and are amenable to analysis by time resolved fluorescence microscopy. The cationic 
and lipophilic complexes generally give brighter images' in cellula' than their neutral 
and anionic analogues. However, determination of the intracellular lanthanide 
concentration has revealed that the complexes are taken up to a similar extent. 
Further work should be aimed towards determining the factors that govern 
localisation of the complex; subsequently, conjugates of the complexes could be 
synthesised in order to target specific intracellular compartments. The ultimate aim, 
would be to be able to carry out time-resolved luminescence assays inside live cells. 
The use of lanthanide complexes as probes offers a unique advantage over current 
alternatives as information about their local coordination environment, or the 
concentration of a specific analyte in solution can be gained through monitoring 
changes in their spectral emission profile, lifetime or circular polarisation. 
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5 General Experimental 
All reagents were used as supplied by commercial sources unless otherwise stated. 
Solvents were dried over the appropriate drying agents when required (CH3CN over 
CaH2, CH30H over Mg/h and THF over Na/benzophenone). Water and H20 refer to 
high purity water with conductivity < 0.04 JlS cm -], obtained from the "PuriteSTILL 
Plus" purification system. 
Thin layer chromatography was carried out using silica plates (Merck Art 5554) or 
neutral aluminium oxide plates (Merck Art 5550), both of which fluoresce under UV 
irradiation (254 nm). Preparative column chromatography was performed using 
neutral aluminium oxide (Merck Aluminium Oxide 90, activity II-III, 70-230 mesh), 
washed in ethyl acetate, or silica (Merck Silica Gel 60, 230-400 mesh). 
IH and I3C NMR spectra were recorded on a Varian Mercury-200 eH at 199.975 
MHz, I3C at 50.289 MHz) on a Varian Unity-300 eH at 299.908 MHz, I3C at 75.412 
MHz) on a Bruker Avance spectrometer eH at 400.13 MHz, I3C at 100.61 MHz) on 
a Varian Inova-500 eH at 499.78 MHz, 13C at 125.67 MHz) or on a 1.53 T magnet 
connected to a Varian VXR400 console eH at 65.6 MHz). All spectra were 
referenced to solvent residual proton signals, except for complexes in D20, where 
tert-butanol was added as an internal reference (8 = 0 ppm).9 All chemical shifts are 
given in ppm and coupling constants in Hz. 
Electrospray mass spectra were recorded on a VG Platform II instrument (Fisons) 
with methanol as the carrier solvent. Accurate masses were measured on a Thermo 
Finnigan LTQ or by the ESPRC Mass Spectroscopy Service at the University of 
Wales in Swansea. 
Melting points were measured using a Reichart-Kofler block and are uncorrected. 
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All pH measurements were performed using a Jenway 3320 pH meter attached to an 
Aldrich Chemical Company micro-pH combination electrode, calibrated using pH 4, 
7 and 10 buffer solutions. 
UV/vis absorption spectra were recorded using a Perkin Elmer Lamda 900 UV/vis/IR 
spectrometer. Emission spectra were recorded at 295 K using an Instruments SA 
Fluorolog 3-11 spectrometer and DataMax v2.1 for Windows. 
Luminescence spectra of the lanthanide(III) complexes were recorded at 295 K in 
aerated aqueous solution following indirect excitation of the lanthanide(III) ion via 
the tetraazatriphenylene chromophore, dpqC, at a wavelength of 348 nm. 
Phosphorescence emISSIon spectra were recorded at 77 K usmg an Oxford 
Instruments optical cryostat and LS 55B spectrometer, with EPA (diethyl ether, 
isopentane and ethanol, 5:5:2) as solvent. 
Lifetime measurements were measured by excitation of the sample by a short pulse 
of light (348 nm) followed by monitoring the integrated intensity of light (545 nm for 
terbium, 620 nm for europium) emitted during a fixed gate time, tg , a delay time, td, 
later. At least 20 delay times were used covering 3 or more lifetimes. A gate time of 
0.1 ms was used, and the excitation and emission slits were set to 10 and 2.5 nm 
bandpass respectively. The obtained decay curves were fitted to the equation below 
using Microsoft Excel. 
where J 
k 
J=Ao + Alexp(-kt) 
= intensity at time t after the flash 
= intensity after the decay has finished 
= pre-exponential factor 
= rate constant for decay of the excited state. 
The excited state lifetime, L, is the inverse of the rate constant, k. 
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Time 
Measured parameters for lifetime measurements 
The quantum yield for a given process is defined as the total number of photons 
emitted by that process divided by the total number of photons absorbed. The 
techniques and equipment necessary to make an absolute determination of quantum 
yields are not generally available. Therefore the usual method is to determine a 
relative quantum yield where the compound of unknown yield is compared to a 
compound of known yield. The unknown quantum yield can then be calculated 
using the following equation. 
Where r and x refer to reference and unknown respectively 
A = absorbance at Acx 
E = corrected integrated emission intensity 
I = corrected intensity of excitation light 
(as all of the measurements were taken using identical excitation conditions 
this tenn can be ignored) 
n = refractive index of solution. 
The measurements were made relative to two known complexes. For europium this 
was EuPh3dpqC and for terbium TbPh3dpqC. For each of the standards and the 
unknown, five solutions with absorbances between 0.02 and 0.1 were used. For each 
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of these solutions the absorbance at the excitation wavelength and the total integrated 
emission was determined. A plot of total integrated emission against absorbance 
gives a straight line with slope EI A. The unknown quantum yield can thus be 
calculated from the following equation. Since values for both the sample and 
reference compounds were recorded in water the refractive index term cancels out. 
cI>x =cI>r· slopex .(nxJ2 
sloper nr 
Errors in quantum yield determinations can arise due to the inner filter effect or 
errors in the amount of absorbed light. This effect can be minimised by only using 
samples with absorbances below 0.2. Errors in the amount of light absorbed by each 
sample can be minimised by choosing the excitation wavelength to be on a relatively 
flat area of the absorption curve and by using a small bandpass for excitation. 
Epifluorescence images were taken on a Zeiss Axiovert 200M epifluorescence 
microscope with a digital camera, or a custom, time-resolved fluorescence 
microscope using nitrogen laser excitation at 337nm with the assistance of Michel 
Laget (Cisbio International, France); filters used were as stated in Chapter 4; 
confocal images were taken on a Zeiss LSM 500 META confocal microscope with 
405 nm diode laser excitation and an LP 505 emission filter for europium complex 
luminescence and with 488 nm argon laser excitation and a BP 505-550 filter for 
SYTO dye fluorescence. 
Flow cytometric analysis and sorting was conducted using a DakoCytomation Inc. 
MoFlo multi-laser flow cytometer (Fort Collins, CO, USA) operating at 60psi, 70 
micron nozzle. Samples were interrogated with a 100 m W 488 nm solid state laser: 
(FSC, SSC). Fluorescence signals were detected through interference filters: (FL 1 
530/40, FL2 580/30, FL3 630/30, FL4 670/30). Fluorescence signals were collected 
in the logarithmic mode. The data were analyzed using Summit \4.0 
(DakoCytomation) software. 
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CPL measurements were made usmg a home-built (Glasgow University) CPL 
spectrometer based on a Spex Fluoromax-2 spectofluorimeter with the assistance of 
Dr R. D. Peacock. 
Inductively coupled plasma mass spectrometry determination of europIUm 
concentrations were made by Dr C. Ottley in the Department of Earth Sciences at 
Durham University. 
Relaxivity measurements were made at 37°C and 60 MHz on a Bruker Minispec 
mq60 instrument. The mean value of three separate measurements was recorded. 
NMRD profiles were recorded in Durham on a Stelar Spinmaster, in the field range 
0.001 - 20 MHz and in Ivrea, Italy on a similar instrument operating up to 90 MHz. 
Reverse phase HPLC were performed at 298 K on a Perkin Elmer system using 
either a 4.6 x 20 mm 4J..l Phenomenex Synergi Fusion RP analytical column or the 
equivalent 21.1 x 20 mm semi-semi preparitive column. In each case an H20 + 0.1 0/0 
TFA / CH3CN + 0.1 % TF A solvent system was used (gradient elution). Chapter 
2.2.2.1, Figure 2.12, gradient programme: 
Time (Mins) H20 + 0.1 % TFA (%) CH3CN + 0.1 % TFA 
0 70 30 
10 15 85 
13 0 100 
15 0 100 
20 70 30 
I ~ I 
Chapter 5 - General Experimental 
5.1 Synthetic Procedures 
1. 2-Methyl-1, 1 O-phenanthroline 1 
A solution of 1,1 O-phenanthroline (lOg, 55 mmol) in dry THF (l00 ml) was added 
dropwise to a stirred solution of methyl lithium (1.6 mol dm-3 in Et20, 34.5 ml, 55 
mmol) in dry THF (150 ml) at O°C under argon. The mixture was stirred overnight at 
room temperature under argon to give a dark green solution. The reaction was 
quenched by careful addition of water (100 ml) at O°C. THF was removed under 
reduced pressure using a rotary evaporator and the product extracted into diethyl 
ether (3 x 150 ml). Activated manganese dioxide (53 g, 0.61 mol) was added and the 
solution stirred for 1.5 hours; magnesium sulphate was added and the solution stirred 
for a further 2 hours. Filtration through a celite plug yielded a clear yellow solution. 
The solvent was evaporated to dryness to yield the crude product, which was purified 
by recrystallisation from ethyl acetate/hexane to give a white product (5.50 g, 28 
mmol, 51 0/0). IH NMR (300 MHz, CDCb): 2.97 (3H, s, CH3), 7.54 (lH, d, J = 8.1, 
H3), 7.63 (lH, dd, J = 8.1, 4.2, H8), 7.75 (IH, d, J = 8.7, H6), 7.79 (lH, d, J = 8.7, 
H5), 8.16 (lH, d, J = 8.4, H4), 8.26 (lH, dd, J = 8.1,1.5, H7), 9.22 (lH, dd, J = 4.2, 
1.2, H9). I3C NMR (75 MHz, CDCb): 25.9 (CH3), 122.8 (C8), 123.7 (C3), 125.5 
(C6), 126.5 (C5), 126.7 (q Ar), 128.8 (q Ar), 136.1 (C7), 136.2 (C4), 145.7 (q Ar), 
146.0 (q Ar), 150.3 (C9), 159.5 (C2). mlz (ES+) 195 (MH+), 217 (MNa+), 411 
(M2Na +); m.p. 75-76°C (lit. 3378°C). Elemental analysis: found C 79.5, H 5.44, N 
14.5%; CI3HION2.0.17H20 requires C 79.2, H 5.23, N 14.20/0. 
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2. 2-Methyl-1, 1 O-phenanthroline-5,6-dione 1 
o 
o 
A mixture of 2-methyl-l,10-phenanthroline (2.00 g, 10.29 mmol) and potassium 
bromide (12.25 g, 102.9 mmol) was placed in an ice bath. Cold sulphuric acid (43 
ml) was added carefully to the flask dropwise turning the solution to a dark reddish 
colour. Concentrated nitric acid (21.5 ml) was then added in a similar way and the 
solution boiled under reflux overnight. The mixture was cooled, poured into water 
(500 ml) and neutralised by addition of sodium hydroxide pellets. The product was 
extracted into dichloromethane (3 x 300 ml), which was dried over K2C03 and 
removed under reduced pressure to yield a yellow solid. Purification was achieved by 
chromatography on silica (1.79 g, 7.98 mmol, 77 0/0) (gradient elution: CH2Ch to 10/0 
CH30HlCH2Ch, Rf = 0.34 [50/0 MeOHlCH2Ch]). IH NMR (300 MHz, CDCh): 2.86 
(3H, s, CH3), 7.44 (1H, d, J = 7.8, H3), 7.58 (lH, dd, J = 7.8, 4.8, H8), 8.40 (lH, d, J 
= 8.1, H4), 8.50 (1H, dd, J = 7.8,2.0, H7), 9.14 (lH, dd, J = 4.8,2.0, H9). I3C NMR 
(75 MHz, CDCh): 26.2 (CH3), 125.6 (C8), 125.9 (C3), 126.2 (q Ar), 128.3 (q Ar), 
137.5 (C7), 137.7 (C4), 152.7 (q Ar), 153.2 (q Ar), 156.6 (C9), 167.4 (C2), 178.7 
(C5), 179.2 (C6). mlz (ES+) 246 (MNa+), 279 (MNa+ + MeOH), 471 (M2Na+),503 
(M2Na + + MeOH), 535 (M2Na + 2MeOH). IR (KBr) 3074 (C-H Ar), 1681 (C=O), 
1568, (py ring vibration) 1436 and 1301 (C=C py), 1216, 1123, 1013,925,829,739 
em-I; m.p. 98-1 OO°C. Elemental analysis: found, C 66.3, H 3.46, N 12.20/0~ 
CI3HgN202.0.67H20 requires C 66.1, H 3.94, N 11.9%. 
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3. 3-Methyl-1 0,11,12, 13-tetrahydrodipyrido-[3,2a:2' ,3' -c]-phenazine 
To a solution of 2-methyl-l, 1 0-phenanthroline-5,6-dione (0.65 g, 2.90 mmol) in 
absolute ethanol (50 ml) was added trans-I,2-diaminocyc1ohexane (0.33 g, 2.90 
mmol) and the resulting mixture boiled under reflux for 5 hours. The solution was 
allowed to cool and solvent removed under reduced pressure. The product was 
recrystallised from ethanol to give white crytals (0.81 g, 2.90 mmol, 93 0/0), m.p. 
>220°C (dec). IH NMR (300 MHz, CDCh): 2.09 (4H, m, HIO, 13), 2.98 (3H, s, 
HI5), 3.24 (4H, m, HII, 12),7.63 (lH, d, J = 8.3, H2), 7.73 (lH, dd, J = 8.2, 4.4, 
H7), 9.26 (lH, dd, J = 4.4,1.8, H6), 9.35 (lH, d, J = 8.3, HI), 9.47 (lH, dd, J = 8.2, 
1.8, H8). I3C NMR (75 MHz, CDCh): 22.7 (CII), 22.8 (CI2), 25.7 (CH3), 32.7 
(C I 0), 32.8 (C 13), 123.4 (C7), 124.2 9C2), 124.8 (q Ar), 151.5 (C6), 153.2 (q Ar), 
153.6 (q Ar), 160.9 (q Ar). HRMS (+ m1z): [M + Ht calculated for CI9HI6N4Na, 
323.1273; found, 323.1269. 
4. 3-Carboxaldehyde-1 0,11,12, 13-tetrahydrodipyrido-[3,2a:2' ,3' -c]-
phenazine 
o 
H 
S I · d··d (0 96 g 8 66 mmol) was added to a solution of 3-methyl-e emum 10XI e . ,. 
10,11,12,13_tetrahydrodipyrido-[3,2a:2'J'-c]-phenazine (l.30 g, ~.33 mmo)) in 
dioxane (200 m]) and the Inixture boiled under reflux for 4 hours. The solution \\"as 
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cooled to room temperature and filtered through a celite plug to afford a crude 
product that was used directly in the next step. IH NMR (300 MHz, CDCI
3
): 2.11 
(4H, m, H10, 13),3.28 (4H, m, H11, 12), 7.83 (IH, dd, J = 8.2, 4.5, H7), 8.41 (lH, d, 
J = 8.3, HI), 9.33 (lH, dd, J = 4.5, 1.8, H6), 9.53 (IH, dd, J = 8.2, 1.8, H8), 9.68 (lH, 
dd, J = 8.3), 0.9, H2), 10.60 (IH, d, J = 0.9, CHO). I3C NMR (75 MHz, CDCh): 22.5 
(C11), 22.6 (CI2), 32.7 (C10), 32.8 (CI3), 120.2 9C7), 124.1 (c1), 127.5 9q Ar), 
130.0 (q Ar), 133.0 (c8), 134.1 (C2), 136.6 (q Ar), 138.3 9q Ar), 146.2 (q Ar), 146.7 
9q Ar), 151.7 (C6), 153.1 (q Ar), 154.4 (q Ar), 155.1 (q Ar), 193.9 (CHO). EI (+): 
[M+] 314. 
5. 3-Hydroxymethyl-1 0,11,12, 13-tetrahydrodipyrido-[3,2a:2' ,3' -c]-
phenazine 
HO 
Sodium borohydride (164 mg, 4.33 mmol) was added to a solution of 3-
carboxaldehyde-1 0, 11,12, 13-tetrahydrodipyrido-[3,2a:2' ,3' -c ]-phenazine (1.36 g, 
4.33 mmol) in CHCh/EtOH (200 mI). The mixture was heated under reflux for 2 
hours. The solvent was evaporated and the orange solution taken into a saturated 
solution of Na2C03 (200 mI) and extracted with CH2Cb (3 x 150 ml) then CHCl3 (1 
x 150 ml). The organic phase was dried over Na2S04 filtered and the solvent 
removed under reduced pressure to afford a yellow solid (0.89 g, 2.81 mmol, 65 0/0), 
m.p. 210°C (dec). IH NMR (300 MHz, CDCh): 2.10 (4H, m, HI0, 13),3.25 (4H, m, 
Hll, 12),5.18 (2H, s, CH20H), 7.75 (lH, dd, J = 8.2, 4.4, H7), 7.80 (lH, d, J = 8.3, 
H2), 9.20 (1 H, dd, J = 4.4, 1.7, H6), 9.47 (l H, d, J = 8.3, HI), 9.49 (l H, dd, J = 8.2, 
1.7, H8). I3C NMR (75 MHz, CDCh): 22.7 (C11, 12),32.8 (CIO, 13),65.7 (CH2), 
]21.0 (C7), 123.6 9C2), 125.9 (q Ar), 127.2 9q Ar), 132.9 (C8), 133.4 (CI). 137.4 (q 
Ar), 151.1 (C6), 153.5 (q Ar), 153.8 (q Ar), 162.3 (q Ar). HRMS (+ m/z): [M + Nat 
calculated for C19H16N40Na, 339.1222~ found, 339.1219. 
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6. 3-Chloromethyl-1 0,11,12, 13-tetrahydrodipyrido-[3,2a:2' ,3' -c]-
phenazine 
CI 
To a solution of 3-hydroxymethyl-l 0, 11,12, 13-tetrahydrodipyrido-[3,2a:2',3' -c]-
phenazine (0.84 g, 2.66 mmol) in CHCh (450 ml) was added phosphorus trichloride 
(1.46 g, 10.6 mmol). The mixture was heated under reflux for 4 hours. The solution 
was neutralized by addition of a saturated aqueous solution ofNa2C03 (500 mI). The 
organic layer was separated and the aqueous layer extracted with CH2Ch (2 x 400 
ml) and CHCh (1 x 400 ml). The combined organic layers were dried over K2C03 
and the solvent evaporated to afford a yellow solid. Purification by chromatography 
on silica (gradient elution: CH2Ch to 1 % CH30HlCH2Ch) gave a pale yellow solid 
(Rr 0.38, 50/0MeOHlCH2Ch; 0.75 g, 2.25 mmol, 84 0/0), m.p. 207-8 °C. IH NMR 
(300 MHz, CDCh): 2.05 (4H, m, HI0, 13),3.17 (4H, m, HII, 12),5.10 (2H, s, 
CH2CI), 7.70 (lH, dd, J = 8.2, 4.4, H7), 7.97 (lH, d, J = 8.3, H2), 9.23 (lH, dd, J = 
4.4, 1.8, H6), 9.37 (lH, dd, J = 8.2, 1.8, H8), 9.40 (lH, d, J = 8.4, HI). I3C NMR (75 
MHz, CDCh): 22.7 (Cll, 12), 32.2 (CI0, 13), 47.0 (CH2), 122.3 (C7), 123.2 (C2), 
125.7 (q Ar), 126.7 (q Ar), 128.9 (q Ar), 130.1 (q Ar), 132.2 (C8), 133.4 (C 1), 145.4 
(q Ar), 145.9 (q Ar), 151.1 (q Ar), 153.3 (C6), 157.9 (q Ar). HRMS (+ mJz): [M + 
Nat calculated for CI9HlsN4NaCl, 357.0883; found, 357.0885. 
7. 1,4,7 -tris-tert-Butoxycarbonyl-1 ,4,7,1 O-tetraazacyclododecane 
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A solution of di-tert-butyl dicarbonate (3.05 g, 13.92 mmol) in CH2Ch (70 ml) was 
added dropwise to a stirred solution of 1,4,7,10-tetraazacyclododecane (I g, 5.80 
mmol) in CH2Ch (290 ml). The mixture was stirred at room temperature for 2 hours. 
Evaporation of the solvent afforded a transparent oil, which was purified by 
chromatography on silica (gradient elution: CH2Ch to 5 % CH30HlCH2Ch, RF = 
0.29, 10 % CH30HlCH2Ch) to give a colourless solid (1.71 g, 10.95 mmol, 56 %). 
IH NMR (300 MHz, CDCh): 0 1.42 (I8H, s, CH3), 1.44 (9H, s, CH3), 2.81 (4H, br 
m, CH2), 3.26-3.35 (8H, br m, CH2), 3.60 (4H, m, CH2). 13C NMR (75 MHz, 
CDCh): 0 28.9 (CH3), 29.0 (CH3), 46.1 (CH2), 49.9 (CH2), 51.2 (CH2), 79.4 (C), 
79.6 (C), 155.8 (C=O), 156.0 (C=O). mlz (ES+): 495 (MNa+), 967 (M2Na+). 
8. 1-{3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine)-4,7,1 O-tris{tert-butoxycarbonyl)-1 ,4,7,10-
tetraazacyclododecane 
N~ 
\ J--/ 
N 
Potassium carbonate (124 mg, 0.716 mmol) and a catalytic amount (2 mg) of KI 
were added to a solution of 1,4,7-tris-tert-butoxycarbonyl-l,4,7,10-
tetraazacyclododecane, 17, (77 mg, 0.179 mmol) in CH3CN (3 mI). The mixture was 
heated at 60°C and a solution of 3-chloromethyl-1 0, 11,12, 13-tetrahydrodipyrido-
[3,2a:2',3'-c]-phenazine (60 mg, 0.179 mmol) in CH2Ch (3 mI) was added. The 
reaction Inixture was boiled under reflux under argon overnight. The solution was 
filtered and the salts washed with CH2Ch. The residue was purified by 
chromatography on silica gel (gradient elution: CH2Ch to 3 % CH30HlCH2Ch, RF = 
0.44, 10 % CH30HlCH2Ch) to yield a pale yellow solid (105 mg, 0.136 mmol, 76 
0/0), m.p. 114-II6°C. IH NMR (300 MHz, CDCh): 0.92-0.71 (27H, br m, CH3), 2.04 
(4H, m, HIO, HI3), 2.42-2.99 (4H, m, CH2 ring), 3.07-3.87 (I6H, br m, CH2 ring + 
HII, H12). 4.24 (2H, s, CHrdpqC), 7.67 (IH, dd, J = 8.2, 4.4, H7), 7.72-7.97 (IH. 
187 
Chapter 5 - General Experimental 
br s, H2), 9.71 (1 H, br s, H6), 9.26-9.44 (2H, br m, H8, HI). I3C NMR (75 MHz, 
CDCh): 22.7 (CIO, CI3), 28.3 (CH3), 28.5 (CH3), 32.7 (Cll, CI2), 46.2-51.3 (C 
ring), 60.0-61.2 (CHrdpqC), 79.3 (CHN), 123.3 (C7), 123.8 (C Ar), 125.9 (c Ar), 
127.0 (C2), 129.3 (C Ar), 130.4 (C Ar), 130.5 (C Ar), 137.6 (C Ar), 142.2 (C Ar), 
146.4 (C Ar), 146.8 (C Ar), 151.3 (C Ar), 153.3 (C Ar), 154.7-157.0 (C=O). HRMS 
(+ m1z): [M+Nat calculated for C42HsgNg06Na, 793.4377; found, 793.4379. 
9. 1-{3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine)-1 ,4,7,1 O-tetraazacyclododecane 
N~ 
\ N 
N 
Trifluoroacetic acid (10 ml) was added to a solution of 1-(3-methyl-1 0, 11,12,13-
tetrahydrodipyrido[3,2-a:2',3' -c Jphenazine )-4,7,1 O-tris(tert-butoxycarbonyl)-
1,4,7,10-tetraazacyclododecane (104.7 mg, 0.136 mmol) in CH2Ch (3 ml). The 
mixture was stirred for 2 hours at room temperature. The solvent was evaporated and 
the residue redissolved for 3 times to facilitate elimination of excess acid and tert-
butyl alcohol. The residue was taken into a I M KOH solution (5 ml) and the product 
extracted into CH2Ch (3 x 5 ml). The organic layer was dried over K2C03. Removal 
of the solvent under reduced pressure yielded an orange solid (52.5 mg, 0.112 mmol, 
82 %). m.p. >240 °C. IH NMR (300 MHz, CDCh): 2.09 (4H, m, HIO, 13),2.60-3.00 
(16H, m, CH2 ring), 3.24 (4 H, m, H II, H 12), 4.16 (2H, s, CH2-dpqC), 7.69 (I H, d, J 
= 8.0, H2), 7.76 (IH, dd, J = 8.2, 4.4, H7), 9.26 (IH, dd, J = 4.4, 1.4, H6), 9.40 (lH, 
d, J = 8.0, HI), 9.46 (1H, dd, J = 8.2, 1.4, H8). I3C NMR (75 MHz, CDCh): 22.6 
(CH2), 32.6 (CH2), 45.2, 46.3, 47.1, 52.0 (CH2 ring), 61.7 (CH2), 122.8 (C7), 123.2 
(C2), 125.9 (q Ar), 127.0 (q Ar), 132.7 (C8), 133.5 (CI), 137.1 (q Ar), 146.0 (q Ar), 
146.8 (q Ar), 151.3 (C6), 153.3 (q Ar), 153.6 (q Ar), 162.3 (q Ar). 
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10. {S)-N-Chloroethanoyl-2-phenylethylamine2,3 
Chloroacetyl chloride (1.45 ml, 18.47 mmol) was added dropwise to a stirred 
solution of (S)-I-phenylethylamine (2 ml, 15.1 mmol) and triethylamine (2.45 ml, 18 
mmol) in dry THF (75 ml) at -5°C under argon. The reaction mixture was allowed to 
return to room temperature and stirred for 1 hour. The product was extracted into 
diethyl ether, which was then washed with 0.1 M hydrochloric acid (15 ml), water (3 
x 10 ml) and dried over K2C03 . Recrystallisation from diethyl ether yielded the 
product as white needles (1.17 g, 5.92 mmol, 39 %). M.p. 95-96°C. IH NMR (300 
MHz, CDCh): D 1.55 (3H, d, J = 6.9, CH3), 4.08 (2H, m, CH2), 5.15 (1 H, q, J = 7.2, 
CH), 6.79 (lH, br s, NH), 7.35 (5H, m, Ph). 
11. N-Chloroacetyl-L-alanine ethyl ester4 
A solution of chloroacetyl chloride (0.81 g, 7.15 mmol) in THF (10 ml) was added 
dropwise to a stirred solution of L-alanine-ethyl-ester-hydrochloride (1 g, 6.5 mmol) 
and triethylamine (1.31 g, 13 mmol) in THF (25 ml) maintained at O°C. The reaction 
was allowed to return to room temperature and stirred for approximately 90 minutes. 
The resulting suspension was filtered and washed with THF (2 x 25 ml) to give a 
slightly greenish solution. Upon reduction of the solvent volume and washing with 
slightly acidic water a greenish oily product was obtained (1.07 g, 5.53 mmol, 85 0/0). 
IH NMR (300 MHz, CDCh): D 1.27 (3H, t, J = 7.2, CH2CH3), 1.43 (3H, d, J = 7.2, 
CHCH3), 4.05 (2H, s, CH2Cl), 4.19 (2H, q, J = 7.2, CH2CH3), 4.55 (l H, m, CHCH,). 
7.18 (l H, br s, NH). 
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12. N-Chloroacetyl-L-glutamic acid diethyl esterS 
A solution of chloroacetyl chloride (0.78 g, 6.89 mmol) in THF (10 ml) was added 
dropwise to a stirred solution of L-glutamic acid-diethyl-ester-hydrochloride (1.5 g, 
6.26 mmol) and triethylamine (1.26 g, 13.5 mmol) in THF (25 ml) maintained at 
O°C. The reaction was allowed to return to room temperature and stirred for 
approximately 90 minutes. The resulting suspension was filtered and washed with 
THF (2 x 25 ml) to give a clear solution. Removal of the solvent under reduced 
pressure and washing with slightly acidic water yielded the product as a clear oil 
(1.66 g, 5.94 mmol, 95 %). IH NMR (300 MHz, CDCh): () 1.27 (6H, m, CH2CH3), 
2.08 (4H, m, CH2CH3), 4.07 (2H, s, CH2CI), 4.14 (2H, q, J = 15, CHCH2CH2), 4.23 
(2H, q, J = 15, CHCH2CH2), 4.61 (1H, m, CH), 7.25 (1H, br s, NH). 
13. 1-{3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine)-4,7, 1 O-tris[{S)-1-{1-phenyl)ethylcarbamoylmethyl]-
1,4,7,10-tetraazacyclododecane 
MeyPh 
HN'(~ 
N NJ Ph )L5N N )- LJ, 
Me ~ o~ 
NH 
N 
Ph...-Z 
Me 
Potassium carbonate (138 mg, 0.995 mmol) and a catalytic amount of KI were added 
to a solution of 1-(3-methyl-l0,1 LI2,l3-tetrahydrodipyrido[3,~-a:~'.3'-
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c]phenazine)-1,4,7,10-tetraazacyc1ododecane (94.1 mg, 0.199 mmol) in CH3CN (7 
ml). The reaction mixture was heated at 60°C and a solution of (S)-N-(l-phenyleth-
1-yl)chloroacetamide (118 mg, 0.597 mmol) in CH2Ch (7 ml) was added. The 
reaction mixture was boiled under reflux overnight, under argon. The solution was 
filtered and the salts washed with CH2Ch. The product was purified by 
chromatography on neutral alumina to yield a yellow solid (gradient elution: CH2Ch 
to 1 % CH30H/CH2Ch, RF = 0.55, 7.5 % CH30HlCH2Ch). (91 mg, 0.096 mmol, 48 
0/0), m.p. 148-150°C. IH NMR (300 MHz, CDCh): l.35 (6H, d, J = 6.7, CH3), l.56 
(3H, d, J = 6.7, CH3), 2.06 (4H, m, CH2), 2.16-3.12 (l6H, br m, CH2 ring), 3.21 (4H, 
d, J = 4.0, CH2), 3.42-4.45 (8H, br m, CH2CO, CH2-dpqC), 4.57 (lH, br m, CH), 
4.75 (2H, br m, CH), 6.70-7.49 (l8H, m , Ar, NH), 7.53 (lH, d, J = 8.3, H2), 7.96 
(lH, br m, H7), 8.30 (lH, br m, H6), 9.37 (lH, d, J = 8.3, HI), 9.48 (lH, d, J = 8.2, 
H8). I3C NMR (75 MHz, CDCh): 22.2 (CH3), 22.7 (CI0, CI3), 22.8 (CH3), 32.7 
(C11, C12), 49.5 (CRN), 49.8-52.4 (CH2 ring + CH2CO), 60.4 (CHydpqC), 123.4 
(C2), 125.1 (C7), 126.3 (C Ar), 126.4 (C Ar), 126.8 (C Ar), 126.9 (C Ar), 127.4 (C 
Ar), 128.1 (C Ar), 128.2 (C Ar), 128.4 (C Ar), 133.2 (C8), 134.1 (Cl), 137.0 (C Ar), 
137.5 (C Ar), 143.5 (C Ar), 144.2 (C Ar), 145.6 (C Ar), 146.2 (C Ar), 153.6 (C Ar), 
153.9 (C Ar), 154.1 (C Ar), 159.9 (C Ar), 169.1 (C=O), 170.7 (C=O). HRMS (+ 
mlz): [M+Ht ca1cd for CS7H68NII03, 954.5506; found, 954.5497. 
14. 1-(3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine)-4,7,1 0-tris(ethyl-N-acetylalanine)-1 ,4,7,10-
tetraazacyclododecane 
OEt 
Me 0-0 
HN'(~ 
N NJ EtO~O 0 eN N J--/ LJ') N N \ 
Me H 0 
NH 
°YMe 
EtO 
N~ 
'\ )-J 
N 
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Potassium carbonate (I16 mg, 0.840 mmol) and a catalytic amount of KI were added 
to a solution of 1-(3-methyl-1 0, 11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine)-I,4,7,10-tetraazacyclododecane (79.1 mg, 0.168 mmol) in CH3CN (6 
ml). The reaction mixture was heated at 60°C and a solution of N-chloroacetyl-L-
alanine ethyl ester (97.6 mg, 0.504 mmol) in CH2Ch (6 ml) was added. The reaction 
mixture was boiled under reflux overnight, under argon. The solution was filtered 
and the salts washed with CH2Ch. The product was purified by chromatography on 
neutral alumina. (gradient elution: CH2Ch to 1 % CH30HlCH2Ch, RF = 0.55, 7.5 0/0 
CH30HlCH2Ch) to give a yellow solid. (94 mg, 0.10 mmol, 59 0/0). IH NMR (400 
MHz, CDCh): 0.90-1.58 (I8H, m, CH2CH3, CHCH3), 2.06 (4H, m, HIO, HI3), 2.24-
3.18 (I6H, br m, CH2 ring), 3.21 (4H, m, Hll, HI2), 3.42-4.45 (l7H, m, CH2CO, 
CH2-dpqC, CH), 7.60 (lH, m, H2), 7.77 (lH, br m, H7), 7.89 (lH, br m, H6), 9.24 
(lH, m, HI), 9.43 (lH, m, H8). I3C NMR (75 MHz, CDCh): 14.1 (CH3), 14.2 (CH3), 
17.1 (CH3), 17.1 (CH3), 17.5 (CH3), 22.8 (C 1 0, C 13), 32.9 (C 11, C 12), 48.3-57.4 
(CH2 ring, CH2CO, CH2CH3), 61.3 (CH2-dpqC), 124.2 (C2), 124.9 (C Ar), 126.7 (C 
Ar), 127.6 (C7), 133.2 (C8), 134.1 (Cl), 137.4 (C Ar), 146.4 (C Ar), 146.9 (C Ar), 
151.6 (C6), 154.3 (C Ar), 157.5 (C Ar), 160.9 (C Ar), 169.0 (C=O), 172.5 (C=O), 
172.7 (C=O). m/z (ES+): 491 (MCa2+), 508 (MCu2+) 965 (MNa+). 
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1-(3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2_a:2' ,3'-
c]phenazine)-4, 7,1 O-tris(diethyl-N-acetyl-L-glutamate)_1 ,4,7,10-
tetraazacyclododecane 
OEt 
o 
HN 0 
'(~ 
Ni) eN N O~N NJ \ h N 
N U) 
EtO H 0 
0 0 NH 
o 
EtO 
Potassium carbonate (129 mg, 0.935 mmol) and a catalytic amount of KI were added 
to a solution of 1-(3-methyl-l 0, 11,12, 13-tetrahydrodipyrido[3,2-a:2',3'-
c ]phenazine )-1,4,7,1 O-tetraazacyclododecane (87.8 mg, 0.187 mmol) in CH3CN (7 
mI). The reaction mixture was heated at 60°C and a solution of N-chloroacetyl-L-
glutamic acid diethyl ester (157 mg, 0.561 mmol) in CH2Ch (7 ml) was added. The 
reaction mixture was boiled under reflux overnight, under argon. The solution was 
filtered and the salts washed with CH2Ch. The product was purified by 
chromatography on neutral alumina to yield a pale yellow solid (gradient elution: 
CH2Ch to 1 % CH30HlCH2Ch, RF = 0.54,7.5 % CH30HlCH2Ch), (105 mg, 0.089 
mmol, 48 0/0), m.p. 82-84°C. IH NMR (300 MHz, CDCh): 0.96-1.34 (l8H, m, CH3), 
1. 74-2.56 (l6H, m, CH2CH3, HI 0, H 13), 2.82-3.42 (20H, br m, CH2 ring, H II, H 12), 
3.72-4.64 (2IH, m, CH2CO, CHrdpqC, CHCH2Cfu, CHCH2CH2, CHCH2CH2), 
7.68 (lH, In, H2), 7.76 (lH, br m, H7), 7.95 (lH, br m, H6), 9.35 (lH, m, HI), 9.45 
(lH, m, H8). I3C NMR (75 MHz, CDCI3): 14.1 (CH3), 14.2 (CH:;), 22.8 (CIO, CI3), 
26.2 (CH2), 30.4 (CH2), 30.6 (CH2), 32.9 (C 11, C 12), 50.4-60. 7 (CH~ ring, CH2CO. 
CH2CH3), 61.6 (CH2-dpqC), 124.2 (C2). 124.7 (C Ar), 126.7 (C /\r). 127.7 (C7). 
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133.2 (C8), 134.1 (Cl), 137.4 (C Ar), 146.3 (C Ar), 146.9 (C Ar), 151.9 (C6), 154.2 
(C Ar), 157.5 (C Ar), 160.9 (C Ar), 169.4 (C=O), 171.3 (C=O), 171.6 (C=O), 172.4 
(C=O), 172.8 (C=O). mlz (ES+): 620 (MCa2+), 632 (MCu2+), 1223 (MNa +) 
16. [EuPh3dpqC]Cb, [Eu.1] 
N~ 
\ N 
N 
A solution of 1-(3-methyl-l 0, 11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3' -c ]phenazine)-
4,7,1 O-tris[ (S)-I-( I-phenyl)ethylcarbamoylmethyl]-I ,4,7,1 O-tetraazacyclododecane 
(31.8 mg, 0.033 mmo!) and Eu(OTf)3 (20.0 mg, 0.033 mmol) in dry CH3CN (5 ml) 
was boiled under reflux under argon overnight at 80°C. The solution was then added 
dropwise to ether (~ 20 ml) with stirring, the precipitate centrifuged and the solvent 
decanted. The solid was re-dissolved in CH3CN and the process repeated to yield an 
off-white solid product (39 mg, 0.025 mmol, 76 %). mlz (ES+): 628 (MOTF+), 1402 
(MOTf2 +). This complex was converted to the more water soluble chloride salt by 
ion exchange chromatography in water using an Amberlite IRA resin. Amax (H20) 
348 nm; 1 (H20) = 1.04ms; 1 (D20) = 1.59 ms, <\> (H20) = 16%, <\>(D20) = 200/0. I H 
NMR (CD30D) Partial assignment () 37.51 (lH, s, Hax), 36.88 (l H, s, Hax), 31.43 
(lH, s, Hax), 27.03 (lH, s, Hax), 26.45 (H6-dpqC), 15.17 (dpqC), 14.39, 10.27,9.56,-
2.06, -2.62, -3.78, -4.14, -7.40, -7.71, -8.08, -15.71, -16.24, -16.84, -17.13, -17.85,-
18.49, -24.32. HRMS (+ mlz): [MCF3S03]2+ calcd for CS8H68NII06F3SEu, 627.7081: 
found, 627.7080. 
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N~ 
\ )J 
N 
A solution of 1-(3-methyl-l 0, 11,12, 13-tetrahydrodipyrido[3,2-a:2',3' -c ]phenazine)-
4,7,1 O-tris( ethyl-N-acetylalanine )-1,4,7,1 O-tetraazacyc1ododecane (27.7 mg, 0.029 
mmol) and Eu(OTf)3 (17.4 mg, 0.029 mmol) in dry CH3CN (5 ml) was boiled under 
reflux under argon overnight at 80°C. The solution was then added dropwise to ether 
(~ 20 ml) with stirring, the precipitate centrifuged and the solvent decanted. The 
solid was redissolved in CH3CN and the process repeated to yield an off-white solid 
product (23mg, 0.015 mmol, 51 %). m/z (ES+): 365 (M3+), 621 (MOTr+). The 
product was hydrolysed immediately to give the zwitterionic complex (see 22). 
19~ 
OEt 
o 
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N~ 
\ )-J 
N 
An analogous procedure to that described in 17 was followed using I-(3-methyl-
10,11,12, I3-tetrahydrodipyrido[3,2-a:2',3' -c ]phenazine )-4,7,1 O-tris( diethyl-N-acetyl-
L-glutamate )-1,4,7,1 O-tetraazacyclododecane (25.4 mg, 0.021 mmol) and Eu(OTf)3 
(12.5 mg, 0.021 mmol) in dry CH3CN (5 ml). The product was obtained as an off-
white solid (36 mg, 0.02 mmol, 94 0/0). mlz (ES+): 451 (M3+), 751 (MOTf+). The 
product was hydrolysed immediately to give the anionic complex (see 23). 
19. [TbPh3dpqC]Cb, [Tb.1] 
An analogous procedure to that described in 17 was followed using 1-(3-methyl-
10,11,12, 13-tetrahydrodipyrido[3,2-a:2',3' -c ]phenazinyl)-4, 7,1 O-tris[ (S)-I-( 1-
phenyl)ethylcarbamoylmethyl]-1 ,4,7,1 O-tetraazacyclododecane (30.9 mg, 0.032 
mmol) and Tb(OTf)3 (19.6 mg, 0.032 mmol) in dry CH3CN (5 ml). The product was 
obtained as a pale-yellow solid (39.5 mg, 0.0253 mmol, 79 0/0). Amax (H20) 348 nm; 't 
(H20) = 1.56 ms, 't (D20) = 1.72 ms, <1>(H20) = 40 0/0, <1>(020) = 48 0/0. I H NMR 
(C0300): 8 118.57, 93.49, 73.02, 67.19, 64.91, 63.33, 54.31. 37.96, -2.26. -7.03, -
7.28, -8.1 L -9.07, -9.35, -15.62, -17.19, -41.84, -73.53. -79.19, -110.18. m/z (ESt): 
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371 (M
3
+), 631 (MOTf?+), 1411 (M[OTl]2+). HRMS (+ m1z): [M + CF
3
S0
3
12+ ca1cd 
forCs8H68N]]06F3STb, 630.7101; found, 630.7099. 
An analogous procedure to that described in 17 was followed using 1-(3-methyl-
10,11,12, 13-tetrahydrodipyrido[3,2-a:2',3' -c Jphenazine )-4,7,1 O-tris( ethyl-N-
acetylalanine)-1,4,7,10-tetraazacyc1ododecane (25.4 mg, 0.027 mmol) and Tb(OTf)3 
(16.4 mg, 0.027 mmol) in dry CH3CN (5 ml). The product was obtained as an off-
white solid (14.8 mg, 0.0957 mmol, 35 0/0). mJz (ES+): 367 (M3+), 625 (MOTf+), 
1399 (M[OTf]2 +). The product was hydrolysed immediately to give the zwitterionic 
complex (see 24). 
An analogous procedure to that described in 17 was followed using 1-(3-methyl-
10, 11,12, I 3-tetrahydrodipyrido[3,2-a:2',3 , -c Jphenazine )-4,7, I O-tris( diethyl-N-acetyl-
L-glutamate)-1,4,7,10-tetraazacyc1ododecane (22.9 mg, 0.0190 mmol) and Tb(OTf)3 
( 11.5 mg, 0.0190 mmol) in dry CH3CN (5 ml). The product was obtained as an off-
white solid (34.1 mg, 0.189 mmol, 99 %). mJz (ES+): 453 (M3+), 754 (MOTf+), 1657 
(MOTf2 +). The product was hydrolysed immediately to give the anionic complex 
(see 25). 
The series of anioniclzwitterionic complexes 22 - 25 were prepared in the following 
manner, containing sodium chloride that was not considered sign~ficant in assessing 
their photophysical properties. In each case, hydrolysis was followed by monitoring 
the disappearance of the ESMS peaks corresponding to the parent cationic complex. 
The zwitterionic and anionic complexes appeared to have poor mobility in either 
negative or positive ion mode. 
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22. EuAla3dpqC, [Eu.2] 
0-
Meh HNr-~ \. r\\ \ 
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To EuAlaEt3dpqC (CF3S03)3 (23.0 mg, 0.0150 mmol) was added a 0.02 M solution 
of sodium hydroxide (3.00 ml, 0.0600 mmol) and the mixture stirred overnight. The 
solution was neutralised using dil. HCI and the product was obtained following 
evaporation of the solvent under reduced pressure. Amax (H20) 348 nm; 't (H20) = 
0.96 ms, <I> (H20) = 18 %. 
23. [EuGlu3dpqC]Na3, [Eu.4] 
o 
o 
-0 
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yO \. r\\ \ 
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Complex EuGluEt3dpqC (CF3S03)3 (35.6 mg, 0.0198 mmol) was hydrolysed using a 
procedure identical to that described for compound 22. Amax (H20) 348 run; 't (H20) 
= 1.0 ms, <I> (H20) = 15 %. 
24. TbAla3dpqC, [Tb.2] 
Complex Tb(Ala-Et)3dpqC (CF3S03)3 (14.8 mg, 0.0096 mmol) was hydrolysed 
using a procedure identical to that described for compound 22. Amax (H20) 348 nm; 't 
(H20) = 1.49 ms, <I> (H20) = 36 %. 
25. [TbGlu3dpqC]Na3, [Tb.4] 
Complex Tb(Glu-Et)3dpqC (CF3S03)3 (34.1 mg, 0.0189 mmol) was hydrolysed 
using a procedure identical to that described for compound 22. Amax (H20) 348 nm; 't 
26. 1-{3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine )-4, 7,1 O-tris-terl-butoxycarbonylmethyl-1 ,4,7,10-
tetraazacyclododecane 
N~ 
\ ~ 
N 
Potassium carbonate (40 I mg, 2.90 mmol) and a catalytic amount of KI were added 
to a solution of 1,4,7 -tris-tert-butoxycarbonylmethyl-l ,4,7,1 O-tetraazacyclododecane 
, 22, (299 mg, 0.580 mmol) in CH3CN (15 mI). The mixture was heated at 60°C and 
a solution of 3-chloromethyl-1 0, 11,12, 13-tetrahydrodipyrido-[3.2a:2'.J· -c]-
phenazine (223 mg. 0.580 mmo]) in CH2Cb (20 ml) was added. The reaction mixture 
was boi1cd under reflux overnight, under argon. The solution \\as filtered and the 
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salts washed with CH2Ch. evaporation of the solvent afforded the crude residue. The 
product ester was purified by chromatography on silica gel to yield a very pale 
yellow solid (gradient elution: CH2Ch to 3.3 % CH30HlCH CI R = 047 10 01 2 2, F ., 10 
CH30HlCH2Ch. (68 mg, 0.084 mmol, 15 %), m.p. 137-139°C. IH NMR (300 MHz, 
CDCh): 1.08 (I8H, s, CH3), 1.41 (9H, s, CH3), 2.05 (4H, m, HI 0, H 13), 2.25-3.58 
(28H, br m, CH2 ring, Hll, HI2), 7.68 (lH, m, H7), 7.75 (lH, m, H2), 8.76 (lH, dd, 
J = 4.2, 1.2, H6), 9.42 (lH, m, HI), 9.48 (lH, m, H8). 13C NMR (l00 MHz, CDCh): 
27.9 (CH3), 50.9-60.4 (CH2 ring), 81.6-82.7 (CH2CO), 123.6 (C2), 123.9 (C Ar), 
126.2 (C Ar), 127.7 (C Ar), 133.5 (C Ar), 133.9 (C Ar), 137.2 (C8), 137.5 (C 1), 
145.8 (C Ar), 146.4 (C Ar), 151.0 (C6), 154.2 (C Ar), 154.5 (C Ar), 160.4 (C Ar), 
172.5 (C=O), 172.9 (C=O). ). m1z (ES+): 836 (MNa +). 
27. EuD03AdpqC, [Eu.3] 
Trifluoroacetic acid (4 ml) was added to a solution of I-(3-methyl-1 0, 11,12,13-
tetrahydrodipyrido[3,2-a:2' ,3' -c Jphenazine )-4,7, I O-tris-tert-butoxycarbonylmethyl-
1,4,7,10-tetraazacyc1ododecane (33.8 mg, 0.042 mmol) in CH2Cb (2 ml). The 
mixture was stirred overnight at room temperature. The solvent was evaporated and 
the residue re-dissolved in CH2Cb for 3 times to facilitate elimination of excess acid 
and tert-butyl alcohol. The product, was checked by I H NMR to ensure complete 
ester hydrolysis, and was used for complexation immediately. IH NMR (300 MHz, 
CD30D): 2.06 (4H, m, HIO, HI3), 2.90-3.96 (28 H, br m, CH2 ring, CH::, CHrdpqC, 
HII, HI2), 8.21 (2H, m, H7, H2), 9.19 (lH, m, H6), 9.38 (lH, d, HI), 9.72 (IH. m, 
H8). The ligand was dissolved in a mixture of methanol and water (1: L 10 ml) and 
the pH raised to 5.5 by addition of aIM solution of KOH. EuCI3.6H::O (15.-+ mg. 
0.042 ITIITIOI) was added and the ITIixture heated at 90°C overnight. After being 
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allowed to cool to room temperature the pH of the mixture was raised to 10.0 using 
dilute KOH solution and the mixture further stirred for 1 hour in order to precipitate 
excess lanthanide as its hydroxide salt. The solid in the suspension was removed by 
syringe filtration and the pH of the resulting clear solution again reduced to 5.5. The 
solution was freeze-dried to yield a pale yellow solid product. 10 mg were further 
purified by chromatography on alumina for use in quantum yield determination 
(gradient elution: CH2Ch to 30 % CH30HlCH2Ch, RF = 0.33 30 % CH30HlCH2Ch), 
to give a colourless complex. Recovery was only 10 0/0. Amax (H20) 348 nm; 't (H20) 
= 1.06 ms ; <I>(H20) = 18 %. 
28. TbD03AdpqC, [Tb.3] 
TbD03AdpqC was prepared using the same quantities and followed an identical 
procedure to that desribed for the synthesis of compound 27. Amax (H20) 348 nm; 't 
29. 1,7 -Bis(benzyloxycarbonyl)-1 ,4,7,1 O-tetraazacyclododecane6 
Cyclen (5 g, 0.029 mol) was dissolved in a mixture of H20 (50 ml) and dioxane (20 
ml). Na2HP04 (14 g, 0.099 moles) was added and the pH of the solution adjusted to 
approximately 2.5 by addition of c. HCl. Benzyl chloroformate (12 g, 0.070 mol) 
was then added dropwise within 2.5 h to give a colourless, transparent solution. The 
solution was stirred at room temperature for 18 h; during this time a quantity of white 
solid precipitated from the mixture. The solvent was removed under reduced pressure 
to yield a white selni-solid. This was washed with diethyl ether (3 x 50 ml) (the 
mixture sonicated for 5 Inins). H20 (lOO ml) was added and the pH made slightly 
basic by addition of a concentrated aqueous NaOH solution. The product was 
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extracted from the aqueous mixture with diethyl ether (3 x 150 mI). The organic 
layer was dried over Na2S04, filtered and evaporated to yield the product as a 
viscous oil (0.5 g, 0.0238 mol, 82 %). M.p. 113 - 116°C. IH NMR (500 MHz. 
CDCh): 7.40 - 7.30 (m, 10H, Ph), 5.14 (s, 4H, OCH2), 3.41 (br m, 8H, NCH2), 2.95 
- 2.72 (br m, 8H, NCH2). I3C NMR (125.7 MHz, CDCh): 156.9, 156.8 (C=O), 
136.8, 136.7 (Ph(q», 128.6, 128.5, 128.1, 128.0, 127.9, 127.5 (Ph), 67.2, 67.1 
(OCH2), 51.2, 50.8, 50.7, 50.3,49.7,49.2,48.6,48.3 (NCH2). mJz (ES+) 441 (MH+), 
881 (M2H+). 
30. 1,7 -Benzyloxycarbonyl-4, 1 O-(1-(1-phenyl)ethylcarbamoylmethyl)-
1,4,7,10-tetraazacyclododecane 
CS2C03 (1.85 g, 5.67 mmol) and 2-chloro-N-[(S)-I-phenylethyIJethanamide (1.12 g, 
5.57 mmoI) were added to a solution of 1,7 -bis(benzyloxycarbonyl)-1 ,4,7, I 0-
tetraazacyc1ododecane (1.13 g, 2.58 mmol) in CH3CN (5 cm3). The mixture was 
heated at 80°C with stirring for 48 h. After the mixture had cooled the inorganic salts 
were removed by filtration and the solvent removed to yield the crude product. 
Purification by chromatography on silica (gradient elution: CH2Ch to 3 0/0 
CH30HlCH2Ch. Rf = 4 % CH30HlCH2Ch) gave the product as a solid (1.39 g, 1.79 
mmol, 69 %). M.p. 64 - 66°C. IH NMR (300 MHz, CDCh): 7.50 - 7.20 (m, 22H, 
Ph + NHCO), 5.11 (m, 2H, CH), 3.41 (br, 8H, ring CH2), 3.14 (s, 4H. NCH~), 2.73 
(br, 8H, ring CH2), 1.43 (d, 6H, J = 5.7 Hz, CH3). 13C NMR (75.4 MHz. CDC))): 
170.0 (OC=O), 156.8 (NC=O), 143.7 (Ph(q», 136.3 (CH~Ph(q», 1:28.6, 12g.). 12g.:2. 
J 27.2, 126.3. 67.3 (OCH~Ph), 59.0 (NCH2C=O), 56. I, 55.2, 54.7. 48.8. 47.6. 4(d': 
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(all CH2 ring), 48.5 (CH), 21.8 (CH3). mJz (ES+) 763 (MH+), 785 (MNa+). HRMS (+ 
mJz): [M+Ht ca1cd for C44HssN606, 763.4187; found, 763.4178. 
31. 1,7 -(1-(1-Phenyl)ethylcarbamoylmethyl)_1 ,4,7,10-
tetraazacyclododecane3 
1 ,7-Benzyloxycarbonyl-4, 1 0-( 1-(l-phenyl)ethy1carbamoylmethyl)-1 ,4,7,10-
tetraazacyclododecane (1.39 g, 1.79 mmol) was dissolved in ethanol (- 30 ml). 
Pd(OH)rC (-120 mg) was added and the mixture hydrogenated at 45 psi for 48 
hours. The solution was then filtered through celite and the solvent removed to yield 
the product (0.88 g, 1.78 mmol, 99 0/0), m.p. 140 - 143°C. IH NMR (500 MHz, 
CDCb): 7.94 (d, 2H, J = 8.5 Hz, CONH), 7.34 (d, 4H, J = 7.5 Hz, Ph(o)), 7.28 (t, 4H, 
J = 7.5 Hz, Ph(m)), 7.20 (t, 2H, J = 7.5 Hz, Ph(p)), 5.04 (m, 2H, CH), 3.27 (s, 4H, 
NCH2CO), 2.73 (s, 8H, CH2 ring), 2.64 (s, 8H, CH2 ring) 1.44 (d, 6H, J = 7.0 Hz, 
CH3). I3C NMR (125.7 MHz, CDCb): 170.4 (C=O), 143.8 (Ph(q), 128.5 (Ph(m)), 
127.1 (Ph(p)), 126.5 (Ph(o)), 60.1 (NCH2), 52.7 (CH2 ring), 48.7 (CH), 46.8 (CH2 
ring), 21.7 (CH3). mJz (ES+) 495 (MH+). HRMS (ES+) (+ mlz): [M + Nat calculated 
for C28H42N602, 495.3447; found 495.3431. 
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1-(3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2',3'_ 
c]phenazine)-4,1 0-(1-(1-phenyl)ethylcarbamoylmethyl)_1 ,4,7,10-
tetrazacyclododecane 
N~ 
\ J-J 
N 
1,7-( 1-( 1-Phenyl)ethyIcarbamoylmethyl)-I,4, 7,1 O-tetraazacyclododecane (100 mg, 
0.202 mmol), 3-chloromethyl-l 0, 11,12, 13-tetrahydrodipyrido-[3,2a:2' ,3' -c]-
phenazine (67.6 mg, 0.202 mmol) and K2C03 (27.9 mg, 0.202 mmol) were dissolved 
in CH3CN (10 ml) and refluxed for 2 days with a CaCb drying tube. The reaction 
mixture was filtered and the solvent removed to yield the crude product. Purification 
was by chromatography on alumina yielded the product as an off-white solid (54.1 
mg, 68 J.lmol, 34 %). (gradient elution: CH2Cb to 0.5 % CH30HlCH2Cb). IH NMR 
(500 MHz, CDCb): 9.56 (d, IH, J = 8.0, H8), 9.43 (d,IH, J = 8.0, HI), 8.96 (m, IH, 
H6), 8.77 (br, IH, CONH), 8.62 (br, IH, CONH), 7.84 (m, H, H7), 7.60 (d, 1 H, J = 
8.0, H2), 7.40 - 7.04 (m, 10H, Ph), 5.00 (m, 2H, CH), 3.72 - 2.22 (br m, 26H, 
NCH2CO, CH2-dpqC, CH2 ring), 2.09 (br m, 4H, CH2), 1.38 (br, 6H, CH3). 13C 
NMR (125.7 MHz, CDCb): 170.1 (C=O), 160.1 (C Ar), 155.1 (C Ar), 155.0 (C Ar), 
150.4 (C Ar), 146.2 (C Ar), 146.0 (C Ar), 144.3 (Ph( q)), 137.3 (C Ar), 137.0 (C Ar), 
134.8 (C1), 134.6 (C8), 128.5 - 128.3 (Ph(m)), 127.0 - 126.2 (Ph(o, p), 125.4 (C7), 
124.7 (C2), 61.1 (CHrdpqC), 55.8 (ring CH2), 52.8 (ring CH2), 51.4 (NCH2), 49.3 
(NCH2), 48.5 (CH), 47.1 (CH), 32.9 (CII, CI2), 22.7 (CH3), 22.6 (CIO, CI3). mJz 
(ES+) 428 (MCu)2+, 793 (MHt. 
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33. (4-Aminobutyl) carbamic acid tert-butyl ester7 
1,4-Diaminobutane (4.4 g, 0.05 mol), was dissolved in a solution of Et3N and 
methanol (10 % Et3N in MeOH, 110 ml). A solution of di-tert-butyl-dicarbonate 
(3.63 g, 0.017 mol) in methanol (10 ml) was added dropwise to the mixture with 
vigorous stirring, and the mixture was stirred at room temperature overnight. The 
methanol and Et3N were removed in vacuo to yield an oily residue that was dissolved 
in CH2Ch (100 ml) and washed with a solution of aqueous Na2C03 (2 x 100 mI). The 
organic layer was dried over anhydrous Na2S04, filtered and the solvent removed in 
vacuo. Purification by flash column chromatography gave a colourless oil (2.22 g, 
1l.97 mmol, 70 0/0) (gradient elution: CHCh to 1:10:89 NH40H:CH30H:CHCh, RF 
= 0.38 1:10:89 NH40H:CH30H:CHCh). IH NMR (300 MHz, CDCh): 4.73 (br s, 
IH, NHCO), 3.l3 (dt, 2H, CH2NH), 2.68 (t, 2H, CH2NH2), 1.41 (m, 4H, 
(CH2)2CH2NH2), l.39 (s, 9H, (CH3)3), 1.21 (s, 2H, NH2). 
34. N-(4-Chloroacetimidobutyl)-tert-butyloxycarbonamide 
H 0 -..J--OI(N~N~CI 
I 0 H 
To (4-aminobutyl) carbamic acid tert-butyl ester (2.22 g, 11.97 mmol) in 6 ml of 
CH2Ch was added NaOH (0.47 g, 11.97 mmol) in 0.6 ml H20. To the cooled 
solution was added chloroacetylchloride (1.31 g, 11.97 mmol) in 6cm3 CH::Ch whilst 
maintaining a temperature of <-10°C. After 1 h the precipitated white product which 
had formed was collected by filtration and dried under reduced pressure. The organic 
layer was washed with H20, dried over anhydrous K2C03 and the solvent removed to 
yield more of the title compound as a colourless solid (l. 73 g, 6.53 mmol, 55 0':0). 'H 
NMR (300 MHz, CDCh): 6.69 (s, 1 H, CH2NHCOCH::), 4.62 (s, 1 H. CH::NHCO~). 
4.05 (s, 2H, CH::Cl), 3.37 (q, 2H, J = 6.2, CH::NHCO::). 3.1'+ (q. 2H, J = 6.2. 
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CH2NHC02), 1.56 (m, 4H, (CH2)2CH2NHCO), 1.44 (s, 9H, (CH3)3). l3C NMR (75 
MHz, CDCh): 166.1 (C=O amide), 156.2 (C=O carbamate), 42.8 (NCH2), 40.2 
(C(q)), 39.6 (NCH2), 28.5 ((CH3)3), 27.6 (CH2), 26.7 (CH2). 
35. 1-(4-( tert-Butyloxycarbamoyl-butyl-carbamoylmethyl)_7 -(3-methyl-
10,11, 12, 13-tetrahydrodipyrido[3,2-a:2',3'-c]phenazine)-4, 10-(1-(1-
phenyl)ethylcarbamoylmethyl)_1 ,4,7,1 O-tetraazacyclododecane 
N~ 
'\ )-J 
N 
1-(3-Methyl-l 0, 11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3' -c ]phenazine )-4,10-( 1-( 1-
phenyl)ethylcarbamoylmethyl)-1 ,4,7,1 O-tetrazacyc1ododecane (54.1 mg, 6.83 x 10-5 
mol), N-( 4-chloroacetimidobutyl)-tert-butyloxycarbonamide (18.1 mg, 6.83 x 10-5 
mol), CS2C03 (22.3 mg, 68 Ilmol) and a catalytic amount of KI were dissolved in a 
mixture ofCH2Ch and CH3CN (1:1,8 ml) and the mixture boiled under reflux for 24 
hours. The salt was removed by filtration and the solvent removed in vacuo to yield 
the crude product. Purification by chromatography on alumina yielded the product as 
a glassy solid (40 mg, 39 Ilmol, 57 %). (gradient elution: CH2Ch to 0.5 0/0 
CH30HlCH2Ch, Rf = 0.47, 5 % CH30HlCH2Ch). IH NMR (500 MHz, CDCh): 9.44 
(m, 2H, H8, HI), 9.23 (m, IH, H6), 7.95 (br m, 2H, CONH), 7.72 (m, IH, H7), 7.68 
(d, IH, J = 8.5, H2), 7.16 - 6.70 (m, IIH, Ph, NHCOCH2), 4.85 (m, 2H, CH), 4.80 
(t, IH, NHC02), 4.26 - 4.00 (m, 6H, NCH2CO, CHrdpqC), 3.56 (br, 2H, NCH2CO), 
3.26 - 2.80 (br m, 24H, ring CH2, HII, HI2, C02NHCH2, CH2NHCO), 2.08 (br m, 
4H, HI 0, H 13), 1.50 (m, 4H, (CH2hCH2NHCO), 1.40 (s, 9H, (CH3h). 1.30 - 1.16 
(br, 6H, CH3)' JJ C NMR (125.7 MHz, CDCI3): 168.0 (C=O amide). 167.7 (C=O 
amide), 156.3 (C=O carbamate), 154.4 (C Ar), 152.0 (C Ar). 146.9 (C Ar). 146.3 (C 
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Ar), 143.5 (C Ar), 142.8 (Ph(q)), 137.6 (C Ar), 137.4 (C Ar), 134.l (CI), 133.2 (C8), 
128.8 - 128.3 (Ph(m)), 127.2 - 126.2 (Ph(o, p)), 124.5 (C7), 124.2 (C2), 61.6 (CH
2
-
dpqC), 56.5 (ring CH2), 55.7 (ring CH2), 50.3 (NCH2), 49.1 (NCH2), 48.5 (CH), 40.2 
(NCH2 linker), 39.1 (NCH2 linker), 32.9 (Cll, CI2), 28.6 «CH3)3), 27.7 (CH2), 26.5 
(CH2), 22.9 (CH3), 22.2 (C 1 0, C 13). m1z (ES+) 531 (MCa)2+, 542 (MCU)2+. HRMS 
(+ m1z): [M + Nat calculated for C58H7605NI2Na 1043.593; found 1043.595. 
36. 1-(4-Aminobutylcarbamoylmethyl)_7 -(3-methyl-1 0,11,12,13 
tetrahydrodipyrido[3,2-a:2' ,3'-c]phenazine)-4, 10-(1-(1-
phenyl)ethylcarbamoylmethyl)-1 ,4,7,1 O-tetraazacyclododecane 
N~ 
\ ~ 
N 
1-( 4-(tert-Butyloxycarbamoyl-butyl-carbamoylmethyl)-7-(3-methyl-I 0, 11,12,13-
tetrahydrodipyrido[3,2-a:2' ,3' -c ]phenazine )-4,10-( 1-( 1-
phenyl)ethylcarbamoylmethyl)-1 ,4,7,1 O-tetraazacyclododecane (21.5 mg, 2.11 x 10-5 
mol) was dissolved in a mixture of CH2Ch (1.5 ml) and TF A (3 ml) and was stirred 
overnight at room temperature. The solvent and acid were removed under reduced 
pressure. The residue was redissolved 3 times in CH2Ch (3 ml) to facilitate 
elimination of excess acid and tert-butyl alcohol. The crude product was taken into 
an aqueous KOH solution (1 M, 5 ml) and was extracted 3 times with CH2Ch (5 ml) 
to yield an orange oily product. (12.9 mg, 1.40 x 10-5 mol, 66 0/0). The product was 
used directly for complexation. IH NMR (300 MHz, CDCI3): 9.49 (d, I H, J = 7.8, 
H8), 9.36 (d, IH, J = 8.4, HI), 9.22 (m, IH, H6), 7.90 - 7.00 (m, 14H, H7, H2, 
CONH, Ph), 5.10 (m, 2H, CH), 4.08 (s, 2H, CHrdpqC), 3.50 - 2.32 (m. 30 H. ring 
CH 2, NCH 2CO, H II, H 12, NH 2CH2, CONHCH2), 2.10 (br m, 4H, HI 0, H 13). 1.76-
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1.14 (m, 10H, (CH2)2CHNHCO, CH3). mlz (ES+) 480 (MCa)2+, 492 (MCU)2+. 921 
(MHt, 943 (MNat. 
N~ 
\ J-J 
N 
1-( 4-Aminobutylcarbamoylmethyl)-7 -(3-methyl-l 0, 11,12,13 tetrahydrodipyrido[3,2-
a:2' ,3' -c ]phenazine )-4,10-( 1-( I-phenyl)ethylcarbamoylmethyl)-1 ,4,7,10-
tetraazacyc1ododecane (12.9 mg, 1.400 x 10-5 mol) and Tb(OTf)3.6H20 (8.49 mg, 
1.400 x 10-5 mol) were dissolved in CH3CN and mixture heated at 80°C overnight. 
After cooling, the volume of solvent was reduced to < 0.5 ml and the solution added 
dropwise to ether (~ 20 ml) with stirring. The precipitate was centrifuged and the 
solvent decanted; the solid was redissolved in CH3CN and the process repeated to 
yield the product as a pale yellow solid (20.1 mg, 1.32 x 10-5 mol, 94 0/0). mJz (ES+) 
363 (M)3+, 549 (MF)2+, 614 (MOTf)2+, 1377 (MOT6t, 1527 (MOTf3Ht. 
[TbPh2dpqC _ NH2]30Tf (20.1 mg, 1.32 x 10-5 mol) was converted to the more 
soluble chloride form by ion exchange using 'Dowex' l-X8 (Cr) standard grade ion 
exchange resin and was eluted with purite water. Preparation of the resin involved 
overnight reflux in methanol, followed by washing with 1 M HCI and with successive 
portions of H20 until the eluent had a constant pH. Removal of the water by freeze 
drying yielded the product as a pale yellow solid (13 mg, 1.14 x 10-5 mol, 86 0/0) .. mJz 
(ES+) 539 (M)2+, 549 (MF)2+. Amax (H20) 348 nm~ Tfb (H20) = 1.5 ms 
38. 
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3-Chloromethyl-1 0,11,12, 13-tetrahydrodipyrido-[3,2a:2' ,3' -c]-
phenazine-N-oxide 
CI 
A stirred solution of 3-chloromethyl-l 0, 11 ,12, 13-tetrahydrodipyrido-[3,2a:2',3' -c]-
phenazine (22 mg, 6.58 x 10-5 mol) in glacial acetic acid (1.4 ml) and H20 2 (0.4 ml) 
was heated to 65°C. After approximately 30 mins, the solution was allowed to cool 
to room temperature, diluted with distilled water (3 ml) and concentrated in vacuo. 
The dilution and concentration cycle was repeated 3 times. The residue was 
neutralised with saturated aqueous Na2C03 and extracted into CH2Ch (3 x 5 ml). The 
combined extracts were dried over anhydrous Na2S04 and the solvent removed under 
vacuum to afford a yellow-brown solid. The product was purified by column 
chromatography on alumina (gradient elution: CH2Ch to 0.5 % CH30HlCH2Ch, Rr = 
0.6, 2.5 % CH30HlCH2Ch) and was obtained as a yellow solid. IH NMR (300 MHz, 
CDCb): b 2.11 (4H, m, HI0, 13),3.24 (4H, m, Hll, 12),5.11 (2H, s, CH2Cl), 7.67 
(l H, dd, J = 8.4, 6.3, H7), 8.1 ° (l H, d, J = 8.4, H2), 8.83 (l H, d, J = 6.3, H6), 9.15 
(lH, d, J = 8.4, H8), 9.56 (lH, d, J = 8.4, HI). I3C NMR (75 MHz, CDCh): b 22.7 
(Cll, 12),33.5 (CI0, 13),47.8 (CH2), 122.2 (Ar), 123.7 (Ar), 124.2 (Ar), 126.4 (Ar), 
132.2 (Ar), 134.1 (Ar), 136.6 (Ar), 136.8 (Ar), 142.2 (Ar), 142.4 (Ar), 154.8 (Ar), 
156.0 (Ar), 157.9 (Ar). mlz (ES+) 351 (MHt· 
2()9 
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39. 1-(3-methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine-N-oxide )-4, 7,1 O-tris-( tert-butoxycarbonylmethyl)-
1,4,7,10-tetraazacyclododecane 
A stirred solution of 1-(3-methyl-IO,II,12,13-tetrahydrodipyrido[3,2-a:2',3'-
c ]phenazine )-4,7,1 O-tris-(tert-butoxycarbonylmethyl))-I ,4,7,10-
tetraazacyclododecane (32.1 mg, 3.95 x 10-5 mol) in glacial acetic acid (0.84 ml) and 
H20 2 (0.24 ml) was heated to 65°C. After approximately 30 mins, the solution was 
allowed to cool to room temperature, diluted with distilled water (2 ml) and 
concentrated in vacuo. The dilution and concentration cycle was repeated 3 times. 
The residue was neutralised with saturated aqueous Na2C03 and extracted into 
CH2Ch (3 x 5 ml). The combined extracts were dried over anhydrous Na2S04 and 
the solvent removed under reduced pressure to yield the product (26.5 mg, 3.20 x 10-
5, 81 %) which was used directly in the formation of the europium complex. "'max 
(H20) = 375 nm (cf. 348 nm for 26) 
40. EuD03AdpqC_NO, [Eu.7] 
Trifluoroacetic acid (1 ml) was added to a solution of 1-(3-methyl-l 0.11.12, 13-
tctrahydrodipyrido[3.2-a:2',3' -c ]phenazinc-N-oxidc )-4,7.1 O-tris-tcrt-
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Chapter 5 - General Experimental 
butoxycarbonylmethyl-I,4,7, 1 O-tetraazacyclododecane (12.6 mg, 1.52 x 10-5 mol) in 
CH2Cb (1 ml). The mixture was stirred overnight at room temperature. The solvent 
was evaporated and the residue redissolved in CH2Cb for 3 times to facilitate 
elimination of excess acid and tert-butyl alcohol. The product was checked by I H 
NMR to confirm the disappearance of the signal corresponding to the tert -butyl 
groups and was used for complexation immediately. The ligand was dissolved in a 
mixture of methanol and water (1: 1, 5 ml) and the pH raised to 5.5 by addition of a 1 
M solution of KOH. EuCh.6H20 (5.57 mg, 1.52 x 10-5 mol) was added and the 
mixture heated at 90°C overnight. After being allowed to cool to room temperature 
the pH of the mixture was raised to 10.0 using dilute KOH solution and the mixture 
further stirred for 1 hour. The solid in the suspension was removed by syringe 
filtration and the pH of the resulting clear solution again reduced to 5.5. The solution 
was freeze dried to yield a solid product. m1z (ES+) 833 (MNat, 849 (MKf. Amax = 
375 nm. The complex is unstable with respect to reduction. (See chapter 2.3.2.2 for 
discussion). 
41. TbD03AdpqC_NO, [Tb.7] 
Complex TbD03AdpqC_NO, [Tb.7] was prepared as for the europium analogue 40. 
Amax (H
2
0) = 375 nm. m1z (ES+) 839 (MNa+), 855 (MK+). The complex is unstable 
with respect to reduction. (See chapter 2.3.2.2 for discussion). 
42. 1-(3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine)- 4,7,1 O_tris(methyl-ethyloxyphospihnatomethyl)-
1,4,7,10- tetraazacyclododecane 
Me OEt 
" '-0 P--
(/\ 
o eN NJ 
1\ N N 
EtO;p-J LJ / 
Me 
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To a solution of 1-(3-methyl-l0,11,12,13-tetrahydrodipyrido[3,2-a:2',3'-
c]phenazine)-1,4,7,10-tetraazacyclododecane (50 mg, 1.06 x 10-4 mol) in dry THF 
(25 ml) was added methyldiethoxyphosphine (72.3 mg, 5.31 x 10-4 mol) and 
paraformaldehyde (19.9 mg) and the mixture was heated to reflux (16 h) in a Soxhlet 
apparatus, equipped with 4 A molecular sieves, under argon. After removal of the 
solvent under reduced pressure the residue was purified by column chromatography 
on neutral alumina (gradient elution: CH2Ch to 2.4 % CH30H/CH2Ch) to yield a 
yellow oil (22.1 mg, 2.66 x 10-5 mol, 25 %). IH NMR (300 MHz, CDCh): 8 l.27 
(9H, t, J = 7.2, OCH2CH3), 1.48 (9H, d, J = 14, PCH3), 2.04 (4H, br m, HI0, HI3), 
2.6 - 3.2 (22 H, br, ring CH2 and PCH2), 3.24 (4H, br m, Hll, HI2), 3.81 (2H, d, J = 
4.8, CH2dpqC), 4.10 (6H, m, OCH2CH3), 7.70 (1H, m, dpqC), 8.02 (1H, m, dpqC), 
9.22 (1H, m, dpqC), 9.43 (2H, m, dpqC). 31 p NMR (81 MHz, CDCh): 8 53.2 (3P, 
br). mJz (ES+) 435 (MCa)2+. 
43. 1-(3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine)-4,7,1 O-tris(phosphinoxymethyl)-1 ,4,7,10-
tetraazacyclododecane 
N~ 
\ ~ 
N 
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I-(3-Methyl-I 0, 11,12, I3-tetrahydrodipyrido[3,2-a:2',3' -c Jphenazine )-4,7, I 0-
tris(methyl-ethyloxyphospihnatomethyl)_1 ,4,7,1 O-tetraazacyclododecane (22.1 mg, 
2.66 x 10-
5 
mol) was dissolved in KOD (0.02 M, I ml) and the mixture was boiled 
under reflux overnight. The product was obtained following evaporation of the 
solvent under reduced pressure and was complexed immediately. Hydrolysis was 
carried out in KOD in order that the reduction could be monitored by NMR. 31 p 
NMR (81 MHz, D20): 037.7 (3P, br). 
44. TbPMe3dpqC, [Ln.8] 
I-(3-Methyl-1 0, 11,12, I 3-tetrahydrodipyrido[3,2-a:2',3 , -c Jphenazine )-4,7,10-
tris(phosphinoxymethyl)-1,4,7,10-tetraazacyclododecane (19.9 mg, 2.66 x 10-5 mol) 
was dissolved in a mixture of methanol and water (l: I, 3 ml) and the pH raised to 5.5 
by addition ofa I M solution ofKOH. Tb(OAc)3.xH20 (15.3 mg) was added and the 
mixture heated at 90°C overnight. After being allowed to cool to room temperature 
the pH of the mixture was raised to 10.0 using dilute KOH solution and the mixture 
further stirred for 1 hour. The solid in the suspension was removed by syringe 
filtration and the pH of the resulting clear solution again reduced to 5.5. The solution 
was freeze dried to yield the solid product. Amax (H20) 348 nm; 't (H20) = 2.90 ms : 
45. 1,4,7 -tris(Trifluoromethylcarbonyl)-1 ,4,7,10-
tetraazacyclododecane8 
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Ethyl trifluoroacetate (16.5 g, 13.8 ml, 0.12 mol) was added dropwise to a solution of 
cyclen (5g, 0.029 mol) and triethylamine (4.04 ml) in dry MeOH (25 ml) cooled to 
O°C. The reaction mixture was stirred at room temperature under argon for 4 hours. 
The solvent was removed in vacuo. The residue was purified by column 
chromatography on silica (CH2Ch to 50/0 MeOH) to give the product as a white solid 
(11.7 g, 0.025 mol, 86%). M.p. 77 - 80°C. IH NMR (300 MHz, COCh): 82.96 (4 H, 
m, NCH2), 3.55 (8 H, m, NCH2), 3.91 (4 H, m, CH2). I3C NMR (75 MHz, COCh): b 
43.26-52.91 (NCH2), 116.21 (q, CF3, JCF = 210),157.12-157.96 (m, CO). 19F NMR 
(188 MHz, CDCh): b -69.36 (m, CF3) . mlz (ES+) 483.3 (MH+). 
46. 1-tert-Butoxycarbonyl-4,7, 1 O-tris(trifluoromethylcarbonyl)-
1,4,7,10-tetraazacyclododecane9 
Oilerlbutyl dicarbonate (1.42 g, 6.51 mmol) was added to a solution of 1,4,7-
tristrifluoroacetyl-I ,4,7, 10-tetraazacyclododecane (2.0 g, 4.34 mmol) and triethyl 
amine (0.3 ml) in dry MeOH (20 ml). The reaction mixture was stirred under argon 
at room temperature for 24 h after which further ditertbutyl dicarbonate (1.0 g) was 
added. Further additions of ditertbutyl carbonate (1.0 g) were made after 48 and 72 
hours. The reaction was carried out over the period of 100 hours. The solvent was 
relnoved in vacuo. The residue was purified by colmnn chromatography on silica 
(CH~Ch to 7% ethyl acetate/CH2Ch. RF = 0.56, 10 % ethyl acetate/CH2CI~) to gin? 
the product as a white solid (540 lng, 0.96 mInot Ilo"~). M.p. 119 - 122°(. IH N\lR 
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(300 MHz, CDCh): 8 1.47 (9 H, s, C(CH3h), 3.20-3.95 (16 H, bm, NCH2). 13C NMR 
(75 MHz, CDCh): 8 27.98 (CH3), 48.54-50.70 (NCH2), 81.04 (C), 116.03 (q, CF-" 
JCF = 210), 156.67-158.70 (m, CO). 19F NMR (188 MHz, CDCh): 8 -69.70 (m, CF3) 
. mlz (ES+) 583.3 (MH+). 
47. 1-tert-Butoxycarbonyl-1 ,4,7,1 O-tetraazacyclododecane 10 
Solution of KOH (2M, 6ml) was added to a solution of 1,4,7 -tristrifluoroacetyl-I 0-
tectbutoxycarbonyl-l,4,7,10-tetraazacyc1ododecane (3.0 g, 5.35 mmol) in a mixture 
of MeOH (30 ml) and water (12 ml). The reaction mixture was stirred at room 
temperature under argon for 8 hours. The solvent was removed in vacuo. The residue 
was dissolved in CH2Ch and washed with concentrated Na2C03 and NaCl solutions 
respectively. The organic phase was dried with K2C03 and solvent was removed in 
vacuo to yield the product as a colourless oil. (1.0 g, 690/0). IH NMR (300 MHz, 
CDCI3): 8 1.39 (9 H, s, C(CH3)3), 2.64 (4 H, t, J = 4.5, NCH2), 2.74 (8 H, q, J = 5.4, 
NCH2), 3.35 (4 H, t, J = 5.4 Hz, NCH2). mlz (ES+) 273.3 (MH+). 
48. Benzyl diethoxyphosphine 
A solution of diethoxychlorophosphine (5.0 g, 31.9 mmol) in dry Et20 (50 ml) was 
added dropwise to a solution of benzyl magnesium chloride in Et20 (I M, 32 ml), 
cooled to -15°C. The reaction mixture was warmed up and heated to reflux overnight. 
The reaction mixture was filtered and solvent was removed by distillation. The 
residue was purified by vacuum distillation (0.15 mbar, 52-56°C) to yield the product 
as a colourless liquid (2.5 g, 37 0/0). IH NMR (300 MHz. CDeh): 8 1.22 (6 H. t. J = 
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7.2, CH3), 2.98 (2 H, d, J = 3.9, CH2), 3.89 (4 H, m, OCH2), 7.24 (5 H, m, Phenyl). 
31 p NMR (120 MHz): 8 171.01. 
49. 1,4,7 -tris(Ethoxybenzylphosphinylmethyl)_1 O-tert-
butyloxycarbonyl-1 ,4,7,1 O-tetraazacyclododecane 
Benzyl diethoxyphosphine (1.4 g, 6.6 mmol) was added to a mixture of I-tert-
butyloxycarbonyl-l,4,7,10-tetraazacyclododecane (0.4 g, 1.47 mmol) and 
parafonnaldehyde (0.3 g) in dry THF (23 ml). The reaction mixture was heated to 
reflux for 8 hours. The reaction mixture was filtered and the solvent was removed in 
vacuo. The residue was purified by column chromatography on alumina (CH2Cb to 
6% CH30HlCH2Cb) to yield the product as a colourless oil (0.3 g, 240/0). IH NMR 
(300 MHz, CDCh): 8 1.18 (9 H, ill, CH3), 1.39 (9H, s, C(CH3)3), 2.60-3.80 (28 H, m, 
NCH2,PCH2), 3.95 (6 H, ill, OCH2), 7.30 (15 H, ill, Phenyl). 31 p NMR (120 MHz): 8 
50.31 (P). (ES+) 883.4 (M+Na +). 
50. 1,4,7 -tris(Ethoxybenzylphosphinylmethyl)-1 ,4,7,10-
tetraazacyclododecane 
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Chapter 5 - General Experimental 
A solution of 1,4,7 -tris( ethoxybenzylphosphinylmethyl)-1 O-tert-butyloxycarbonyl-
1,4,7,10-tetraazacyclododecane (450 mg, 0.523 mmol) in CH2Ch (10 ml) and TFA 
(20 ml) was stirred at room temperature under an argon atmosphere overnight. The 
solvent was removed in vacuo. The residue was dissolved in CH2Ch (30 ml) and 
saturated Na2C03 solution (30 ml). The product was extracted into CH2Ch (3 x 30 
ml). The combined organic extracts were dried over K2C03, filtered and the solvent 
removed in vacuo to give the product as a pale brown oil (330 mg, 0.434 mmol, 
83%) which was used directly in the next step. IH NMR (300 MHz, CDCb): 8 1.18 
(9 H, m, CH3), 2.60-3.40 (28 H, m, NCH2, PCH2), 3.90 (6 H, m, OCH2), 7.25 (15 H, 
m, phenyl). 3lp NMR (120 MHz): 851.45 (P). mlz (ES+) 761.3 (MH+). 
51. 1-(3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine)-4, 7,1 O-tris(ethoxybenzylphosphinylmethyl)-1 ,4,7,10-
tetraazacyclododecane 
Bn OEt 
, '-0 p-
(/\ 
o eN NJ 
EtO-'p-JN N~ / L..J I Bn 
N::/\ 
'\ );-J 
N 
1,4,7 _tris(Ethoxybenzylphosphinylmethyl)-I,4, 7,1 O-tetraazacyc1ododecane (100 mg, 
1.31 x 10-4 mol), 3-Chloromethyl-l 0,11,12, 13-tetrahydrodipyrido-[3,2a:2',3' -c]-
phenazine (44.0 mg, 1.31 x 10-4 mol), CS2C03 (51.3 mg, 1.57 x 10-4 mol) and a 
catalytic quantity of KI were dissolved in CH2Ch/CH30H (1: 1, 10 ml); the mixture 
was heated at 60°C overnight. The reaction mixture was filtered and the crude 
product following removal of the solvent under reduced pressure. The product was 
purified by column chromatography on alumina (gradient elution CH2Ch to 1 0/0 
-5 I 47 01.) IH NMR (300 CH30HlCH2Ch) as a brown oil (64.7 mg, 6.11 x 10 tnO, 0 . 
MHz, CDCh): 8 I H NMR (300 MHz, CDCh): 8 1.04 (6H. tn. OCH 2CH)). 1.13 (3 H, 
t J = 7.2, OCH
2
CH3), 2.05 (4H, br tn, HIO, H13). 2.60 - 3.40 (26 H, br, ring (,H2. , 
PCH:: and HII, HI2), 3.40 - 4.20 (8H, tn, CH::dpqC. OCH::CH'). 7.70 (IH, 111, 
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dpqC), 8.04 (IH, m, dpqC), 9.22 (IH, m, dpqC), 9.43 (2H, m, dpqC). 31 p NMR (120 
MHz): 8 49.0 (2P), 51.2 (IP). HRMS (+ mlz): [M + Ht calculated for 
C57H7406N8P3, 1059.4936; found, 1059.4938. 
52. 1-{3-Methyl-1 0,11,12, 13-tetrahydrodipyrido[3,2-a:2' ,3'-
c]phenazine )-4,7,1 O-tris{benzylphosphinoxymethyl)-1 ,4,7,10-
tetraazacyclododecane 
N~ 
\ J-J 
N 
1-(3-Methyl-l 0, 11,12, 13-tetrahydrodipyrido[3,2-a:2',3' -c ]phenazine )-4,7,10-
tris(benzyl-ethyloxyphosphinatomethyl)-1 ,4,7,1 O-tetraazacyclododecane (64.7 mg, 
6.11 x 10-5 mol) was dissolved in HCI (6 M, 1 ml) and the mixture was boiled under 
reflux overnight. The product was obtained following evaporation of the solvent 
under reduced pressure and was complexed immediately. Attempts were made to 
monitor the reaction by 31 P NMR, but the ligand became very insoluble upon 
hydrolysis and was therefore used for complexation imediately. 
53. EuPBn3dpqC, [Eu.9] 
N~ 
\ J-J 
N 
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I-(3-Methyl-I 0, 11,12, 1 3-tetrahydrodipyrido[3,2-a:2',3 , -c ]phenazine )-4,7,10-
tris(benzylphosphinoxymethyl)-I ,4,7,1 O-tetraazacyc1ododecane (25.0 mg, 2.6 x 10-5 
mol) was dissolved in a mixture of methanol and water (1: 1, 10 ml) and the pH 
raised to 5.5 by addition of aIM solution ofKOH. EuCh.6H20 (9.52 mg, 2.6 x 10-5) 
was added and the mixture heated at 90°C overnight. After cooling, a considerable 
quantity of solid was apparent in the reaction mixture. The solvent was removed 
under reduced pressure; the residue was very insoluble in all but a 1: 1 mixture of 
CH2Ch and CH30H under high dilution. The complex solution was filtered to 
remove insoluble salts. Characterisation proved very difficult given the poor 
solubility of the complex. A I H NMR spectrum was obtained in a 1: 1 mixture of 
CDCl3 and CD30D. Amax (H20) 348 nm; 't (H20) = 1.14 ms, T (D20) = 1.69 ms. I H 
NMR (300 MHz, CDCh) partial assignement: 8 25.0 (lH), 25.8 (l H), 34.0 (I H), 
36.1 (1 H) assigned as the four most shifted axial cyclen protons, suggestive of one 
main Isomer in solution at ambient temperature. See chapter 2.4.1.2 for a full 
discussion. 
54. TbPBn3dpqC, [Tb.9] 
Complex TbPBn3dpqC, [Tb.9], was prepared in an analogous manner to that 
described for complex 53. Amax (H20) 348 nm; 't (H20) = 1.13 ms, 't (D20) = 1.80 
ms. See chapter 2.4.1.2 for a full discussion. 
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